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Abstract
The metabolism of two terpenoid food flavours, linalool. and linalyl 
acetate, has been studied in the rat.
14Linalool was labelled with C in the 1- and 2-positions and 
administered intragastrically to rats; absorption from the gut was 
rapid. Approximately 58% of the dose was recovered in the urine within 
72 hours as linalool, dihydrolinalool and tetrahydrolinalool, mainly 
conjugated with, glucuronic acid or sulphate. Some radioactivity in 
the urine (101 of dose) was present as ^C-urea, and 25% of the label 
appeared as ^ ’002 in expired air, indicating that linalool entered into 
pathways of intermediary metabolism. A small proportion of the dose was 
excreted in the faeces as free and conjugated linalool and as its 
reduction products.
The reduction products of linalool were shown to arise by metabolism 
occurring in the gut microflora. Both the liver and the intestinal 
mucosa were shown to conjugate linalool with glucuronic acid in vitro 
but the activity was much higher in the liver.
After intraperitoneal administration of linalool a substantial 
proportion was excreted as conjugates in the bile and these were hydrolysed 
in the gut with resultant enterohepatic circulation of linalool and its 
metabolites.
Linalyl acetate was readily hydrolysed in the gut and was subsequently 
metabolised similarly to linalool.
Studies of the effects of linalool on the hepatic drug metabolizing 
enzymes showed that repeated daily intragastric doses (500 mg/kg body wt.)were 
required before significant effects on these enzymes were observed. Dosing
(i)
for up to 64 days caused hepatomegaly with a transient increase of 
DNA concentration suggestive of hyperplasia as well as cell hypertrophy. 
Methylumbelliferone glucuronyltransferase activity was increased within 
7 days whereas cytochromes P-450 and underwent a biphasic response 
being initially inhibited and subsequently increased in concentration.
Linalool was shown to interact 'with cytochrome P-450 in vitro 
producing a reverse type 1 binding spectrum (K = 1.9 x 10 ’M) and to
_3
inhibit biphenyl-4-hydroxylase (10 = 1.9 x 10 M). The observed changes 
in vivo are indicative of an adaptive response to this mild inhibitor 
but sensitivity to carcinogens may be increased during the period of 
hyperplasia.
Studies of the metabolism of linalool by the intestinal microflora 
of rat, mouse, guineapig, sheep, cow and human, revealed substantial 
interspecies differences. Inter-individual differences in humans 
appeared to depend on diet. Analysis by GC/MS, i.r. and n.m.r. showed 
reduction products to be the most common metabolites in most species but 
a novel intestinal reaction involving cyclisation of linalool to 
a-terpineol and y”teipinolene was also observed in some species.
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CHAPTER 1 
General Introduction
1
INTRODUCTION
In order for food to be acceptable to the consumer it must possess 
desirable organoleptic properties, namely, an attractive appearance, texture 
and flavour. All of these properties are of considerable importance but 
even if a food looks ’right* it will not be eaten if the consumer does not 
find the flavour acceptable. There are, of course, no universally agreed 
standards of what constitute an acceptable flavour and wide cultural 
variation occurs. However, there is an increasing internationalization of 
eating habits as instanced by the increasing acceptance of oriental cuisine 
in Europe, and the substitution of bread for rice in the Orient.
Traditionally man has for many centuries used herbs and spices in food 
both to add flavour interest and to mask unpleasant off-flavours. The 
practice of using food flavours has been continued in industrialized food 
production and is likely to be of increasing importance in imparting an 
acceptable flavour to novel food materials such as spun or texturised 
vegetable protein, leaf protein, fish meal or single cell protein. There is 
a history of resistance to the acceptance of novel foods unless they can be 
made to resemble traditional foods in appearance, texture and flavour and 
the application of food additives of both natural and synthetic origin to 
achieve this seems inevitable. While herbs and spices have been and are still 
major sources of food flavours, they possess certain disadvantages to the 
commercial food processors, viz:
(a) They have a weak flavour intensity and considerable quantities
need to be used.
(b) They are very variable in composition depending on the variety,
strain and growing conditions.
(c) They are periodically in short supply leading to wide price
fluctuations.
In order to overcome these disadvantages and to enable the food manufacturer
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to produce a standardized product, use is widely made of extracted and 
blended essential oils from traditional sources or of synthetic flavours 
which may or may not have natural counterparts. At present essential oils, 
or plant materials containing them, remain the most widely used food 
flavours to which man is exposed and we are largely ignorant about the 
consequences of this exposure. It is not only in foods and beverages that 
man is exposed to essential oils, since they are also widely used in perfumes, 
toiletries, cosmetics, aerosols ’air freshners', pharmaceuticals, tobacco, 
furniture polishes and many other applications. They may be ingested, inhaled 
or absorbed through the skin, and the fact that they are of natural origin 
and have been used for centuries is no guarantee of their safety, of course. 
Oil of sassafras and coumarin are examples of naturally occurring compounds 
long used to flavour foods which have subsequently been shown to be 
unacceptably toxic and which therefore no longer have GRAS status.
Further work on other natural flavours and aromatics would seem to be 
of importance.
Composition of essential oils
The most important aromatic constituents of plant essential oils are 
the monoterpenes and their oxygenated derivatives, terpenoid alcohols, 
aldehydes and ketones. Alicyclic hydrocarbons, e.g. myrcene, ocimene and 
cyclic hydrocarbons like limonene, a-pinene, etc. are frequently major 
constituents of essential oils of citrus fruits, herbs and spices. Carbonyl
compounds are commonly encountered, e.g. - citral, citronellal,carvone and
A
dihydrocarvone in caraway, cloves, spearmint, etc. Terpene alcohols are 
important constituents of many oils, e.g. citronellol in citrus oils and 
menthol in mint oils. Linalool and linalyl acetate, the compounds,studied in 
this thesis, occur in a wide range of oils including cardamom, cinnamon, 
coriander, laurel leaves, nutmeg, spearmint, sweet basil and thyme essential 
oils. They are used in synthetic food flavours, in perfumary and other 
non-food applications.
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Toxicology of essential oils and terpenoid compounds
In view of the wide applications of essential oils and their components, 
surprisingly little is known of their toxicology but the acute-toxicity 
of any of them appears to be low (Jenner, et al, 1964). • There are a number 
of reports, however, which indicate that one cannot feel conplacent about 
the chronic toxicity and carcinogenicity of these compounds.
Over 30 years ago, Mackenzi, et al^(1941) reported that terpentine oil 
and 1-pinene, its major constituent, were promoters of skin tumours in the 
rabbit when applied topically.This report was substantiated by Salaman (1961) 
who reported that application of citrus oils,, eucalyptus and linseed oil caused 
epidermal hyperplasia in mice; activity in orange oil appeared to reside 
mainly in the terpene hydrocarbon fraction. Tumour promoting activity was 
reported for these terpene fractions but negative results were obtained with 
terpeneless fractions. Roe, et al^(1960) and Roe and Field (1965) have 
also reported that citrus oils are skin tumour promoters in mice but it 
remains to be seen whether the terpenes can produce or promote tumours in other 
tissue like the lung or gastrointestinal tract after chronic inhalation or 
injestion.
While the non-oxygenated terpenes appear to be responsible for the tumour 
promoting effects reported above, adverse reactions to a number of oxygenated 
terpenes have also been reported. Thus, Leach, et al«^ (1956) reported that 
citral caused lesions of the vascular endothelial cells when administered to 
rabbits orally or subcutaneously at dose levels of 5yg/kg per day for 3 Weeks. 
Similar lesions were observed in monkeys exposed to doses as low as 1 yg/kg/d 
for the same period. Since this condition could be prevented by vitamin A, 
it was suggested that citral might compete with retenene in the metabolism of 
the endothelial cells and these observations raise the question whether 
excessive consumption of citrus fruit beverages and marmalades might be 
involved in the aetiology of the cardiovascular disease. In contrast to these 
results, Benkos (1961) reported that terpenes inhibit the devebpment of
atherosclerotic plaques in rabbits receiving a diet rich in cholesterol.
The short-term toxicity of the terpenoid cyclic ketone, carvone was
studied in the rat by Hagan (1966) who reported growth depression in both
sexes at levels of 1000 ppm in the diet with testicular atrophy in males
receiving 10,000 ppm. The levels are of course, much higher than are likely
to be injected by man and problems of acceptability of diets containing such
high concentrations of flavours may have contributed to the observed growth-
depression. More serious-toxicity was reported for isobomeol acetate by
Gaunt, et alp(1971) who observed renal toxicity in rats receiving 90 mg/kg/d
for 13 weeks with liver damage at higher dose levels. The no effect level was
concluded to be 15 mg/kg/d which was stated to give a safety margin of over
one-hundred-fold the likely maximum daily intake in man but it is not clear
whether the calculation of this safety margin included likely exposure from
the many non-food applications mentioned earlier.
The fragmentary information on the toxicity of terpenes in experimental
• animals is supplemented by several reports of adverse reactions in humans.
Early work on skin sensitivity to terpenes (Hellstrom, et al«, 1953; Pirila
and Pirila, 1955, 1956, 1958, 1964) indicated that hydroperoxides of a number
of terpenes, particularly carene, are eczematogenic in man, which explained
■ %
a number of adverse reactions to industrial exposure to terpenes, and 
N u e y r 3d(1967) found that workers in a Shoe-polish factory inhaling (+)a-pinene 
developed erythema, pruritis, neurological disorders, macrohaematuria 
and methaemoglobinaemia.
It is not only industrial exposure to terpenes and terpenoids which has 
been reported to cause a toxic response in man since heavy smoking of 
mentholated cigarettes was reported to cause psychological disorders and 
gastrointestinal symptoms (Luke, 1962).
Pharmacological properties of essential oils
Essential oil,herbs and spices have long been used in folk-medicine and 
herbal remedies and examination has revealed a scientific basis for some of
5
these practices.
A number of essential oils,notably the oils of cloves and thyme , have 
been reported to have fungicidal and bacteriostatic properties (Olcazki and 
Oshima, 1952; Parry, 1969) and oil of caraway is used in the treatment of 
scabies.
In a review of pharmacological properties of essential oils, Tucavon 
(1960) noted that oils of mint, basil, lavender, caraway, fennel and 
martricaria have an antispasmodic action on smooth muscle. Oils of cinnamon 
and cassia are stated to have carminative and stimulatory properties (Pany,
1969). Camphor a constitutent of many oils, in low doses has a stimulatory 
effect on the central nervous system while menthol in high doses appears to 
be a CHS depressant (vide Supra) . Oil of matricaria is reported to have 
antispasmodic and local anaesthetic properties in addition to antimicrobial 
properties (Tucanov, 1960). Its ingestion increases the number of 
circulating leucocytes up to three fold and its anti-inflammatory properties 
have been claimed to be due to azulene content, principally chamazulene and' 
guaiazulene.
While the observed pharmacological effects may suggest useful pharmaceutical 
applications for essential oils, it is to be expected that at higher than 
therapeutic dose levels adverse and possibly toxic side effects may occur.
Many essential oils are used as adjuvants in pharmaceutical preparations and 
this adds to the total human exposure from the other sources mentioned earlier 
but little is known about the effects of this exposure. Synergistic or 
antagonistic effects on the pharmacological and/or toxic effects of drugs and 
other environmental compounds might occur directly or due to effects on the 
mammalian drug metabolizing enzymes. In view of this and the known hazardous 
interactions between some drugs and dietary constituents (monoamine oxidase 
inhibitors and tyramine) the consequences of increased environmental exposure 
to essential oils and their use in pharmaceutical preparations along with
other drugs warrants closer investigation.
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Detoxication mechanisms
Ingestion of low doses of potentially toxic compounds does not 
necessarily result in a toxic response. Detoxication of such compounds may 
occur by specific enzymic mechanisms and it would be expected that these 
might have evolved, at least in herbivores and omnivores, to detoxicate 
dietary terpenoid compounds.
The metabolism of foreign compounds may be considered as occuring in two 
phases based on the nature of the reactions talcing place (Williams, 1970). In 
both phases the compound is made more polar to facilitate excretion. In the 
first phase the compound undergoes reactions classified as oxidations, 
reductions and hydrolysis by which the compound requires suitable polar groups 
for subsequent phase II conjugation reactions, which are essentially synthetic 
in nature. For example the major pathways of metabolism of lipid soluble 
benzene consists firstly of its oxidation to phenol and in the next step the 
phenol is conjugated with glucuronic acid via its hydroxyl group to foim 
phenyl glucuronide which is a fairly strong acid, soluble at physiological pH 
values, and is readily excreted by the kidney.
C6H6 Phay  1 -----> C6H50H phase II  ^ C6H50 . C6H906
b oxidation b conjugation '■ b
Typical Phase I reactions are classified in table 1.1 and the major routes of 
conjugation are listed in table 1.2.
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*Table 1.1 Typical Phase I Reactions
Chemical
reaction
Microsomal drug 
metabolising enzymes
Non-micros omal 
mammalian enzymes
Oxidation
(oxygenation)
Aromatic hydroxylation 
Acyclic hydroxylation
Alcohol oxidation
(cytoplasm)
Aldehyde oxidation 
(cytoplasm)
Alicyclic hydroxylation Alicyclic Aromatization
Epoxidation
N-oxidation
S-oxidation
Desulphurat ion
Dealkylation
Deamination Deamination
(Mitochondria & plasma)
Reduction Nitroreduction Reduction of sulphoxides 
and N-oxides (cytoplasm)
Azoreduction 
Dehalogenation
Reduction of 
Disulphides
Hydrolysis Ester hydrolysis Hydrolysis of esters and 
amides (blood plasma)
Hydrolytic ring scission
Dehalogenation (cytoplasm
* From Parke (1968)
*Table 1-.2 Types of conjugation for animals
Conjugate Major target groups Deficient species
1. Glucuronic acid
conjugation
2. Sulphate conjugation
3. Glycine conjugation
Ornithine conjugation'
. IGlutamine conjugation
4. Acetylation
5. Mercapturic acid
synthesis
6. Methylation
-OH, -COOH, -NH2, >NH, -SH Cat, Gunn rat
aromatic-OH, aromat ic-NH2, 
some alcohols
aromtic-COOH,
aromatic-alkyl-COOH
aromatic-COOH
aromatic-CH2-C0QH
aromatic~NH2 
some aliphatic~NH2 
hydrazides, S02NH2
aromatic hydrocarbons, -Cl, 
~Br, -F, -N02
aromatic OH, NH2, >NH,
-SH
Pig
Certain birds and 
reptiles
Most
Most
Dog
Guinea pig, Man
Certain birds and reptiles only.
Man and certain monkeys only.
* From Mandel (1971)
Phase I reactions
Site of reactions: The enzymes which carry out oxidations, reductions
and hydrolysis of foreign compounds, after absorption, are those which occur 
predominantly in the liver,, although some activity is also found in kidney, 
gastrointestinal tissue and to a lesser extent in the lungs, adrenals and 
blood. Most of these reactions are carried out by the enzymes located in the 
hepatic endoplasmic reticulum (enzyme of the microsomal mixed function oxidase). 
The alcohol dehydrogenase in the soluble fraction and amine oxidase in the 
mitochondria also catalyse phase I reactions to a certain extent.
Microsomal oxidation
Microsomal oxidation has a specific requirement for NADPH and O2 and is 
catalysed by enzyme systems known as mixed function oxidases. During the 
process one molecule of oxygen per molecule of substrate is consumed with 
one atom of oxygen appearing in the product and the other undergoing an 
equivalent reduction and appearing in water.
Mixed function oxidase activity appears to depend on the haemoprotein, 
-cytochrome P-450, so-called because the reduced form of this enzyme binds 
carbon monoxide with the formation of a peak in the absorption spectrum at 
450 nm (Omura and Sato, 1964). The mechanism by which oxidation of the 
substrate occurs is given in Fig.1.1
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P-4503
P-4503
I
s cyt c k—  
reductase
NADPH
0  2U
s
I
P- 4503
V/.
o|
cyt b5 ■cyt b5 
reductase
f
NADH
Fig. 1.1 Scheme for cytochrome P-450 drug oxidation (Hildebrandt and
Estabroolc, 1971).
Components of the hepatic drug metabolizing enzymes
A. Terminal oxidase: cytochrome P-450
The terminal oxidase in the microsomal electron transport chain is a 
haemoprotein having iron porphyrin as the prosthetic group. It is found in 
hepatic microsomes and also in the microsomes and mitochondria of the adrenal 
cortex (Estabrook, et al, 1963; Omura, et al, 1965a) and to a lesser extent 
in the kidney and intestinal mucosa (Takesue, et al, 1965). Yohro and Horie 
(1967) reported that mitochrondria of the corpus luteum also contains 
this haemoprotein.
Evidence for the involvement of cytochrome P-450 in drug metabolism
Cooper, et alr3(1965) observed that carbon monoxide had an inhibitory 
effect on the metabolism of certain drugs, e.g. codeine, monomethylaminopyrine 
and acetanilide and reversal of this inhibition could be effected by irradiating 
with light of .the same spectral characteristic as the carbon monoxide complex 
of cytochrome P-450.
Cyanide does not bind with cytochrome P-450 and is not an inhibitor of 
drug metabolism (Cooper and Brodie, 1955; Gillette, 1957) whereas carbon 
monoxide form a complex with P-450 and inhibits drug metabolism.
Posner, et alp (1961) and Gillette, et ak^(1957) have shown that substances 
such as deoxycholate , steapsin and snake venom which convert cytochrome P-450 
to the inactive foim cytochrome P-420 also destroy the drug metabolizing 
activity of the microsomes. Gillette (1966) and Silverman and Talalay (1967) 
reported the detergents Triton N-101 and iso-octylphenoxypolyethoxy-ethanol 
could partially solubilize lives*microsomes and have the ability to inhibit 
the rate of drug metabolism in direct proportion to the conversion of 
cytochrome P-450 to cytochrome P-420.
The parallel increase in the ratio of drug metabolism and cytochrome 
P-450 levels during the administration of phenobarbital and 3-methylcholanthrene 
and their parallel decrease ' to normal values after withdrawal of the drugs
led Sladek and Mannering (1968) to conclude that cytochrome P-450 is the
necessary component for drug metabolism. The implications of cytochrome P-450
‘ in drug metabolism, was also demonstrated by employing the inhibitors like
SKF 525A. Imai and Sato (1966) reported that the kinetics of binding of
aniline with oxidized cytochrome P-450 was similar to the kinetics of
hydroxylation of aniline by the same microsome (K = K = 2-3 nM in rabbit
liver microsomes). These workers therefore suggested that cytochrome P-450
is involved as the oxygen activating enzyme in the drug hydroxylation.
Binding to drugs of P-450
Remmer, et al (1966) and Schenkman, et ahj(1967) reported that there
are at least two types of P-450-drug complexes. The drugs ethylmorphine,
amidopyrine, hexobarbitone and most other drugs interact with cytochrome P-450
and cause a spectral change characterised by the appearance in the difference
spectrum of an absorption peak at 388 nm and a trough at 420-2 nm. The
second group of compounds, basic amines such as aniline, antipyrine,
nicotinamide, are known to cause type II interactions characterized by the
appearance of a peak at 430 and trough at 390.
A third type of spectral change known as Reverse Type I (RI) characterised
by a trough at 390 nm and a peak at 420 nm has been reported by Schenkman et ah,
' %
(1972). The substrates which cause RI type interactions are usually the 
short chain alcohols (methanol, ethanol, butanol ) and phenacetin.
Schenkman and Sato (1968) reported that type I binding spectra are 
caused by interaction of the substrates with the haem moiety of the haemoprotein 
with the modification of an existing ligand of the haem to the protein. A 
wide range of compounds including drugs, mentioned above, fatty acids and 
steroids show type I interactions with cytochrome P-450 and all these drugs 
appear to be substrates of this enzyme (Ellin, et al.',' 1971).
The compounds causing type II spectral changes react with both the 
ferricytochrome P-450 (absorption spectrum 419 nm) and substrates bound 
haemoprotein (394 nm peak) as determined in the absolute spectrum, by
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Remmer, et al^ i(1969) and in the difference spectrum by Schenkman, et al^
(1970). Omura and Sato (1964) reported that type II compounds interact at 
the haem iron from the evidence that type II compounds, aniline and isocyanide 
displace carbon monoxide from the reduced cytochrome P-450.
Schenkman, et ah, (1972) have suggested that reverse type I spectral 
change is due to interaction of lipid soluble compounds with the substrate 
bound form of cytochrome P-450 at a site other than type I. Both free and 
endogenous substrate bound formsof P-450 exist in the liver microsomes. 
Schenkman, et ah3(1969) also suggested that type I spectral change in both 
absolute and difference spectra was .due to displacement. of some pre-existing 
substance, bound in vivo, from the enzyme.
B. Cytochrome Pi-450
An observation that phenobarbital induced the metabolism of a much 
larger number of drugs and other foreign compounds than did 3-methylcholanthrene 
or 3,4 benzpyrene, or other polycyclic hydrocarbons (Mannering, 1968) led to 
the assumption that two different inductive processes are involved (Mannering, 
1968). It was concluded that polycyclic hydrocarbons cause synthesis of a 
modified P-450. Imai and Siekevitz (1971) suggested that cytochrome P-450 
and Pi"450 are interconvertible and are the physical modification of the 
same enzyme system although Comi and Gaylor (1973) have reported these to be 
different entities based on the evidence of the analysis of the soluble
cytochrome P-450 with ion exchange resin chromatography.
C. Reductases
NADPH Cytochrome c Reductase
Gillette (1966) suggested that NADPH cytochrome c reductase might be 
a component of the microsomal electron transport system. His assumption was 
based on the fact that the electron receptor cytochrome c and other electron 
acceptors inhibited microsomal drug metabolizing enzymes. As there is no 
cyctochrome c present in the microsomes and since there is no other known 
natural substrate for the reductase in these organelles, NADPH cytochrome c 
reductase is considered to play a role in the transfer of electrons from
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NADPH to cytochrome P-450 across the microsomal electron transport chain 
(see Fig.l).
NADPH Cytochrome P-450 Reductase 
The implication of this enzyme in the microsomal electron transport 
chain was demonstrated by Gigon, et al (1969). . They demonstrated that carbon 
monoxide forms a complex with cytochrome P-450 in a microsomal suspension 
that contained NADP and an electron generating system but not with oxidized 
cytochrome P-450. Gillette and Gram (1967) and Gillette (1969) in a variety 
of experiments have shown that the rate of drug metabolism more closely 
related to the rate of reduction of cytochrome P-450 than the total amount 
of cytochrome P-450. Gillette’s group thus concluded that NADP-cytochrome 
P-450 reductase is rate-limiting in the overall reaction involving microsomal 
drug metabolism.
D, Non-haem iron protein
Adrenodoxin, a non-haem iron protein, in presence of adrenodoxin reductase 
and NADPH caused reduction of cytochrome P-450 in submicrosomal liver particles. 
Omura, et al (1966); Kimura and Suzuki (1967) have shown that adrenodoxin is 
a component of the electron transport system for the hydroxylation of steroids 
by the adrenal microsomes and mitochondria and because of the similarity of 
the microsomal hydroxylase systems of the adrenal and liver, it has been 
assumed that adrenodoxin or some other non-haem iron protein is involved in 
carrying electron between flavin enzyme (adrenodoxin reductase) and cytochrome 
P-450 (Kimura and Suzuki, 1967).
E« A Lipid factor '
It has been shown by Lu and Coon (1968) that all three fractions 
(a) cytochrome P-450; (b) an NADPH dependent reductase and (c) a heat stable
lipid factor (unaffected by heating at 100° C for 2 hours) separated from 
solubilized microsomes were required for maximal drug-metabolizing activity. 
Mannering (1972) has suggested that the lipid factor may act physically to 
provide drugs access to cytochrome P-450.
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Microsomal reduction
Microsomal enzyme systems can also catalyse reductive reactions.
Gillette (1966) demonstrated the reductions of azo and nitro compounds
RN = N-R' azo reductase—  ^RNn2 + r' - nh2
rN02 nitro reductase > ^
There appear to be two pathways for these reactions one inhibited by carbon-
monoxide and the other not inhibited by carbonmonoxide. The first pathway .
involves cytochrome P-450 whereas the other pathway is catalysed by
NADPH-cytochrome c reductase alone. Oxygen inhibits the nitroreductase
activity and therefore occurs only in anaerobic conditions. Azoreductase
activity occurs in both aerobic and anaerobic conditions.
Phase II reactions: Conjugations
Foreign compounds or their phase I metabolites having suitable functional
groups for conjugation can couple with endogenous glucuronic acid, glucose,
cysteine via glutathione, glycine, ornithine, glutamine, sulphate, sulphur
from thiosulphate, methyl group from methionine and acetic acid (see table 1).
The route of conjugation varies with the foreign compounds, the species
and strain of animal and with dose, however, with few exceptions conjugation
‘ %
with glucuronic acid is the most common. In some cases other glycosides,
e.g. glucosides are formed instead of glucuronides. Conjugations with 
amino acids are also common, e.g. the conversion of benzoic acid to hippuric 
acid in man, but the amino acid involved is species dependent (see table 1). 
Hydroxyl compounds are frequently conjugated with sulphate while amino 
compounds commonly form acetyl derivatives. Other routes of conjugation, e.g. 
conjugation of cyanide with sulphur to form thiocyanate, usually represent a 
detoxication mechanism specific to a particular compound or relatively small 
number of similar compounds.
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Biological consequences of phase I and phase II metabolism
The metabolic transformations in phase I reactions may alter the 
biological activity of a foreign compound. The product may be less active 
or more compared to the parent substance. However, in the phase II reactions
most of the compounds are made water soluble for ready excretion in urine
or bile to eliminate the toxic effect of a drug.
An example of detoxication by phase I reactions occurs with the short 
acting hypnotic, hexobarbitone. This is metabolized by oxidation to 
hydroxyhexobarbitone and other products which have little or no biological 
activity (Tsukamoto, et ah, 1956). When the foreign compound is converted 
to a toxic metabolite the process is known as intoxication or lethal synthesis. 
For example the inactive insecticide parathion is metabolized by oxidation 
to paraoxon which possesses a powerful anticholinesterase activity (Gage, 1953). 
Parke (1968) and Peters (1963) describe the process of lethal synthesis where 
some foreign compounds by virtue of their sufficient similarity to normal 
endogenous substances enter the pathways of intermediary metabolism and as a 
result become incorporated into the tissues. Fluoroethanol is not intrinsically 
toxic but is oxidized in the body to fluoroacetic acid and this is converted 
to fluorocitric acid which is highly toxic because of its inhibitory activity on 
aconitase of the Tricarboxylic acid cycle,the energy yielding mechanism of 
the body.
Although, as stated above, conjugation reactions usually lead to 
detoxication a few examples are known where the conjugate may be more toxic 
than the parent compound. For example, the glucuronide of N-hydroxy 
fluorenylacetamide is a more potent carcinogen than the original compound 
as is the acetyl derivative of I’-hydroxysafrole (Borchert, et aly 1973a,b). 
Factors affecting drug metabolism
The metabolism of drugs is affected by a variety of factors (a) genetic 
factors (species and strain differences; (b) physiological factors (age, sex, 
nutritional status, pregnancy and disease) and (c) environmental factors
(stress due to adverse conditions, exposure to ionizing radiations and
ingestion of other foreign compounds that lead to inductive, inhibitory or
\
synergistic effects), Parke (1968) recently reviewed the subject. The 
phenomena of inductive, inhibitory and synergistic effects of drugs will be 
discussed here briefly.
Stimulation of foreign compound metabolism
It has been established that drugs, pesticides and polycyclic hydrocarbons 
activate the metabolism of other foreign compounds leading to the phenomenon 
of drug synergism and tolerance, enzyme induction and carcinogenesis (Parke, 
1968). Stimulation of the microsomal enzyme systems have been demonstrated 
in various species and internal tissues. Most of the studies on mechanisms of 
induction have been carried out with phenobarbitone and 3-methylcholanthrene 
or 3,4-benzpyrene.
Phenobarbitone enhances almost all the drug metabolizing enzymes and 
also elicits an increase in the magnitude of the type I and type II spectral 
shifts. Chronic oral administration of phenobarbitone increases the size of 
the liver and causes proliferation of the endoplasmic reticulum (Conney, 1967).
The stimulatory effect by 3-methyltholanthrene is much more rapid and 
selective in contrast to phenobarbitone (Conney, 1967). Schuster (1964); 
Emster and Orrenius (1965); Parke (1968) reported that the increase in the 
microsomal enzymes caused by the foreign compound may result from an increased 
rate of synthesis of these enzymes and/or decreased rate of breakdown. 
Inhibition of drug metabolism
The hypnotic effect of hexobarbitone was prolonged by the administration 
of the drugs SKF 525 A and Lilly 18947 and chlorpromazine. This evidence led 
Gillette (1966) to suggest that co-administration of foreign compounds may 
inhibit the metabolism of one another. In view of the spectral changes 
exhibited by the foreign compounds in the liver microsomes it is expected that 
the type I blocking agents should competitively inhibit the type I substrates
and type II substrates will be inhibited competitively by type II blocking
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agents. This has been found to be true with SKF 525, a type 1 inhibitor, and 
hexobarbitone, amidopyrine and ethylmorphine, type 1 substrates. . However,
’the phenomenon of inhibition by type II inhibitors and its relation to spectral 
interaction is not very clear, e.g. nicotinamide, a type II compound inhibits 
the hydroxylation of aniline (a type II substrate) and also the demethylation 
of ethylmorphine and amidopyrine, the type I substrates.
Synergism
The changes in toxicity and in the intensity of pharmacological activity 
of foreign compounds could result due to inhibitory or stimulatory effects 
by other foreign compounds. Philleo, et al«t(1965) have demonstrated the 
synergistic effect of piperonyl butoxide, the inhibitor of microsomal 
hydroxylation^on the toxic action of insecticides. In determining doses in 
multiple prescribing,synergism of drug action plays an important role (Parke, 
1968). In the treatment of epilepsy the combination of phenobarbitone and 
diphenylhydantoin is used. As a result of chronic administration of 
phenobarbitone the metabolism of diphenylhydantoin is accelerated and thus the 
anticonvulsant effect is reduced. Sulser, et al->(1966) reported that the metabol' 
of amphetamine was inhibited by desmethylimipramine and thus potentiated and 
prolonged the effect of the drug.
%
Effects of terpenes on the drug metabolizing enzymes
Since the influence of foreign compounds on the drug metabolizing enzymes 
can have the profound consequences discussed above, the effects on these 
enzymes of chronic exposure to dietary terpenes is of considerable importance 
and a number of terpenes have been shown to affect the activity of enzymes 
involved in both Phase I and Phase II detoxication reactions.
Jori, et ab, (1969) studied the effects of menthol, a- and $-pinene and 
eucalyptol (1,8 cineole) on the metabolism of other xenobiotics in the rat. 
Eucalyptol, administered subcutaneously or by aerosol spray was found to 
increase the in vitro (9000 g fraction) liver metabolism of aminopyr jne,, 
p-nitroanisole and aniline and jn -vivo metabolism of pentobarbital. This
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demonstrated that the increased tolerance of barbiturates shown by mice or 
rats housed on soft wood beddings may be dependant on an increased microsomal 
enzyme activity displayed by these animals compared with animals kept on 
hardwood beddings (Vessel, 1967). Recently Wade, et al',(1968) showed that 
volatile hydrocarbon constituents of cedarwood such as the sesquiterpenes 
cedrol and cedrene, are effective inducers of microsomal enzymes via the 
inhalation route of administration.
Parke and Rahman (1969) studied the ability of the terpenes bomeol, 
citral, terpineol, limonene, nerolidol,carvone ? and squalene to effect the 
induction of the hepatic drug metabolizing enzymes after oral and parenteral 
administration for 3 days (185 mg/kg/day). They reported that 3"ionone 
increased the activities of biphenyl 4-hydroxylase, glucuronyl transferase and 
4-nitrobenzoate reductase and cytochrome P-450 of about 50-751. Bomeol, 
citral, limonene and terpineol caused smaller increasesof the order of 251.
Hie levels of biphenyl 4-hydroxylase, glucuronyl transferase or cytochrome P-450 
were unaffected by linalool, nerolidol or squalene but these terpenes effected 
the increase of the activity of 4-nitroreductase by 20-25%. They also 
observed that 3-ionone which exhibited maximum inductive effect amongst the 
terpenoids studied was the only one to be metabolized by hydroxylation. The 
other terpenoids were metabolized by reduction and conjugation with glucuronic 
acid. They concluded that amongst these classes of substances it was likely 
that a compound could induce those enzymes which were involved in its: own 
metabolism.
It seems that, if continued use of essential oils is to be made in food, 
drinks and other applications leading to human exposure, both domestically and 
industrially, it is highly desirable that more information should be obtained 
about the pharmacology and chronic toxicity of essential oils and their 
constituents.
In view of continued use of linalool and its esters, such as linalyl 
acetate, linalyl cinnamate and linalyl isobutyrate attempts have been made
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in the current work to study the effect of linalool, on the drug metabolizing 
enzymes in the liver and in the intestinal mucosa.
The role of the gut microflora in the metabolism of foreign compounds
Attention has so far been directed at the metabolism of foreign compounds 
by mammalian enzyme systems but in the case of orally ingested compounds, 
or compounds which are secreted into the gut in bile, the gut microflora may 
play a major role in the overall metabolism (Scheline, 1973).
In contrast to the mammalian detoxication reaction, the intestinal 
reactions generally have a common characteristic .in that they involve 
degradative processes so that various compounds undergo reduction in molecular 
■size. It is of great significance that the altered compound may have increased 
biological activity or toxicity. The major classes of reactions brought about 
by the intestinal microflora are summarised in table l.*3.
Aspects of the Gastrointestinal metabolism of foreign compounds
A. Species variation
The 8-methyl ether of xanthurenic acid is known to be metabolized by 
the gut microflora of rabbits by O-demethylation and dehydroxylation (Lower 
and Bryan, 1969). The former reaction was found to account for about 20% 
of the dose whereas values from about 2 to 9% were found for the dehydroxylation 
reaction. When mice were given the same dose 99% was excreted unchanged.
Studies on the metabolism of homoprotocatechuic acid in rats and rabbits 
have shown that dehydroxylation by the gut microflora occurs with part of 
orally administered dose. The proportion of the dose dehydroxylated in 
rabbits was about twice that obsewed in rats when the same dose was employed.
The aromatization of quinic acid is carried out by the gut microflora of 
man and old world monkeys whereas new world monkeys and many species of lower 
animals showed little or no conversion (Adamson, et al, 1970). These 
variations may be related to the difference in the composition of the microbial
population in different species. The variation of microbial population of 
different species along the gut from stomach to rectum and faeces has been 
compared in tables 1.4, 1.5, 1.6, 1.7, 1*8.
Table 1.3 Reactions of foreign compounds by the gastrointestinal
microflora
1. Hydrolysis of glucuronides 10. Dehalogenation
2. Hydrolysis of glycosides 11. Heterocyclic ring fission
3. Hydrolysis of etheral sulphates 12. Reduction of double bonds
4. Hydrolysis of -CO-NH- compounds 13. Reduction of nitro groups
a. amides -i* r» j .r14. Reduction of azo groups
b. glycine conjugates
' c. N-acetyl compounds 15‘ Red«ction of aldehydes
16. Reduction of ketones
17. Reduction of alcohols
18. Reduction of N-oxides
a. C-dehydroxylation 19. Reduction of arsonic acid
5. Hydrolysis of esters
6. Hydrolysis of sulphamates
7. Dehydroxylation
b. N-dehydroxylation 2Q_ Aromatization
8. Decarboxylation Deajnination
9. Dealkylation 22. Nitrosamine formation
a. Odemethylation
b. N-demethylation 23 • Acetylation
24. Esterification %
After Scheline (1971, 1973).
The Stomach
virtually
The stomach contents from humans are/sterile (Sternberg, 1896, Dick, 1941 
and Drasar, 1970). The bacterial count per gram of stomach contents from man 
and common laboratory animals have been compared in table 1.4. The human 
stomach contains 100-fold fewer bacteria per gram contents in contrast to 
guinea pig, rat or mouse, and is only comparable to that of rabbit (like man, 
a good producer of gastric acid).
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Table 1.4 The flora of the stomach
Logio no. of viable organisms’, per gram of sample wet weight.
Man Rabbit Guinea pig Rat Mouse
No. of individuals examined 55 3 3 3 3
Enterobacteria - - 0-2 3-6 2-4
’Viridans' streptococci 0-5 - - - 5-6
Staphylococci - - - 0-5
Yeasts - - -- 4-5 0-7
Lactobacilli 0-4 - 2-4 7-9 8-9
Bacteroides 0-4 0-6 - 6-7 7-9
Bifidobacteria 0-3 0-6 4-6 7-8 7-9
Clostridia - - 0-4 2-3 0-3
Veillonella 5-7 6-7
- indicates the organism was not isolated.
The proximal small intestine
Cregan and Hayward (1953) and Bomside and Cohn (1965) have demonstrated 
that most of the samples from the upper small intestine of fasting people are 
bacteriologically sterile. Drasar, et alp (1969) isolated bacteroides from 
3 out of 25 fasting samples. The microbial count of the upper intestinal 
contents are summerized in Table 1.5.
•Table l.js* The flora of the proximal intestine
Logio no. of viable organisms per gram of sample wet weight.
Man Rabbit Guinea pig Rat .Mouse
No. of individuals examined 25 3 3 3 . 3
Enterobacteria - - - 3-5 3-6
Enterococci - - 0-2 3-5 3-5
Viridans' Streptococci 5 - . - 4-5 3-4
Staphylococci - - . 0-3 0-3 0-2
Yeasts. - - 0-3 3-5 0-7
Lactobacilli
C
MI
O
— 2-5 6-7 7-8
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Bacteroides 0-5 0-5 - 5-6 5-8
Bifidobacteria 0-4 0-5 4-5 5-7 6-8
Clostridia - - 0-3 - . 2-3
Veillonella - - 0-3 - 2-3
The distal small intestine
Although the stomach and upper small intestine of man are essentially 
sterile, except immediately after a meal, the lower small intestine usually 
is rich with permanent flora (Cregan and Hayward, 1953). Samples from various 
levels of the lower small intestine of six subjects were examined by Drasar, 
et al (1969) indicated that the numbers of microflora increase as the terminal 
ileum i$ approached. From table (1.6 ) it can be observed that relatively little 
difference exists in the microflora of the distal small intestine in man and 
the common laboratory animals.
Table l.o The flora of the distal small intestine
Logio no. of viable organisms per gram of sample wet weight.
Man Rabbit Guinea pig Rat Mouse
No. of individuals examined 6 3 3 3 3
Enterobacteria 3-4 - 0-2 3-5 3-6
’Viridans’ Streptococci 3-4 0-2 - 2-6 4-7
Staphylococci - 0-2 0-2 0-2 -
Yeasts - - 0-6 3-5
Lactobacilli 3-6 - 2-3 6-7 7-8
Bacteroides 5-7 4-7 0-6 6-8 7-8
Bifidobacteria 5-7 5-7 4-6 6-8 7-8
Clortridia - 2-4 2-4 - 2-3
Veillonella - - - 4-5
- indicates the organism was not isolated.
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Hie large intestine, rectum and faeces
Although the microflora of the faeces may very closely reflect the 
microbial population of the large intestine (Drasar, et al, 1970), the 
microflora in these two areas were studied separately (Seeliger and Werner, 
1963 and Drasar, et al, 1969).
Table 1.7 The flora of the large intestine
Logio no. of viable organisms per gram of sample wet weight.
Man Rabbit Guinea pig Rat Mouse
No. of individuals examined 11 3 3 3 3
(appendices)
Enterobacteria 6-8 - - 4-7 3-6 •
Enterococci 5-9 - 2-3 3-6 3-7
Viridans Streptococci * -3 - - -
Yeasts * - - 5-7 4-7
Lactobacilli 4-9 - • 3-4 7-9 7-9
Bacteroides 6-10 8-9 6-8 7-8 8-9
Bifidobacteria 4-8 4-5 8-7 7-9 7-9
Clostridia * 0-4 . 2-3 i
O
2-3
Veillonella 0-4 - 2-4 0-4 3-6
* Indicates the organism was not mentioned
- Indicates the organism was not isolated.
Table 1.3 The flora of the rectum and faeces
Logio no. of viable organisms per gram of sample wet weight.
Man Rabbit Guinea pi«g Rat Mouse
No. of individuals examined 25 3 3 3 • 3
Enterobacteria 4-8 0-2 0-3 5-7 4-6
Viridans Streptococci 2-6 2-4 1
O
5-7 6-8
Staphyl ococci - - 0-4 - 0-2
Yeasts 0-4 - 0-4 5-6 0-6
Lactobacilli 2-7 3 3-4 8-9 8-9
Bacteroides 9-11 7-9 7-9 7-9 8-10
Bifidobacteria 9-11 7-9 8-9 8-9 8-9
Clostridia 0-5 0-3 0-3 . 0-6 0-3
Veillonella 0-6 0-4 0-4 0-6
Human faeces predominantly contain non-snoring anaerobes; bacteroides 
and bifidobacteria. Bacteroides are present in very large numbers and have 
been shorn by Sanborn (1931) and Kaiser, et al^(1966) to be the dominant 
organisms. However, Haenal (1961) considered bifidobacteria to be the dominant 
microbes. Both of these groups of micro-organisms are dominant in the faeces 
of all the animals studied (Drasar, 1970). The faeces of rats and mice 
strikingly contains more lactobacilli and streptococci than in man and other 
animals. There are notably fewer enterobacteria in rabbits and in guinea pigs.
It is therefore noted with interest that the composition of the gut 
microflora of different species differ considerably from one another. Human 
stomach and upper intestine is sterile whereas in rats and mouse is heavily 
colonized. Although, in the guinea pig and rabbit, the flora are distributed 
similarly to that of man, there are considerable qualitative differences. The 
qualitative and quantitative differences in the gut microflora also influence 
greatly the gut redox potential which influences the metabolism of a compound 
in the gut. In view of the striking differences in the composition and nature 
of the gastrointestinal micro-organisms amongst the species it is not 
surprising to observe species variation in the metabolism of a compound by 
their gut microflora.
Appreciable variations in the type of and numbers of micro-organisms have 
been observed by Smith (1965) and Wilson and Miller (1964) in animals of 
different ages with greatest changes occurring during early life. Fischer and 
Weissinger (1972) reported that the deconjugation of diethylstilboestrol by 
the bacterial 3-glucuronidase did not occur in newborn rats until they 
reached the adult level of 25 days when enterohepatic circulation of this
synthetic hormone could be demonstrated (vide infra),
B. Effect of diet
Diet may influence the nature of the gastrointestinal flora (Donaldson, 
1964), yeasts are very-sensitive to the nature of the diet and are numerous 
in animal fed mainly cereals but largely absent when meat and protein are 
fed, (Smith, 1965). Lactobacilli also appear to be present in greater numbers 
in animals fed on cereals. The effect of variation in the diet has been 
observed in the same species. The conversion of cyclamate to cyclohexylamine 
in the gut is carried out by enterococci. The gut microflora of a Japanese 
individual contain large numbers of enterococci which, do not occur to a 
significant extent in the gut of the British. It has been observed that all 
the Japanese under investigation convert a cyclamate to cyclohexylamine 
whereas the British could do so only after prolonged administration to allow 
the gut microflora to adapt to the situation (Kojima and Ichibagase, 1966; 
Renwick and Williams, 1969).
Toxicological implications of some of the reactions carried out by the gut
microflora
a. Hydrolysis of glucuronides
Less polar substances after absorption are conjugated in the liver to 
render more polar and thus increase the water-solubility. These conjugates 
are then excreted in the bile and/or urine. Those compounds which are excreted 
in the bile when reaching the large intestine are hydrolysed by the bacterial 
3-glucuronidase to liberate the aglycone which is reabsorbed and thus enters 
the enterohepatic cycle. The glucuronide of stilboestrol^ a synthetic hormone, 
is excreted extensively (Fischer, et ah, 1966; Clark, et ah, 1969) in bile.
Its excretion from the body through urine and faeces is delayed as its 
glucuronide from the bile is hydrolysed by the gut microflora and the liberated 
free stilboestrol is reabsorbed to establish enterohepatic circulation (see 
Fig. 1.2 ). Toxicological implications of enterohepatic circulation may be 
exemplified by the hydrolysis of the glucuronide conjugate of hydroxylated N-2
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Fig.1.2 .. Enterohepatic .circulation and gut bacteria: 1^C-stilboesterol.
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fluorenylacetamide (FAA). The hydroxylated product is carcinogenic (Scheline,1971. 
It is reabsorbed and reconjugated with.glucuronic acid in the liver the thus 
enters enterohepatic circulation. Formation of another typical toxic 
metabolite by the gut microflora may be exemplified by the production of 
thyrotoxic amino compounds from injected chloramphenicol, an antibiotic.
The antibiotic is excreted in large amounts in the bile as glucuronides 
which are hydrolysed and reduced to aryl amines, the thyrotoxic compounds, 
by the gut microflora.
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b. Hydrolysis of Glycosides
Amygdalin, a glycoside present in almond, has LD^q (rat) 5000 mg/kg 
when administered intraperitoneally whereas LD^q (rat) is 300 mg/kg 
when administered orally. The toxicity lies in the fact that the glycoside 
is hydrolysed by microflora in the gut to unstable mandelo nitrile which 
readily breaks up to yield highly toxic cyanide (Williams, 1970).
CN
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A second example of glycoside toxicity appeared by the microfloral 
hydrolysis in the gut of the gLycoside cycasin, a glucoside of 
methylazoxymethanol, a constituent of cycad seeds which are used as food 
in some parts of the Pacific Ocean region (Yand and Mickelsen, 1969).
The gut microfloral hydrolysis liberates the aglycone which in the lung 
is believed to be metabolized to diazomethane which is a carcinogen. 
However, eyas in itself is not active by injection and is inactive and 
not absorbed when given orally to germ-free animals.
c. Hydrolysis of Sulphamates
The Sweetener cyclamate when administered orally for a long period of
time to animals or humans, cyclohexylamine was excreted as metabolite. These
amines are potentially toxic.
d. Nitro reduction
The reduction of nitro groups by the intestinal bacteria is well known 
(Smith, et ah, 1949; 1950; Glazko, et al, 1952). It has been mentioned 
earlier that chloramphenicol is reduced to amines in the gut ."which are 
reabsorbed producing a thyrotoxic effect.
e. Azoreduction
Azodye food colours undergo reductive fission by the gut microflora. As 
a rule, compounds having sulphonic acid groups on both sides of the azo 
linkage are employed so that the fission products will be fairly highly 
ionized compounds which do not possess appreciable biological activity and 
are soluble in water so that these are easily eliminated from the body 
(Scheline, 1971). One exception to this is the food colour Brown FK which 
consists of sulphanilic acid connected through an azo linkage to several 
diamino compounds lacking the sulphonic acid group. Walker, et al*5(1970) 
have shown recently that the polyamino compounds formed by microbial azo 
reduction are stabilized at the low redox potential in the large intestine 
which does not favour their oxidative condensation. These polyamines are 
absorbed and are myotoxic. This work illustrates an interspecies difference 
in toxicity which results from differences in intestinal metabolism.
Thus, Grasso, et al«3(1968) reported that the azo dye Brown KF is toxic in 
rat but not in mice under similar conditions whereas Walker, et al»j(1970) 
showed that muscle lesions are produced in both cases when polyamino reduction 
products of Brown FIC are given intravenously. These latter workers suggested 
two reasons for the species difference in toxicity, (a) differences in the 
composition of the gut flora, and (b) difference in the environment of the 
large intestine of the two species, i.e. redox potential, which could
influence the stability of the fission products.
An example of pharmacological interest is the splitting of the azo 
linkage of prontosil and neo-prontosil to liberate antibacterial sulphanilamide. 
Sulphanilamide is absorbed and performs its pharmacological activity.
f. Decarboxylation
Hydroxylated benzoic, phenyl acetic and cinnamic acids are 
decarboxylated by intestinal micro-organisms (Scheline, 1966, 1967, 1968;
Indeb and Sdieline, 1968). Hie phenols thus produced are toxic substances and 
have been claimed by Bakke and Midtvet (1970) to play a significant role in 
promoting tumours.
g. Aromatization
Indahl and Scheline (1973) and Goddard and Hill (1972, 1973) have pointed 
out the ability of the gut microflora to aromatize cyclic compounds may lead 
to the formation of polycyclic aromatic compounds from steroids with possible 
carcinogenic activity.
h. Nitrosamine Formation
Nitrosamines are potent carcinogens which could possibly be formed 
in the body from nitrite and secondary amines (Anon, 1970). Hawksworth and 
Hill (1971) have demonstrated that bacterial formation of nitrosamines could 
arise from two sites. The first is the intestine from nitrate in the diet 
which after reduction to nitrite can react with those amines of intestinal 
origin. The second possibility is in the urinary tract in individuals with 
urinary infection. A majority of these infections are due to E.coli which is 
one of the species which catalyses nitrosation of amines. Normal individuals 
contain 5-10 times lower nitrate concentration than that which is apparently 
required for nitros amine production, however, in areas with a high nitrite 
content in the drinking water there is a danger of nitrosamine toxicity.
Metabolic adaptation of the gut microflora to foreign.compounds
Many of the intestinal reactions apparently occur readily without need 
by the micro-organisms to adapt. A few examples are known, however, in which 
prior exposure to the test compound is necessary before’appreciable 
metabolism is observed and it seems likely that in these cases, adaptation 
and selection may have occurred.
An excellent instance in this area has been reported by Kojima and 
Ichibagase (1966) who showed that cyclamate could be metabolized to 
cyclohexylamine. Wallace, et al‘y(1970) reported that no rat initially 
converted cyclamate to cyclohexylamine while at the end of the year on diets 
containing 0.4, 2.0 or 10% cyclamate, only 80% of the animals were 
cyclohexylamine excretors and the amount excreted accounted for 35-40% of 
dose. Drasar, et al (1971) reported that rat faecal micro-organisms coverted 
more than five times as much cyclamate to cyclohexylamine when they were 
incubated with cyclamate in protein containing media.
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Aims of the current work
From the preceding review, it can be seen that dietary terpenes may 
'be potentially toxic and that, after absorption or ingestion they may be 
metabolized by mammalian or microbial systems with consequent changes in 
biological activity. Linalool and its esters are common components in 
essential oils, e.g. citrus oils, cardamom, coriander, etc., and may thus 
have an influence on the consumer directly or by their effects on the 
metabolism of other foreign compounds which may be encountered. In view of 
this, it appeared that it would be of both academic and practical interest to 
embark on the following programme:
i) to synthesize lt+C linalool to study the metabolic fate of linalool;
ii) to study the metabolism of linalool in vitro by the gut microflora of
rat and other species, and to identify the microbial metabolic end products;
iii) to study the metabolism of 1 linalool in vivo in male and female rats
to investigate the absorption, distribution, biotrans format ions and 
excretion and to establish the sex differences, if any; and to 
determine the kinetics of absorption and excretion;
iv) to identify the in vivo metabolic end products with a yiew to finding the 
presence of any possible precursor of toxicity;
v) to study the effect of acute and chronic administration of linalool on 
the drug metabolizing enzymes in the liver and the intestine, in rats and 
to determine the mechanism of toxic response, if any, due to exposure of 
the animal to linalool.
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CHAPTER 2
Synthesis of []l, 2~1 ] Linalool
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INTRODUCTION
Compounds labelled with radioactive tracers are commonly used 
in studies of the metabolism of both endogenous and foreign compounds, 
and tracer techniques are now routinely applied to investigating the 
metabolism of drugs and other anutrients in laboratory animals 
(R. ICuntzman, 1972). Hie radioactive isotopes most commonly employed 
are the weak 8-emitters 3H and llfC which are common to almost all organic 
compounds and present a minimal health hazard to the operator. Tritium 
has the disadvantages that it frequently is labile and may undergo 
exchange with protons of the solvent. Also, oxidations, conjugations etc. 
at the site of labelling or adjacent to it can lead to displacement of 
3H, often with loss' of activity. Consequently 1IfC is preferred as the 
label for most purposes although the double labelling technique involving 
3H and 14C at different sites can be extremely useful in some cases.
In view of the above comments, and to facilitate subsequent 
quantitative studies in the metabolism of linalool, it was decided to 
synthesise the llfC labelled compound. Noimant (1954) reported good yields 
of linalool from the condensation of vinyl magnesium bromide with 
2-methylhept-2-ene-6-one (methylheptenone) and this route was subsequently 
used in a synthesis of [l,2-ltfC2] linalool from [^Cj ethylene by the 
method of Filip and Moravek (1959). Details are shown in Figure 1.
ch2 CHj
Br
Ethylene
■» CH2h CM? KDH.Br 
Dibrome thane
* CH
Br
Mo * * Ik--------- > a \2 = CH.Mg.Br
T etraiiydrofuran Vinylmagnes ium
(THE) Bromide
CH2 = CH.Mg.Br +
Vinyl magnesium 
bromide
H3C ch3 
Methylheptenone
HsC. ^ OMgBr
h 3c
Figure 2.1
*
CH;
CH,
[1,2-14 Linalool
The use of tetrahydrofuran in the Grignard reaction leading to the 
formation of vinyl magnesium bromide is essential since Krestinskiy (1920) 
showed that ethylene and acetylene were formed when diethyl ether was 
used as the solvent. Yields of Grignard reagent from vinyl iodide were 
also very low (Krestinskiy 1920). Nomant (1954) demonstrated that 
improved yields of Grignard reagent from vinylhalides were obtained when 
anhydrous tetrahydrofuran was used as solvent, apparently due to 
stabilization as a result of formation of oxonium salts.
Consequently the method of Filip and Moravek (1959) was taken as the 
basis of the synthesis finally employed, using commercially available 
l,2-lltC labelled dibromoethane as the starting point. Since Filip and 
Moravek (1959) did not report optimal conditions for the synthesis of 
linalool several syntheses using unlabelled dibromoethane were carried 
out first in which yields were checked at the stages of production of • 
vinylbromide and of linalool and an attempt was made to maximize the 
yields at each stage.
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MATERIALS AND METHODS 
MATERIALS
(jL, 2 -14 C]Dibromoethane, 500 yCi (The Radiochemical Centre, Amersham) , 
unlabelled dibromoethane (BDH, minimum assay by g.l.c. was 98.51), 
potassium hydroxide (BDH, Analar), 2-methylhept-2-ene-6-one (Ralph N.
Emanuel, g.l.c. assay was 98.5%), ammonium chloride (BDH, analar).
Carbowax 2QM (Phase Separations Ltd.), Celite 545 acid washed and treated 
with dimethyldichlorosilane (Phase Separations Ltd.), magnesium metal 
turnings for Grignard reaction (BDH).
METHODS
Syntheses
The overall synthesis of linalool involved (a) synthesis of vinyl 
bromide from dibromoethane and (b) synthesis of linalool from vinyl bromide 
by condensing this Grignard reagent with 2-methylhept-2-ene-6-one 
(methylheptenone) and subsequently hydrolysing the reaction mixture.
a) Synthesis of Vinyl bromide
The assembly for the synthesis of vinyl bromide has been shown in 
fig.2.2. It consisted of a three-necked ground-joint flask (flask A, 100 ml) 
fitted with a reflux condenser I (E) provided with a stillhead (L). The still- 
head (L) was connected to a condenser (F) (condenser II) which in turn was joins 
to a second three-necked flask (flask B, 250 ml) via a receiver adaptor (s) 
which dipped into anhydrous tetrahydrofuran (120 ml) in the flask B resting 
in a bath containing freezing mixture (acetone and solid CO 2). Freezing 
mixture was also circulated by a pump through condenser II and a second 
reflux condenser (G) (condenser III) on flask B. Unlabelled dibromoethane
11.5 g (0.063 mole ) was introduced from a dropping funnel into flask A 
which contained 60 ml of 3.5M alcoholic KOH. Hie contents of the flask
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were heated at 45-48°C under reflux. Vinyl bromide (b.p. 16.5°C) 
was produced and swept by dry nitrogen introduced into flask A through 
a tube dipped into the liquid. The Nitrogen flow rate was regulated at 
6 ml per minute. Hie vinyl bromide thus produced passed through the 
condenser I and was condensed in condenser II (-15°C to -20°C) into the 
tetrahydrofuran in flask B. Hie heating of flask A was continued for 
2\ hours until there was no sign of further droplets of vinyl bromide in 
condenser II. Flask B with 120 ml of THF was weighed before distillation 
of vinyl bromide and weighed again after distillation to calculate the 
vinyl halide produced.
To find the optimum concentration of alcoholic KOH to dehydrobrominate 
the dibromoethane Investigations were carried out with four different 
strengths of alcoholic KOH viz. (a) 2M KOH in 95% alcohol (b) 2M KOH in 
absolute alcohol (99.9%),(c) 5.5M KOH in absolute alcohol (d) 4.5M KOH in 
absolute alcohol. The reaction was carried out over a period of 2\ hours.
(b) Synthesis of linalool
Since the preparation of the Grignard reagent and its condensation 
with methylheptenone necessitated the absence of moisture and oxygen, and 
also in view of health hazard due to radioactive gaseous llM2 vinyl bromide 
linalool was synthesised in a closed system. The same assembly (Fig. 2.2) 
as in the synthesis of vinyl bromide was used but included some additional 
operations for keeping the system free from moisture and air. Hie required 
amount of magnesium metal (0.063 mole) was placed in the flask B. Dry 
nitrogen, passed through two U-*tubes containing fused CaC^, was introduced 
into flask A to remove air from the apparatus. When the funnel in vessel 
B was closed a slight positive pressure was maintained at the nitrogen 
tank as indicated by the level of mercury in the escape valve connected
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through a rubber tubing to condenser III. When all the air had been 
displaced, both the flasks (A and B) ivere heated gently 70°C for half 
an hour under a continuous flow of nitrogen to ensure elimination of 
any moisture adhering onto the surface of the glass or to the magnesium 
metals. When the flasks were cooled the nitrogen flow was reduced to 
a barely perceptible rate and 120 ml of tetrahydrofuran (dried over 
metallic sodium) was introduced into flask B. Unlabelled dibromoethane
11.75 g (0.0625 mole) was introduced into the flask A and 60 ml of
3.5 N KOH in absolute alcohol was added from the dropping funnel. Dry 
nitrogen was introduced at the rate of 6 ml/min through the tube (N) 
dipped into the liquid of flask A. All the joints were checked to 
maintain the airtight conditions. The contents of the flask were then 
refluxed in an oil bath to avoid excess environmental moisture at a 
temperature of 45-48°C, as before, and the vinyl bromide was- distilled 
into tetrahydrofuran in flask B. After 2\ hours the heating of flask A 
was discontinued and nitrogen flow rate was reduced. '
In the next stage, the Grignard reagent, vinylmagnesium bromide, 
was prepared from vinyl bromide and this necessitated an alteration in 
the assembly shown in Fig. 2.2. The condenser II was detached from the 
stillhead (L) and traces of vinyl bromide washed into vessel B with 
tetrahydrofuran. The condenser II was then detached from the vessel B 
and thermometer (T) was inserted into the free neck of the vessel. In 
the new assembly (Fig.2.3)which was essentially the second half of the 
Fig.2.2,nitrogen was introduced at the top of the reflux condenser III. 
Thus any air inside the flask was swept through the apparatus and escaped 
at the mouth of the dropping funnel (p). One reason for the nitrogen 
atmosphere was to prevent destruction of Grignard reagent by atmospheric 
oxidation.
2RMgX + 02  — -----> 2R0MgX
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The second reason was to eliminate moisture which could decompose the 
Grignard reagent
RMgBr + H20 -------- — > RH + Mg(OH)Br
A small crystal of iodine was dropped onto the surface of magnesium 
metal to initiate the reaction for the formation of vinyl magnesium bromide. 
The freezing mixture surrounding the flask at this stage was replaced by 
ice cold water (0-4°C). Five minutes after the addition of the iodine, 
bubbles started to appear indicating the beginning of the formation of the 
Grignard reagent. The vessel was kept undisturbed for half an hour then 
stirring was started with a magnetic stirrer and continued for 45 minutes. 
During this period the temperature of the vessel was gradually brought to 
room temperature. Methylheptenone (6.3 g or 0.05 mole) was then added 
drop by drop within a period of 15-20 minutes with stirring. The 
condensation of methylheptenone with vinylmagnesium bromide was exothermic, 
and therefore, was indicative of the progress of the condensation reaction.
At this stage the temperature was raised slowly to 50°G and kept at this 
temperature for half an hour - and then further raised to and kept at 
60°C under reflux for 30 minutes. The flask was then cooled down to room 
temperature and stirring continued for one hour. At the end of the reaction 
the linalool magnesium bromide complex was decomposed by hydrolysis with 
30 ml saturated aqueous ammonium chloride solution to liberate free linalool. 
.Ammonium chloride hydrolysis was preferred to acid hydrolysis because of 
possible acid catalysed isomerisation of linalool to other terpenols.
The hydro lysate was extracted four times with ether and concentrated to 
30 ml at 20°C under reduced pressure in a rotary evaporator. It was then 
kept over anhydrous sodium sulphate overnight.
Analysis and Purification
For analysis and purification a Pye 105 Mark 2 Automatic Preparative
Gas Chromatograph equipped with a flame ionization detector
was used. Separations were accomplished on a 7ft x §in glass column
packed with 20% carbowax 20M on acid-washed and dimethyldichlorosilane-
treated celite 545, 60-80 mesh size. The oven temperature was main- 
o
tained at 140 C and injection temperature at 190°C, nitrogen was used 
as the carrier gas and was introduced in the system at a flow rate of 
110 nd/minute. Six components were detected, separated and collected 
preparatively (fig -Table The peak corresponding to linalool
was characterized by retention time (Fig. 2.4 and by comparison
of its IR spectrum (Fig. 2.5a). See below (Results Section).
Determination of IR Spectra
Infra-red. spectra of the reaction product and authentic linalool 
were recorded on the SP 200 IR spectrophotometer using a film of the 
liquid between potassium bromide windows.
Determination of Radioactivity
Radioactivity was determined in a Packard Tricarb Liquid Scintillation 
spectrometer', model 3320 at 0°, using 70/30 scintillator; 70 ml toluene,
30 ml absolute alcohol containing 0.3% PPO and 0.01% POPOP. The labelled 
compound (lyl) was added directly to 15 ml of the scintillant contained 
in the counting vial. Radioactivity thus measured was corrected for 
quenching and counting efficiencies by internal standardization using 
25 pi 1^ C toluene, (specific activity 5.25 x 10^ d.p.m./g).
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RESULTS
(a) Synthesis of vinyl bromide
The results are shown in Table 21 from which it can be seen that 
maximum yields were obtained using 3.5M KOH in absolute alcohol in 
otherwise similar conditions.
Table 2.1: Percent yield of vinyl bromide on the basis of equimolar
quantities from dibromoethane.
Concentrations of KOH Percent yield of vinyl bromide
2M KOH in 95% aqueous
alcohol 49.2
2M KOH in absolute
alcohol (99.91) 58.7
3.5M KOH in absolute
alcohol (99.9%) 65.5
4.CM KOH in absolute
alcohol (99.9%) 64.8
44
Table 2.2: Retention time of the labelled and unlabelled compounds
in the synthetic mixture.
Compounds Peaks labelled/unlabelled Retention
times (mins)
Ether A unlabelled 0.7
Tetrahydrofuran
(THF)
B 1.6
Methylheptenone C ii 6.2
Unknown D it 11.7
1^ C labelled linalool E labelled 20.4
Unknown F ii 28.8
Authentic linalool — unlabelled 20.4
(b) Synthesis of linalool
The gas chromatographic analysis eluted six well-defined 
symmetrical peaks. Their retention times and the results of the 
radiochemical analysis are shown in Table 2.2 Peaks A, B and C 
corresponded to ether, tetrahydrofuran and methylheptenone 
respectively. Their presence was expected because of thety use in 
different stages of the synthesis. Peak D and F were unknown compounds, 
of which the latter was radioactive. Preparative GC yielded 108 mg 
from Peak D (inactive) and 212 mg from Peak F, with a total activity 
of 3.7 yCi. Neither compound was identified. Peak E was due to 
linalool and was characterised by comparison with the retention time
20.4 min (Table 2.2, fig. 2.4) and infrared spectrum of authentic linalool 
(fig. 2.5a & 2.5b). Hie total activity of the ether extract of the 
synthetic hydrolysate was 200 yCi which was due mainly to 1LfC linalool. 
After purification by preparative gas chromatography the linalool 
fraction weighed 3.28 g (0.0213 mole) with a total activity of 170yCi.
Initially 11.75 g (0.0625 mole) of dibromoethane was used as a 
starting material. Therefore, on the basis of the weight the % yield 
of pure linalool is P»Q2.L^c 100 _ ^   ^ activity of
(jl, 21IfC] dibromoethane was 500 yCi and the activity of the final 
product, 1IfC labelled linalool, was 170 yCi. Therefore, the % yield 
in terms of radio activity is = 34%. Hence the yield both
in terms of weight and radioactivity was 34%. The specific activity 
of [l,214C| labelled linalool was 170 yCi/3280 mg = 0.052 yCi/mg.
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DISCUSSIONS
The use of 2M KOH in absolute alcohol (99.9%) for dehydrobromination 
of dibromoethane produced a higher yield of vinyl bromide compared with 
2M KOH in 951 alcohol over the same period of time. The decomposition of 
dibromoethane with exclusive formation of vinyl bromide with alkali in 
absolute alcohol is purely a bimolecular reaction (Bernoul 1 i, 1933) .
With increased amounts of water, alkaline hydrolysis predominantly 
produces ethylene glycol, and the velocity of reaction is considerably 
reduced (Bernoul 1 i, ' ,1933) .
The reaction velocity changes exponentially with temperature 
(Bernoulli, 1933). The reaction in the vessel A should not be so high 
as to sweep alcohol vapour into the reaction vessel B by the stream of 
nitrogen. Alcohols react with Grignard reagent at a faster rate than 
ketones -(Fincif.-1967). Hence if alcohol was carried over into vessel B 
it would react faster with vinylmagnesim bromide than methylheptenone 
to produce radioactive gaseous ethylene.
*CH2 =*CHMgBr + Q^G^OH
Vinylmagnesium Ethyl 
bromide alcohol
-> O-L = QL + CHXILOMgBr 
Z Z 0 | z
Radioactive I
ethylene
(gas)
Hydrolysis 
CH CH OH 
Ethyl, alcohol
The synthesis of linalool with .improved yield is associated with 
the following points
a. Regulation of temperature at 45°C in reaction vessel A.
b. Control of temperature in the reflux condenser (I) so that 
it would condense all the alcohol that may be vaporized under the
50
reflux condition at 45°C in vessel A.
. c. Dry and inert atmosphere should be maintained during the 
course of synthesis.
d. The reaction mixture in vessel B should be refluxed for at 
least half an hour at 60°C after addition of methylheptenone to 
facilitate the condensation of the ketone with the vinyl magnesium 
bromide.
The total activity of the [i>214C| labelled linalool, synthesised 
by the method described, was 170 yCi. The activity was enough for 
the requirement to study the metabolic fate of _ pL, 2llfC] labelled 
linalool in the rat.
CHAPTER 3
In vitro metabolism of linalyl acetate and linalool 
by the intestinal microflora of rat and other species.
INTRODUCTION
The gastrointestinal microflora are able to metabolize a wide range 
of foreign compounds including some food additives (Scheline, 1973).
The contributors of the gut bacteria to the metabolism of compounds which 
are administered orally or any substance secreted into the intestine has 
been discussed in Chapter 1.
In safety evaluation it is important that the intestinal microflora 
of the potential recipient be taken onto account and compared with that 
of the animal used for testing, for assessing the relevance of results.
Several of the micro-organisms, although common to many species, have been 
found to vary in numbers and location in the intestine of different species * 
and they could vary in the same species with nature of the diet (Miliams'p  ^
1971). Tie composition of the microflora of different species at different 
sections of the gut has been discussed in Chapter 1 (pages 22-26 ).
A striking example of species variation in the metabolism of quinic acid 
(derived from chlorogenic acid, present in tea, coffee, fruits and 
vegetables), by the gut microflora was observed by Adamson, et ah, (1970). It 
was observed that only man and Old World monkeys converted quinic acid 
extensively to benzoic acid (20-701) which was excreted entirely as hippuric 
acid in the urine. In other species like rat, guinea pig, mouse, dog, cat, 
ferret the excretion of hippuric acid was 0-10%. When Adamson et al,, (1970) 
injected quinic acid intraperitoneally no quinic acid was found but oral 
administration was followed by urinary excretion of hippuric acid. This thus 
demonstrated that hippuric acid was formed by the action of microflora and 
not by tissue metabolism.
Another example of a species variation influenced by the gut bacteria 
is to be found in the metabolism of a food colour Brown FK. Brown FIC when 
administered orally is toxic to rats but not to mice (Walker, et ah, 1970).
On further investigation by these workers it was found that gut microflora
of rat produced two myotoxic amines from Brown FK. When these two myotoxic 
substances were injected to rat and mouse, cardiac and muscular lessions 
were produced in both cases. It was therefore, suggested that the orally 
administered Brown FK was myotoxic in rats but not in mouse due,probably,to 
differences ,in the metabolism by intestinal microflora in the two species 
(see Chapter 1).
In view of the ability of the microflora to introduce, remove or modify 
the substituents and/or the structure of a compound thus altering its 
toxicological and pharmacological properties the metabolism of linalylacetate 
and of linalool by the gut microflora of rat and other species has been 
investigated in relation to their safety in use as food additives.
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Materials
Linalool and linalyl acetate S6% g.l.c. pure grade (Koch-Light Laboratories 
Ltd.), 1^C-labelled linalool (specific activity 0.52 yCi/mg, synthesised as 
described in Chapter 2), silicagel G (E. Merck, Germany). Dimethyldichloro- 
silane (British Drug House, England), celite 575 (60-80 mesh, Phase Separations 
Ltd., England). Glucose-’Analar’ (British Drug House), peptone (Difco), 
yeast extract (Difco). Tween 80 and anhydrous sodium sulphate-analar 
(British Drug House).
Methods
Rat caecal preparation
Two Wistar albino rats, 10 weeks old kept on standard laboratory pellet 
diet were sacrificed by decapitation and the caeca were removed. The caecal 
contents were then suspended in 10 ml of sterilized broth media. The caecal 
preparation was then made according to Scheline (1966). The composition of 
the culture medium was 0.51 glucose, 0.5% peptone and 0.5% yeast extract in 
0.1 M phosphate buffer, pH 7.4.
Incubations of linalool (3 mg/10 ml) and linalyl acetate were carried out 
anaerobically for 48 hours in liquid broth medium according to Scheline (1966). 
Tween 80 (3 mg/10 ml) was added to the medium to keep the lipophilic linalool 
in suspension. At the end of the incubation period the medium was extracted 
three times with 15 ml diethyl ether. The ether extracts were pooled, dried 
over anhydrous sodium sulphate and concentrated to 2-3 ml in a rotary 
evaporator at room temperature. For preparative scale studies 51 incubation 
medium containing 1.5 g of linalool was incubated with preparations from the 
contents of 6 rat caeca. The incubation was carried out as above. The ether 
extract of the metabolites (4 x 600 ml) was dried over anhydrous sodium 
sulphate and concentrated to 30 ml in a rotary evaporator.
Two controls were prepared similarly except in one case (a) the caecal 
extract was omitted and in other (c) linalool was omitted.
Thin-layer chromatography
Hie ether extracts of linalool and linalyl acetate metabolites, and 
two controls along with authentic samples were chromatographed on thin-layer 
of silicagel G impregnated ivith 2.5% silver nitrate solution in water. The 
solvent system used was chloroform + methylene chloride + n-propanol + 
ethylacetate (10:10:1:1). The chromatogram was developed for 17 cm twice 
in the same direction with the same solvent for better separation.
.Separation, and Characterisation of metabolites by preparative gas chromatography
(i) Preparation of acid washed and dimethyl dichlorosilane treated solid 
support, Celite-545.
Acid washing is needed to remove traces of iron that may catalyse 
decomposition and isomerisation of compounds (Liberti, 1S58). Celite 
545 (60-80 mesh) was treated for sixteen hours with aquaregia. Hie acid 
wash was then followed by several water washes. To remove traces of 
residual acidic reaction which may interfere with the stationary phase 
and also with the solute the solid support was treated with 2 M-NaOH.
It" was then followed by washing several times with water until neutral 
and the Celite was dried at 120°C for eight hours.
(ii) Treatment with dimethyl dichlorosilane (DMCS). The solid supports tend 
to absorb the solute and therefore, interfere to give trailing peaks and 
consequently affect the retention volume. The absorption is particularly 
evident in the case of polar compounds. Hydroxyl groups of silicious 
compounds may be partly responsible for the absorption phenomena and can 
be reduced by treatment with dimethyldichlorosilane (DMCS) followed by
a methanol (absolute) wash. Hie treatment with DMCS replaces the free 
hydroxyl groups near the surface by silylgroups.
- Si - OH 
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- Si - OH
Cl CH3
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The SiCl group may give rise to OH-group after hydrolysis and therefore the 
treatment with DMCS followed by washing with methanol gives rise to an inert 
methoxy derivative as follows:
CH3
ah
-  Si  -  o -  s -  Oh - HCl
0
I
- Si -
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0
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Procedure: Acid washed Celite 545 (100 g) was treatedjvith gaseous nitrogen
bubbled through 40 ml of DMCS according to Prevot (196%), The DMCS treated 
celite was washed with methanol (absolute) and dried at 100°C.
Coating of the solid support with stationary phase
Carbowax 20 M (10 g) was dissolved in 130 ml of methanol, the solution 
was then mixed with 50 g of celite (AW-DMCS) in a 500 ml round bottom quick-fit 
flask. The slurry was agitated gently to coat the solid support evenly with 
the stationary phase. The solvent was evaporated at 40°C in a rotaiy 
evaporator under vacuum.
Packing and purging of column
The packing material coated with stationary phase was seived to obtain a 
60-80 mesh fraction. A 7ft.-x 1" column was packed and purged at
190°C under a slow stream of nitrogen for 16 hours.
Preparative chromatography
The Pye 105 Mark 2 Gas chromatograph equiped with flame ionization 
detector was used for separation and collection of the metabolites in 
milligram quantities, necessary for identification using physico-chemical 
methods such as i.r., n.m.r. and also mass spectrometry. The column packed 
with 20% Carbowax coated on celite 545 as decribed above was used. The 
temperature was programmed from 75°C to 140°C at 2° increase per minute and 
N2 (97 ml/min) was employed as carrier gas. The injection temperature was 
maintained at 190°C. The separated metabolites were collected in U-shaped 
glass traps kept cooled by immersing in liquid nitrogen in a Dewar flask. 
Compounds corresponding to two major peaks A and B of retention time 41 min 
and 28.4 min respectively were collected.
Checking of the homogeneity of the metabolites by thin-layer chromatography 
The homogeneity for purity of the two compounds were checked by thin- 
layer chromatography using silver nitrate impregnated silicagel G and the 
same solvent system as above (Page 56)* Metabolite B was shown to be.homogene­
ous where as a metabolite A revealed the presence of two substances of values
0.34 (Ai)'and 0.52 (A2).
Preparative thin-layer chromatography for the separation of Ai and A2
Silver nitrate thin-layer chromatography and the same solvent system as 
above was used for preparative collection of Ai and A2. Thin-layer silicagel G 
(silver nitrate impregnated) plates (20 x 20 cm) of 0.75 mm thickness was used 
for the purpose. After the application of the material, the plates were given 
a double development. The separated components did not give any fluorescence 
under u.v. light. The positions of the separated components were located by 
spraying, with 7.5% phosphomolybdic acid in 95% ethanol, an exposed part 
(1 cm) of the chromatographic plate whilst the major part was covered with a 
(20 x 20 cm) glass plate. The .area of the plate corresponding to the separated
components was scraped off and extracted with ether.
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Mass spectrometry
The mass spectra of the extracted substances Ai and A2 were obtained 
using the AEI MSI2, high resolution mass spectrometer.
Materials were introduced into the ion source by direct insertion probe 
with inlet temperature 100°C. Source temperature 280°C, ionization voltage 
70 EV and acceleration voltage 8 KV.
Synthesis of 1,2 dihydrolinalool
Dihydrolinalool was not available commercially and therefore, was 
synthesised as follows: ethyl magnesium bromide was prepared from
bromoethane and metallic magnesium in anhydrous ether medium in presence of 
iodine catalyst. The apparatus used for this purpose was similar to that in 
figure 2.3 in Chapter 2. The ethylmagnesium bromide was then condensed with 
methylheptenone in the same apparatus. The hydrolysis of the product formed 
was carried out with saturated aqueous ammonium chloride, as described for the 
synthesis of 11+C linalool in Chapter 2.
CH3-CH2-Br } CH3-CH2-MgBr
Bromoethane Ethylmagnesium bromide
CH3 ch3 ch3
Ethylmagnesium Methylheptenone 
bromide
1,2 dihydrolinalool
Purification
Hie purification was carried out with the Pye 105 Mark 2 Automatic 
preparative Gas chromatograph equiped with flame ionization detector that was 
used for the purification of 1 ^ C-linalool (see Chapter 2). The same column 
and similar conditions as linalool purification were used for the purification 
of 1,2 dihydrolinalool and, strikingly, under the same conditions with 20 M 
carbowax (on celite 545) column both had similar retention times. 
Characterisation
Synthetic dihydrolinalool was characterised by physico-chemical methods 
such as thin-layer chromatography, g.l.c., i.r., n.m.r. and mass spectrometry 
(see below).
i. Thin-layer chromatography
The thin-layer chromatographic investigation was carried out for 
examination of the presence of unsaturation in the synthetic- compound.
Silicagel G coated thin-layer plates were developed in chloroform and the 
plates were sprayed with Fluorescein-Bromine reagent (Runge, 1963).
ii. Gas liquid chromatography
The gas liquid chromatographic analysis was achieved during the purification 
process of the synthetic dihydrolinalool mentioned above. %
iii. Infra-red spectrometry
The infra-red spectrum of the liquid was taken between the two KBr plates 
in the Perkin-Elmer 5133 spectrometer.
iv. Nuclear Magnetic Resonance Spectrometry
The nuclear magnetic resonance spectrum of the compound dissolved in 
CDCI3 was determined with Perkin-Elmer R-10 60 MHz continuous wave n.m.r. 
at magnet temperature of 33.8° with tetramethyl silane as internal standard.
v. Mass spectrometry
Materials were introduced into the ion source by direct insertion probe 
in M.S. 12 mass spectrometry as previously described.
Quantitative determination of metabolites produced from 1^-labelled linalool
by rat gut microflora
The relative concentration of the metabolites were determined by t.l.c. 
and scintillation counting. Hie ether extract was applied on silver nitrate 
impregnated silicagel G plates and developed with chloroform + methylene 
chloride + n-propanol + ethylacetate (10:10:1:1) as before.
For localization of radioactivity the t.l.c. plate was scanned on a 
DUnnschicht-scanner II, (Model L.B. 2723, Counting range 10-101* cps,
Argon:methane gas (90:10) flow, 0.5 1/h, chart speed 2.5 cm/min). For 
quantitative determination of metabolites parallel strips of silicagel (5 mm) 
from the non-peak portion and 3 mm from the peak areas were scraped off from 
the plate and were counted directly in a dioxane base scintillant (see 
Chapter 4). Hie radiochromatogram has been shown in figure 3.1.
Species differences
In vitro metabolism of linalool by intestinal microflora from rat, 
mouse and guinea pig, sheep, ox and two human individuals were carried out 
according to Scheline (1966). Of the two human individuals one was accustomed 
to food with spices whereas the other was used to spiceless food. The sources 
of microflora from rat, mouse, guinea pig were caecal contents; from cow and 
sheep were rumens and from human the source was faecal extract. The 
metabolites along with unreacted linalool were extracted in ether as before. 
The extract was examined for metabolites by t.l.c. and the LKB 2091 combined 
GC/MS system.
Thin-layer chromatography
Silver nitrate impregnated silicagel G and the same solvent system as 
used in earlier investigations were used for analysis of the ether extracts 
from each species. The plates were given double deveopment for better 
resolution of the components of the mixture.
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Analysis with combined gas liquid chromatrography and mass spectrometry system
A Pye 104 analytical g.l.c. linked with LIQ3 2091 Mass Spectrometer was 
used in these studies. The column used was §n i.d. x 3 ft
and was packed with 20% 20 M carbowax on celite 545 (60-80 mesh size,
AW-DMCS). The column temperature was 140°C and injection temperature 190°C, 
helium was used as carrier gas (30 ml/min).
All the components were introduced into the mass spectrometer through 
a j et separator and the spectra were taken at acceleration voltage 3.5 KV 
with a scan speed of 30 decade/sec;(slit setting of 0.05/0.05 mm; filter 
200 Hz).
Quantitation of the metabolites: from the g.l.c. peak areas
The percent conversion was calculated by comparison of the area under 
each peak of g.l.c. trace.
With differential detectors that respond to various concentrations of 
solute in the carrier gas, the curves obtained are mainly Gaussian and the 
areas they enclose are related to the quantity of eluted substance according 
to the relation,
W. = K. A.l i i
where W. is the weight of substance T’ passing through the detector, and K. the
1 -v 1
factor of proportionality, taking into account (amongst other factors) the 
sensitivity of the particular detector to the substance being detected and 
the sensitivity of the recording apparatus.
The area was determined in two different ways depending on shape of the 
curve. For symmetrical peaks the area was determined according to Ball, jet al 
(1968) considering the peak as a Gaussian curve.Where the peak was not 
symmetrical the area was calculated according to..Kaiser (1965).___   —
Statistical Methods
In all experiments at least eight animals (4 treated and 4 controls) 
were used. Statistical evaluation of the results was determined according 
to Bailey (1959).
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RESULTS
Synthesis of dihydrolinalool 
Thin- layer cinematography
Mien the t.l.c. plate was treated with fluorescein-bromine reagent, the 
spot corresponding to the synthetic dihydro-compound prevented eosin formation 
by absorbing bromine. A similar quantity of authentic linalool prevented 
eosin. formation of the larger area than the synthetic dihydro-compound whereas 
tetrahydrolinalool gave no positive results. They have the comparable 
polarities (linalool, value-44, synthetic compound 44, tetrahydrolinalool 
46, using ordinary silicagel G thin-layer plates .and chloroform as solvent). 
This therefore indicated that the synthetic compound possessed unsaturation 
with similar polarity to linalool.
Gas-liquid chromatographic analysis
G.l.c. showed that the synthetic compound had a retention time of 19.6 min 
compared to that of linalool of 20.1 min. This retention time was higher than 
tetrahydrolinalool (14.3 minutes) under similar conditions.
Infra-red spectrometry
Hie i.r. spectral data has been tabulated in table 3.1. The i.r. spectrum 
has been shown in figure 3.2.
Table 3.1 Infra-red spectral data of synthetic 1,2-dihydrolinalool
Compound Infra-red spectrum in KBr Cm 1
CH3 ch3
1,2 dihydrolinalool
y - OH - 3400 (broad)
CH H
\ /
C
II
/ C\
ch3 ch3
Y - CH2 -
( 2970 
(
( 1675 
(
( 835
1460
CH3
i
Y - - C - 1375
Y - OH
tertiary
Y - CH2 ~ CH3
1149
1055
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Mass spectrometry
The mass spectrum showing the relative peak intensity against m/e ratio 
has been shown in fig. 3.3 and the peaks due to possible fragments has been 
worked out in table 3.2.
Table 3.2 Fragmentation pattern of 1,2 dihydrolinalool obtained in MS 12
Mass Spectrometry
Compound m/.e fragments
CH3
r
OH
CH3 
ch3 ch3
A
109
73
OH i.e. A-(CH3-CH2j
A
CH3
I
-J.~~ C -
i l l
.OH
CH3
69
H2C- H
ch3 ch3
55 HC
\
H
ch3
CHs
66
Compound m/e fragments
CH3 
OH I
- HC
CH3
+
57
CH3
1
ch3 ch3
"1
138
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Nuclear magnetic resonance spectrometry
Hie n.m.r. spectrum of authentic linaloolttig 3.4)contains three quartets,
in the olefinic region, two of which are overlapping and one poorly resolved
triplet whereas in dihydrolinalool there is one triplet only. No absorption
(fig.3.6)
peak was observable in tetrahydrolinalool in the olefinic region/and this is 
expected because of absence of unsaturation. The three quartets in linalool 
are due to the proton at 02- and two non-equivalent protons at C-l carbon 
atoms leading to a typical ABX type spectrum (see fig. 4a).
10
CH3
OH
2 / hx 
S.Cl
H, HB9-y* 8 A
I
!ch2 
ch3 ch3
The quartet centered at 6 4.23 is due to the proton at 0 2  split by the 
. protons and Hg (J^ =17 cps; Jg^ = 10 cps). The quartet centered at
6 4.88 and 5 5.0 are due to protons and proton Hg each being split by proton
HX J^AX and by each other (J^ g or JgA - 2 cps). The
NMR spectrum of 1,2 dihydrolinalool shows only a triplet in the olefinic
'v
region (6 4.7 - 5.2, fig. 3.5) which is also present in the spectrum of
linalool (6 5.35 - 5.54, fig. 3.4). This triplet in both cases is due to 
the single me thine proton at C-6. The methine proton couples with the 
methylene (-CH2-) proton at position 5 and the two methylene protons split 
the methine proton absorption into a triplet. This confirms the fact that 
in the synthetic 1,2-dihydrolinalool reduction of the double bond has 
occurred. The downfield appearance of the chemical shift of the triplet in 
the 1,2 dihydrolinalool compared to linalool is due to the dishielding effect 
after the saturation of the tt bond at 1,2 position.
The strong absorption peaks of chemical shifts between 6 = 8.31 to 10.0, 
the legion of the substituted ali.phatic compoundsjare due to tertiary CH3 groups
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in linalool, dihydrolinalool and tetrahydrolinalool. Absorption by the 
methylene groups at and Cg gives rise to multiplets in the same region, 
overlapping in part the peaks due to the methyl groups at Cg and Cg.
Metabolites produced by rat caecal microflora: thin-layer chromatography
Three compounds of values 0.42 (A), 0.50 (B) and 0.70 (C) were 
separated by silver nitrate impregnated silicagel G thin-layer chromatography. 
Linalool, dihydrolinalool (synthetic) and tetrahydrolinalool had R£ values 0.40, 
0.50, 0.68 respectively and are comparable to compounds A, B and C. Thin-layer 
chromatograms of the metabolites of linalyl acetate showed four spots of R^ 
values 0.41, 0.46, 0.50 and 0.70. The material of R^ value 0.46 was due to 
unmetabolized linalyl acetate and the other spots appeared to be identical 
with linalool (0.41) dihydrolinalool (0.50) and tetrahydrolinalool. It appeared 
then, that the rat caecal microflora hydrolysed linalyl acetate prior to 
reduction since acetates of dihydrolinalool and tetrahydrolinalool were not 
detected.
Preparative gas liquid and thin-layer chromatography
Two samples corresponding to the major peaks of. retention times 21 min
(D) and 14.3 (E) were collected by gas liquid chromatography. The compound
(E) had a similar retention time to authentic tetrahydrolinalool. The 
compound (D) was a mixture of two compounds (D^  and D2) as separated by 
silver nitrate t.l.c. had the similar R£ value as linalool p.40) and ^  
similar to dihydrolinalool p. 51).
Infra-red spectrometiy
The i.r. spectrum of B was similar to that of authentic tetrahydrolinalool 
(Fig. 3.7) and this metabolite (B) was identified as tetrahydrolinalool.
Mass spectrometry
Compound and dihydrolinalool had the similar mass spectrum of m/ e 100,
73, 69, 43, 41, 55, 138, 67, 29, 57 (Fig. 3.3). The percent intensity of each 
m/e peak was matchable to each other and therefore D2 was identified as
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F ig . 3. 8 Chromatographic p rofiles of 14C -labelled  
linalool m etabolites produced by the rat 
gut m icroflora.
6 0 -
5 0 -
40-1
3 0 -
2 0 -
10 -
0 .4 1.00. 2 0.6 0.8
Ry Values
A — Unidentified Metabolite 
B - Unmetabolized 14C Linalool 
C - 14C Dihydrolinalool
D - 14C Tetrahydrolinalool 
E - Unidentified Metabolite
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dihydrolinalool. Compound had superimposable m/e ratios with linalool 
and therefore, was identified as unmetabolised linalool.
Quantitative determination of metabolites of ltfC-labelled linalool by rat 
gut microflora
The relative proportions of the radioactivity present in the metabolites 
have been' shown diagrammatically in fig. 3.8. The incubation for 48 hours has 
produced 38% tetrahydrolinalool and 16% dihydrolinalool. Two other 
unidentified metabolites of R£ values 0.24 and 0.9 containing 3.7% and 2.6% 
of radioactivity respectively were also formed by the rat microfloral 
metabolism.
Species differences
The thin-layer chromatographic examination of the products of metabolism 
of linalool by the gut microflora of different species has been recorded in 
table 3.3. It showed that incubation for 48 hours with rat caecal microflora 
produced two metabolites of values 0.5 and 0.7 which corresponded to the 
R£ values of dihydrolinalool and tetrahydrolinalool. The presence of 
unreacted linalool was evident by the Revalue 0.42 of one of the components 
of the earlier extract.
Incubation with intestinal micro flora of mice or sheep resulted in the 
formation of a major metabolite of R£ value (0.50), that corresponded to 
dihydrolinalool. A considerable quantity of unreacted linalool was also 
present.
Incubation with rumen content of cattle gave rise to a metabolite of 
R£ value 0.24 which was not produced by the other species except the human 
individual who traditionally used spices in his food. Hie metabolic pattern 
produced by the microflora of a second human individual who ate spiceless 
food presented a different picture by producing a metabolite of Revalue 0.70 
corresponding to tetrahydrolinalool.
Combined GC/MS revealed that tetrahydrolinalool was the major metabolite
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Table 3.3 Thin layer chromatography of in vitro metabolism of linalool by 
the gut microflora of different species. Silver nitrate 
impregnated silicagel G thin layer (0.25 mm) plates were used 
as stationery phase and chloroform + methylene chloride + 
n-propanol + ethylacetate (10:10:1:1:1) as moAdng phase.
Authentic 
samples and 
metabolites
values Identified as
/
Species
Linalool 0.41 -
Dihydrclinalool 0.52 - -
Tetrahydrolinalool 0.71 - -
A 0.24 not identified Man (spice user), 
cow
B 0.41 linalool (un­
metabolised)
in all species
C 0.51 dihydrolinalool Rat, mouse, sheep
D 0.70 tetrahydrolinalool Rat, man (spice 
non-user)
' %
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and dihydrolinalool, a minor metabolite in rat caecal incubates with 
considerable amounts of unreacted linalool. In mouse caecal incubates no 
tetrahydrolinalool was present and dihydrolinalool was the only major 
metabolite. Butyric acid was present as one of the metabolites and could 
have been produced from the medium and not from linalool metabolism since the 
branched carbon skeleton of linalool would be expected to give isobutyric acid. 
However, butyric acid was not produced as a major metabolite in control 
incubates in the absence of linalool.
In incubates with guinea pig caecal contents there was no sign of the 
presence of metabolites thus suggesting that metabolism of linalool by the 
guinea pig gut microflora was essentially non-significant.
Sheep produced two major metabolites one of which was identified as 
dihydrolinalool the other metabolite F identified as a-terpineol (see below). 
One minor metabolite (metabolite A, table 3.4) of retention time 5.0 min was 
identified as y^terpinolene (peaks at m/1 93, 121, 39, 41, 79, 90, 27, 77,
53, 43).
Cattle rumen microflora produced a compound as major metabolite of 
retention time (13.8) and having the same mass spectrum as that of the 
metabolite F (table 3.4); its mass spectrum has been shown in figure 3.9. 
Computer search revealed that the mass spectrum of metabolite F was a close 
fit to (a) a-terpineol, (b) isopulegol, (c) nerol, (d) thuijyl alcohol; 
however, the best fit was suggested to be the mass spectrum of a-terpineol. 
The possible mechanism of formation of a-terpineol from linalool, under 
anaerobic conditions has been proposed below.
+ OH
OH
•Linalool a-terpineol
Mechanism of foimation of a-terpineol from linalool
Rumen microflora of cattle also produced a metabolite (metabolite J,
- 26.2 min) which was common to that produced by faecal flora of the 
spice-using human subject (see below).
Human (spice user) faecal flora produced a major metabolite of 
retention time 13.6 minutes and possessed mass fragmentation pattern 
as in metabolite F (fig.3.9), the same was the major metabolite both in. 
sheep and cattle. Two other metabolites E and J of retention time 12.2 
and 26.2 minutes were also produced. Their m/e ratio's have been recorded 
in table 3.4. The mass spectrum of metabolite J showed the strongest 
peak at m/e 60, the usual characteristic fragment of carboxylic acids.
Both these metabolites remained unidentified. % .
The faecal microflora of the second human subject (spice non-user) 
produced tetrahydrolinalool (D, table 3.4) and compound F, (X-terpineol 
as major metabolites. Metabolite G having.retention time 14.2 min. was present 
as a minor metabolite, and was identified by mass spectrometry (m/e recorded 
in table 3.4) as ethylhydroxy isobutyrate. The formation of ethylhydroxy
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isobutyrate involves a branched form carbon atom fragment which may have 
been derived from the branching at positions 3 and/or 7 in linalool.
The m/e ratios of the metabolites produced by the gut microflora from 
linalool metabolism together with percent of linalool converted into each 
metabolite have been recorded in table 3.4.
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DISCUSSION
It has been observed that rat gut microflora after 48 hours of Incubation 
converted linalool predominantly to tetrahydrolinalool (38%) and dihydrolinalool 
(16%). The gut microflora under the anaerobic conditions can reduce 
exogenous substances which may either be enzymic or chemical as demonstrated 
by Scheline (1966) and Wilde (1966) (see below). Two unidentified minor 
metabolites (3.7% and 2.6%) were also present in the rat caecal incubates.
•These may be artifacts that have originated under the experimental conditions. 
The similar metabolic pattern of linalyl acetate to that of linalool is largely 
due to the esterase activity of the gut microflora which could hydrolyse the 
ester linkage to liberate linalool. The liberated linalool on further 
metabolism produced metabolites similar to those produced in linalool 
metabolism by the gut microflora. The ability of the intestinal microflora to 
carry out hydrolysis of the ester linkage was reported previously by Scheline 
(1973). Incubation of chlorogenic acid with rat caecal microflora resulted 
in hydrolysis of the ester linkage and the further metabolism of the 
ddsterified compound to m-hydroxyphenyl propionic acid.
It is interesting to note that the metabolism of linalool by the gut 
microflora exhibited considerable species variation. Little metabolism was 
observed as a result of the action of guinea pig caecal microflora whereas, 
in the case of mouse caecal flora and sheep rumen flora, substantial reduction 
to dihydrolinalool was observed In these cases reduction did not proceed 
further whereas rat caecal content effected a second reduction to 
tetrahydrolinalool which was the major metabolite. The rumen flora of the cow 
were not seen to produce any reduction products of linalool, the major 
metabolites being a-terpineol and an unidentified carboxylic acid. 
a-Terpineol and y-terpinolene were also produced in substantial amounts by 
sheep rumen microflora. Hie detection of dihydrolinalool and tetrahydrolinalool 
as metabolites are not unexpected. Previously Scheline (1966) observed that 
rat microflora reduced substituted cinnamic acid to the saturated phenyl
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propionic acid and Wilde et al (1966) reported the reduction of double bonds 
.of linoleic acid and oleic acid by the rumen microflora of sheep. The 
phenomenon of species differences in relation to the metabolism of foreign 
compounds is of great importance in evaluating their pharmacological and 
toxicological implications. The cause of species variations in metabolism by 
the intestinal microflora may be differences in the microbial species 
inhabiting the gut of various animals (Scheline, 1968; Drasar, et al-, 1970, 
see Chapter I). It has been reported that rabbit intestinal microflora have 
been found to metabolize xanthurenic acid 8-methyl ether (Lower and Bryan,
1969) and (+) catechin (Scheline, 1970) differently from that which is seen 
with the gut microflora of mouse and rat respectively. Again Walker, et al«5 
(1970) have found differences in the metabolism of Brown FK by mouse and by 
rat (see page 30 ), with consequent differences in toxicity. The difference 
in metabolism may be due either to differences in the nature of the gut 
microflora and/or differences in the environment in the large intestine of 
these two species, e.g. redox potential. The differences reported here in the 
metabolism of linalool between the gut microflora of mouse, sheep leading to 
1,2 dihydrolinalool and rat leading further to tetrahydrolinalool may be due to 
similar reasons. V
The studies using human faecal microflora revealed interindividual 
differences which were as pronounced as the interspecies differences observed 
above. Thus the individual who habitually used a highly spiced diet showed 
many similarities to the cow in producing substantial quantities of 
a-terpineol and the same unidentified acid metabolite. A second unidentified 
metabolite E (table 3.4), which on the basis of mass spectral data appeared to 
be structurally similar to a-terpineol, was unique to this individual, on the 
other hand, the individual who regularly ate a bland diet more closely 
resembled the rat in producing tetrahydrolinalool as the major metabolite. 
Another interindividual difference was seen in the presence of ethylhydroxy
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isobutyrate in incubates of faecal material from this individual. The 
production of tetrahydrolinalool by the faecal flora of the', spice non-user 
and not by the other may be due to the ability of the former to generate lower 
redox-potential in the gastrointestinal environment.
The difference in the dietary factors may also have selective influence 
in the composition of the gut microflora which may become adapted to metabolize 
certain compounds thus leading to variation in metabolism of a compound. An 
interesting example in this area is the conversion of cyclamate to 
cyclohexylamine. Drasar, et al (1971) found that clostridia in rat faeces 
were able to convert cyclamate to cyclohexylamine whereas in human and rabbit 
enterococci were responsible for the same conversion. Hill, et al (1971) 
showed that faecal enterococci are much higher in the Japanese than in the 
British. Kojima and Ichibagase (1966) actually demonstrated that all 
Japanese individuals investigated, excreted cyclohexylamine following oral 
ingestion of cyclamate. Renwick and Williams (1969), in an experiment with 
rat found that after a single dose of cyclamate no cyclohexylamine was produced. 
However, rats receiving 0.50% cyclamate for 3 months all excreted 
cyclohexylamine as a metabolite up to 351 of the dose.
Oriental foods are usually cooked with spices containing coriander seed 
as an ingredient which contains essential oils, mostly linalool, and therefore, 
it might have a selective influence on the gut microflora of the spice user 
leading to an adaptive situation.
In the metabolism of linalool the observation that gut microflora of some 
species carried out reductive reactions reported here, in general, illustrated 
typical reactions previously reported by (Scheline, 1966 and 1973) and 
Wilde, et al (1966). However, the identification of a-terpineol in the 
incubates of microflora from two human individuals, sheep and cow; and 
y-terpinolene in the incubate from sheep are evidence of a class of reaction 
not previously reported, i.e. cyclisation. These metabolites are lipophilic
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Ethylhydroxy Isobutyrate 
(man spice-nonuser ) /
Several
Steps
Tetrahydrolinalool 
(rat, man spice-nonuser)
Dihydrolinalool 
(rat, mouse, sheep)
h 3c c h 3
o'-Terpineol 
Metabolite F 
(man spice-user, 
man spice- nonuser, 
sheep, cow)
Linalool
CHoOH
Geramol
Metabolite E
(mass spectrum similar to 
o'-Terpineol but not identical 
in man spice-user)
Metabolite J 
(an acid - ,  
in man spice-user, 
cow)
y-Terpinolene
(sheep)
Fig. 3.10 The possible routes of metabolic transformation of linalool by 
the ‘gut-microflora of different species. The compounds in the 
square brackets have not been isolated. The species which can 
produce a metabolite has been put in parenthesis.
substances and therefore could be absorbed and metabolized in the liver.
In metabolic experiments in the rat in vivo it was observed (see Chapter 4) 
that a considerable amount 1^C-labelled linalool was excreted as dihydro- and 
tetrahydrolinalool glucuronides in urine and bile. It was also demonstrated 
that glucuronides excreted in the bile were hydrolysed by the gut microflora 
and linalool and its reduced products were reabsorbed to enter into the 
enterohepatic cycle. As a result the excretion was delayed. The wide range 
of compounds such as dihydrolinalool, tetrahydrolinalool, a-terpineol, 
y-terpinolene, ethylhydroxyisobutyrate along with some unidentified metabolites 
(see fig. 3.10) produced by the gut microflora of different species might have 
pharmacological and toxicological implications regarding which little is 
known. In view of the continued ingestion of linalool by humans and animals 
the toxicology of its metabolites need to be evaluated in its safety testing 
for use as a food additive. These observations clearly indicate the value of 
intestinal metabolic studies, including man, in evaluating the hazard from 
food additives since variations between species and individuals, and as 
a result of dietary factors were observed. These factors have been discussed 
in the literature previously (Scheline, 1971) but, are frequently ignored in 
toxicity testing of food additives and other environmental qhemicals.
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Chapter 4
Absorption, Distribution and Excretion of ^C-.labelled Linalool
in the Rat
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Absorption, Distribution and Excretion of-^G-labelied Linalool in the Rat
1. Introduction to absorption, distribution and excretion of xenobiotics.
A. Absorption of foreign compounds
Absorption of foreign compounds may take place by oral, respiratory 
or dermal routes and hence enter the blood stream. In the course of 
absorption and distribution, the foreign compounds encounter membranes of 
the gastrointestinal epithelium, the lining of the respiratory tract, 
stratum comeum of skin the membranes enclosing the blood and other 
body fluids, cell membranes and membranes within the cells, which control 
the uptake into tissues and subcellular components. These membranes are 
highly complex, dynamic lipoprotein structures consisting of several layers 
of cells, e.g. skin and placenta, single layers of cells, e.g. intestinal 
epithelium or less than one cell thickness, i.e. cell membrane. Substances 
may cross the biological membranes one or more of the processes of (a) passive 
diffusion, (b) filtration, (c) facilitated diffusion, (d) active transport,
(e) pinocytosis. Most foreign compounds cross the lipoidal membrane by 
passive diffusion down a concentration gradient.
a) Gastrointestinal absorption. The mucosa of the gastrointestinal 
tract is a semipermeable membrane across which various nutrients as well as 
foreign compounds are transported into the blood by the above mentioned 
mechanisms.
Passive diffusion is by far the most important process of absorption of 
foreign compounds from gastrointestinal tract. No energy is required, it is 
not saturable and the transport is directly proportional to the concentration 
gradient and to the lipid/water partition coefficient of the drug. The higher 
the concentration gradient and lipid/water partition coefficent the faster 
is the rate of diffusion. Movement stops when the concentration on both the 
sides of the membrane is the same but this equilibrium situation is very 
seldom reached because transfer of the material by blood usually maintains a
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concentration gradient across the membrane. The phenomenon of passive 
diffusion becomes more complicated when the foreign compound is either a 
weak base (e.g. Caffein) or a weak acid (e.g. Barbiturates). If these bases 
and acids are fully ionized they are very slowly absorbed. Non-ionized drugs 
diffuse across the membrane faster as they are readily lipid soluble. The 
degree of ionization is related to pH and also to P^ "a. Acids with higher P^a 
will diffuse faster whereas the reverse is true for a weakly basic drug 
(Schedl, et al, 1961).
Studies of the gastric absorption of drugs in the rat and human have 
shown that the epithelial lining of stomach is permeable to the lipid soluble 
unionized form of drugs and relatively impermeable to the ionized foirni, unless 
these too are highly lipid soluble. Weak acids namely, salicylates and 
barbiturates, which are mainly unionized at the low pH of the stomach contents, 
are readily absorbed. Conversely weak bases such as quinine and amidopyrine 
are hardly absorbed at all. In gastric juice aniline is largely ionized but 
.in the pH of the plasma remains mostly unionized. Therefore, according to 
the pH partition hypothesis aniline will diffuse from plasma to the stomach 
depending on the maintenance of a concentration gradient of the unionized 
molecule.
The intestinal epithelium, like gastric mucosa allows ready penetration 
of lipid soluble, unionized molecules and generally retards that of ionized 
(Parke, 1968; Schanker, 1962). In the small intestine the contents have pH 
of about 6.5 but true pH of the intestinal lumen is 5.3 (due to secretion of 
hydrogen ions, Hogben, et al, 1959) where aniline will be less extensively 
ionized than rat stomach pH and hence will be absorbed in the intestine.
The absorption in rat colon follows the similar pattern as that of 
small intestine (Parke, 1968). The pH increases in the contents of colon 
(pH 7-7.5). Stronger acids that are more highly ionized at this pH are poorly 
lipid soluble and thus do not cross lipoidal membranes readily. Weak acids 
and bases are generally readily absorbed.
The large intestine may be a site of absorption of compounds poorly
absorbed by small intestine, and particularly of their metabolites produced
by the micro flora of the caecum and colon. The main site of
kclabsolution of an ionized substance is largely dependent on itsp , and the 
lipid solubility of its ionized and non-ionized forms.
b) Factors affecting gastrointestinal absorption
(i) Absorptive surface - Hie small intestine has particularly a huge 
surface area. The absorptive surface is increased about thirty to forty times 
by microvilli which are covered with lipid protein membrane and thus provides
one condition for rapid passive drug absorption.
(ii) Gastrointestinal motility - Accelerated gastric emptying reduces 
gastric absorption but increases intestinal absorption. The extent of mixing 
of the intestinal content depends on the rate of intestinal peristalsis which
to some extent influences the absorption (Parke, 1968). It has been reported
that anticholinergic drugs interfere with absorption by diminishing the 
intestinal motility (Binns, 1971).
(iii) Circulation in the gastrointestinal tract - The increased 
intestinal blood circulation will maintain the higher concentration gradient 
and would thus accelerate the absorption of drug.
(iv) Alimentary secretions - The pH of the alimentary secretions varies 
from pH 1-3 in the stomach to pH 6-6.5 of the intestinal and pH 7-7.5 in the 
colon (Binns, 1971; Chasseaud, 1970). The effective pH of the intestinal
ICct lCclsurface is 5.3 and at this pH the acids with P 3 and bases with P > 8  are 
poorly absorbed (Brodie, 1964). The intestinal juices contain numerous 
hydrolytic enzymes such as esterases, amidases and hydrolysis in the gut of 
conjugates excreted in the bile may lead to enterohepatic circulation due to 
reabsorption of the deconjugated compound.
(v) Drug interaction within the lumen - Intraluminal interactions 
affecting absorption were demonstrated by administering activated charcoal,
which decreased the absorption of promazine (Sorby, 1965), while the increased 
absorption of fluoride caused by iron, phosphate and sulphate in the rat is 
probably by the ionic interaction within the lumen (Stookey, et al, 1964).
The absorption of tetracycline is impaired by formation of chelates with 
calcium JLron and other metals (Parke, 1968). Changes in intestinal absorption 
due to change in the composition of diet have been reported (Underwood, et al, 
1951; Reynolds, 1965). Underwood (1951) demonstrated that increased 
absorption of Ca is effected by vitamin D. The absorption of glycine, fat 
and xylase is depressed by the deficiency of vitamin Bi2. Little is so far 
known about the effects of dietary changes on the extent of absorption of 
non-nutrients but Booth, et ab*5(1958) demonstrated that different basal diets 
fed to rabbits affected the absorption of hespiridin.
(vi) Other factors:
Species differences - The different sensitivities of experimental animals 
to foreign compounds is well known. This may be exemplified by the difference 
in absorption of coumarin between man and rat (Crampton, 1970). Daniel, et al.5 
(1968) demonstrated that rat and man differ in their metabolism of 3,-5,di- 
tert-butyl 4-hydroxytoluene (BBT). Such differences could be due to different 
lumen pH affecting ionization (Crampton, 1970).
Sex - Crane (1960) has reported some sex differences in the absorption of 
glucose in male and non-pregnant female rats.
Age - In the elderly decreased absorption of vitamin A and thiamin, 
vitamin Bi2 and amino acids have been reported (Rafsky, et al, 1943; 1948;
Ellenbogen, et al, 1958; Fowler, et al*, 1960). The.primary causes have not 
been established.
Gut microflora - Compounds which are themselves not readily absorbed may 
be bio transformed by the gut microflora (See section C, Bio transformation) and 
the intestinal metabolites subsequently absorbed. In view of the qualitative 
and quantitative differences in the composition of the intestinal microflora
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of different species (Drasar, et al*, 1970) the variation in the nature of the 
metabolism carried out by the gut microflora may lead to increase or decrease 
in absorption of the foreign compounds and their metabolites. Moreover, the 
nature of the gut flora, and hence their metabolism, may also be affected by 
diet.
Disease of the gastrointestinal tract
Removal of part of the gastrointestinal tract in diseases like peptic 
ulcer and malignant tumours leads to the impairment of absorption. Tne removal 
of the stomach, is followed by loss of gastric secretions, increased motility 
of the small intestine and shorter transit times and therefore, a diminished 
absorption is expected (Stammers and Williams, 1967). Underhill (1910-11) 
suggested removal of appreciable segments of small intestine has surprisingly 
little effect on change of absorption, however, diminished absorption of fat, 
calcium, potassium and magnesium, vitamin A and other nutrients have been 
observed when greater length of small intestine is removed (Trafford, 1956-7; 
Croot, 1952; Althausen, et al, 1950).
c) Other routes of absorption
Absorption through skin, from trachea and lungs are of little importance 
to nutrition but may be of considerable toxicological importance. The 
epidermis of skin is a lipoidal barrier and is therefore more readily permeable 
to lipid soluble substances. The topmost homy keratinous layer stratum 
corneum gives the barrier property to the skin (Vinson, 1965).
Inhaled gases and vapours are rapidly absorbed through the alveoli which 
have thin, highly vascular membrane of large surface area. Unlike the body 
membranes, the pulmonary epithelium appeares to be highly permeable to lipid- 
soluble molecules and also to lipid-insoluble molecules and ions (Enna, et aL, 
1969). Absorption through skin and lung becomes important for volatile solvents 
such as aromatic and chlorinated hydrocarbons. The antileprosy drug 
diethyl dithiolisophthalate is administered percutaneously because of the 
nature of the disease and because other usual routes of administration are
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unsatisfactory (Ellard, et ai, 1963).
Administration through lungs becomes important for lipid soluble gases, 
for example, anaesthetic gases. This route is also of some importance when 
drugs are administered as aerosols, e.g. Intal in the treatment of asthma.
B. Distribution
Foreign compounds or their metabolites which are absorbed from the 
gastrointestinal tract enter the liver via the portal vein.Absorption may also 
take place via the lymphatic system and transport to the superior vena-cava. 
Mien the substance reaches the liver it .may be metabolized and/or conjugated and 
transported via the hepatic vein to the kidney for excretion in the urine. 
Xenobiotics or their metabolites may be carried in blood stream (Schanker, 1964) 
in one or more of the following ways.
1. As free-diffusible molecules dissolved in plasma.
2. As molecules reversibly bound to protein and other constituents of
serum.
3. As free or bound molecules contained within the erythrocytes.
These are then distributed by circulation in blood between various organs and 
tissues as well as intracellularly. The concentration of the drug level in 
the blood thus gradually decreases with tissue uptake. Bio transformation and 
excretion further decreases the concentration of the compound in the blood. .
Some of the compound returns from the tissues to the blood, and the process., 
one of mobile equilibrium, continues. Mobile equilibrium involves interrelated, 
interdependent and continuous processes in which the compound is circulated, 
taken in, released and circulated. Finally, the compound is eliminated from 
the body, usually partly bio transformed (Chasseaud, 1970). .The compound may 
not be excreted quickly if it is localized in tissues (including adipose 
tissue), erythrocytes or bound to plasma proteins. Tissue storage and plasma 
binding of foreign compounds increase the residence times of the drug thus 
prolonging its physiological action. Protein binding on one side of the
membrane increases the concentration gradient and thus facilitates absorption 
by passive diffusion. Foreign compounds may displace endogenous substances 
e.g. steroids that are bound to plasma proteins and thus unbalance the 
bound:unbound ratio in the plasma causing altered physiological effects 
(Westphal, 1969; Brodie, 1965).
C. Biotrans formation
The ability of the intestinal microflora to metabolize widely different 
chemical structure has been reported (Scheline, 1973; Shrier & Noller , 1957). 
Water soluble foreign compounds could reach the heavily populated caecum where 
the gut flora may metabolize them before absorption. For example, Radomski 
and Mellinger (1962) demonstrated that a number of water-soluble azo dyes were 
poorly absorbed after oral administration and were metabolized to a large 
extent by the gut microflora. Significant amounts of the metabolites 
(reduction products) were then absorbed.
The metabolites that are produced by the gut microflora may be less or 
•more toxic than the parent compound. Thus, the glycoside amygdalin when 
administered orally to mice is toxic due to the liberation of cyanide after 
hydrolysis of the glycoside by the gut microflora. Parenteral administration 
of amygdalin is practically non-toxic. Similarly, the carcinogenic effect of 
cycasin is due to the production, by the intestinal microflora, of methyl 
azoxymethylglucoside which is believed to be metabolized to the proximate 
carcinogen diazomethane. Cycasin is not carcinogenic when injected.
Bacterial glucuronidase may hydrolyse polar glucuronides of foreign 
compounds or of endogenous substances which are excreted in the bile. The 
parent compound is usually more toxic than the glucuronide and is also less 
polar and thus can be reabsorbed to establish an enterohepatic cycle. The 
effects of the compound would thus be prolonged.
Detoxication which is not common in the gut can be exemplified by the 
deconjugation of biliary excreted carcinogenic N-hydroxy-N-2-fluorenylacetamide
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glucuronide by the gut microflora to the parent compound which has lower 
carcinogenic activity. The parent compound is further metabolized by the 
gut flora to the dehydroxylated compound which in turn is less carcinogenic 
(Walker, 1973; Grantham, et aL, 1970). The potential of the metabolic 
activity of the gut microflora could be comparable to that of liver 
(Drasar, et al, 1970). In addition microbial composition can change due to 
various selection pressures. So that the adaptive capacity of the gut flora 
is greater than that of the liver. For example prolonged exposure to 
cyclamate can lead to increased conversion to cyclohexylamine by the gut 
microflora both in experimental animals and in man (Williams, 1970). Hie 
overall' metabolic transformation in the liver is commonly synthetic whereas 
in the gut it is more usually degradative in nature.
However, the foreign compounds or their metabolites produced by the 
gut microflora enter the portal blood circulation after being absorbed from 
the gastrointestinal tract, and are transformed by the tissues principally by 
the liver but in some cases by other organs like kidney, lung, placenta. The 
nature of reactions and biological properties of metabolites indicate that the 
general pattern of biotransformation is biphasic (Williams, 1960). In the 
phase I reaction foreign compounds undergo oxidation, reduction and/or hydrolysis 
to introduce -OH, -C00H, -NH2 groups. Phase II reactions involve conjugation of 
the xenobiotic or its phase I metabolites with endogenous compounds to produce 
more polar compounds and facilitate urinary and/or biliary excretion. In the 
course of phase I reactions foreign compounds closely resembling endogenous 
substrates may enter pathways of intermediary metabolism (Chasseaud, 1971).
In coprophagic animals, which includes most rodents, the regular ingestion • 
of faeces results in an active microflora throughout the whole length of the 
gastrointestinal tract and microbial metabolism may occur even in the stomach.
D. Excretion
a) Biliary Excretion - As a result of high permeability of the hepatic
parenchymal cells the boundary between the blood and bile is extremely porous 
so that molecules and ions smaller than proteins can pass through. Many 
substances therefore appear in bile in concentration similar to those of 
plasma (Parke, 1968). Highly polar compounds such as bile salts, bilirubin 
glucuronides and conjugates of foreign compounds are excreted into the bile 
in much higher concentration by a process of active transport. Active 
secretion has also been reported to occur with compounds which are present 
in the blood as anions, and have molecular weight greater than 300 and are 
bound to plasma proteins (Brauer, 1959). Food additives having suitable 
conditions for conjugation may-form glucuronides, e.g. erythrosine (Webb, 
et aL, 1962) and less frequently as sulphates, e.g. indocyl sulphate and 
mercapturic acid, e.g. BHT. Compounds may appear in the bile in the original 
form, e.g. Ionox 220 (Wrigert, 1966). DDT and its metabolites are also 
excreted in bile (Bums, 1967).
Species variation has been observed in the excretion of foreign compounds 
in bile. Highest biliary excretion was demonstrated in dog and rat
(Abou-el-Makarem, 1966). Increasing number of hydroxyl groups increases biliary
excretion since 4-4’ dihydroxybiphenyl monoglucuronide is more readily excreted 
than 4 hydroxybiphenyl glucuronide (Parke, 1968). Decreased urinary excretion 
may occur due to increased excretion in bile. This was observed for several
fluorescein dyes in rat (Eakins, et al, 1969).
b) Enterohepatic circulation - The conjugates of foreign compounds 
excreted in the bile may partly undergo hydrolysis by the enzymes 
3~glucuronidases,sulphatases, etc., present in the bile or intestinal secretion 
or enzymes of the gut microflora. The hydrolysed drug may be reabsorbed 
unchanged or metabolized further by the gut microflora before reabsorption.
In the liver the absorbed substances are conjugated and excreted in the bile 
and/or urine. This cyclic process of recirculation of drugs or their 
metabolites through liver-bile-liver is known as enterohepatic circulation.
The existence of enterohepatic circulation with stilboestrol and
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chloramphenicol has been demonstrated (Parke, 1968). The residence time of 
drug in the body is increased due to enterohepatic circulation and thus 
physiological action is also prolonged. .
c) Excretion in Urine - Foreign compounds and their metabolites are 
mostly excreted in the kidney by three distinct processes, glomerular filtration, 
active tubular secretion of ionized substances and passive tubular absorption
of unionized substances (Goldstein, et al., 1968). Although different, these 
mechanisms are complementary to one another. Glomeruli are concerned with 
the ultrafiltration of the blood plasma. The lipid soluble unionized substances 
in the ultrafiltrate passes into the kidney tubules and are reabsorbed into the 
blood stream by passive diffusion across the distal tubular epithelium.
Active transport of certain anions and cations takes place from the blood 
plasma to the glomerular filtrate across the tubular epithelium. Plasma 
protein binding of foreign compounds and rate of renal clearance largely limit 
the rate of urinary excretion of foreign compounds. The rate of renal 
clearance in turn is largely dependant on the rate of glomerular filtration, 
active tubular secretion and passive tubular absorption. Glucuronides, 
sulphates, mercapturates are polar lipid insoluble molecules and are therefore 
readily excreted. Excretion of weak acids and weak bases ai;e pH dependent 
therefore at alkaline pH (larger proportion is ionized) of the tubular urine 
the weak acids will be readily excreted and less is absorbed. The reverse is 
true for the weak bases. Amphetamines when orally administered to humans is 
readily excreted demonstrating the permeability of tubular epithelium to 
unionized molecules (Beckett, 1966).
d) Excretion in Expired Air - Gaseous anaesthetics containing low 
molecular weight compounds having sufficiently high vapour pressure are 
excreted in the expired air. Rabbits when given oral doses (0.5 g/kg) 
excreted 39% of benzene, 44% fluorobenzene, 27% chlorobenzene and 6% 
bromobenzene in expired air (Parke, 1968).
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The enzymes of intermediary metabolism may degrade relatively simple 
foreign molecules or analogues of endogenous substrates wholly or partly 
which may be eliminated in the expired air as CO2 and/or H2O.
The degraded moiety after passing through intermediary metabolism may be 
incorporated into the tissue and therefore its complete excretion is delayed. 
When Maleic acid was administered intraperitoneally to rats, 40% of the dose 
was excreted as CO2 in five hours. Administration of ethylmethane sulphonate 
by the same route in rats resulted in the excretion of 34% in the expired air 
over twenty four hours, (Roberts, et al., 1958).
e) Excretion in gastro-intestinal secretion - Under favourable conditions 
of concentration gradient according to pH partition hypothesis, ionizable 
foreign compounds in circulating blood may be excreted into the gut. Aniline 
base was secreted into stomach (pH 1) of rats from plasma pH'7.4 (Shore, et al., 
1957). As the pH down the intestine increases these bases are reabsorbed 
intestinally.
The essential oils found in nature are mixtures of a number of 
monoterpenes of which the oxygenated monoterpenes are the bearers of specific 
odoures and are important constituents of many essential oils extensively used 
in flavouring foods. Some have medicinal importance as many of them are 
pharmacologically active.
In view of the wide range of use of essential oils the study of 
metabolism and toxicological implications of this class of naturally occurring 
compounds and their metabolites is of considerable significance to their 
safety evaluation.
Hildebrandt (1901), in the course of his study of the phamacological 
activity of many aliphatic terpenes, isolated Hildebrandt acid, and dibasic 
acid, from the urine of rabbit given citral. Kuhn, et al.r(1935, 1936) studied 
the fate in rabbit of a series of open chain terpene derivatives including 
geraniol, citral and geranic acid. All of these were partially metabolized to 
Hildebrandt acid and excreted into the urine. The total metabolic fate of 
these terpenes was not determined.
Linalool, a tertiary unsaturated alcohol, isomeric with geraniol, is 
the chief constituent of linaloe oil and is known as coriandrol in coriander 
seed oil. It also occurs in oil of cinnamon, orange and other citrus fruits. 
As a result of its wide distribution in citrus fruits, herbs and spices 
linalool along with other oxygenated monoterpenes is being ingested by animals 
and humans in significant quantities. Therefore, the study of metabolism of 
linalool and its toxicological implications are of significant importance.
It has been widely accepted (Dacre, 1970) that toxicological studies of food 
additives, whether intentional or unintentional, must include an investigation 
of their metabolic fate. In this regard 1^C-labelled linalool was 
administered and its absorption, distribution, blood levels, tissue storage, 
metabolism and ultimate fate were determined in rat.
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MATERIALS AND METHODS 
Materials
^C-labelled linalool (specific activity 0.52 yCi/mg) was synthesised 
in this laboratory as described in Chapter 2. 2-ethoxy ethanol, 99.51 pure 
by g.l.c., anaesthetic agent ethylcarbamate, hyamine 10-X hydroxide solution 
and all other chemicals were from BDH.
The cannula tubing used for the purpose of bile cannulation had i.d.
0.4 ram and o.d. 0.8 mm (Portex).
Scintillator chemicals such as 2,5-diphenyloxazole (PPO), l,4-bis-2 
(4-methyl-5-phenyloxazolyl)benzene(dimethyl POPOP), "Cab-O-Sil", naphthalene 
and toluene (5.65 x 105 dpm/g) internal standard were obtained from 
Packard Instrument Company.
Experimental
Administration of linalool and metabolic experiments
Three male and 3 female rats of twelve weeks old weighing 355-370 g 
(males) or 210-225 g (females) (Animal Unit of the Surrey University), were 
housed individually in all glass Jencons metabolic cages (Metabowl Mark III, 
Jencons Ltd., Hemel Hemptead, Hertfordshire, England) for at least 24 hours 
for acclimatization prior to administration of linalool. The metabolic cages 
were equipped with two Nilox columns (all glass) and a wash bottle containing
2-ethoxy ethanol:ethanol amine mixture (2:1) for absorption of CO2 from 
expired air. Each column contained 500 ml of the absorbent liquid and the wash 
bottle contain ed 200 ml of the same liquid. The airflow rate through the 
metabowl was adjusted to between 380-400 ml/min. During experimentation, the 
animals were allowed food and water ad libitum and were maintained on 
Spratts laboratory pellet diet No.l. The animals were accommodated under 
controlled conditions of temperature (20-22°C), and lighting (12 h light and 
12 h dark). After the expiry ' of the period of acclimatization the animals 
were given a single dose of 1^C-linalool (500 mg/kg; 5-10 yCi) intragastrically
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as a-251 solution in propylene glycol. Samples of urine, faeces and 
absorbent solution from the Nilox columns were collected at intervals of 
6 h., 12 h., 24 h., 36 h., 48 h. and 72 h after dosing.
Residual radioactivity in tissues 72 hours after dosing: 'preparation of 
tissue homogenates. ■ '
At the end of the excretion studies the animals were killed. To determine 
the distribution of radioactivity in different tissues, homogenates from brain, 
liver, heart, kidney and spleen were prepared using a Potter-Elvehjem 
homogenizer to make a 251 homogenate in water. Skin and skeletal muscle we re 
digested in 6 M NaOH by warning in a water bath at 40°C overnight. In samples 
where dissolution was incomplete, the concentration was increased to 9 M NaOH 
when a homogeneous solution was obtained. The lung was chopped with a scalpel 
and dissolved in 3 M NaOH at 40°C to prepare a 25% homogenate. Tissue from 
the gastrointestinal tract, which contains muscle and .connective tissue, was 
cut into small pieces with a scalpel. Hie mass was then homogenized in water 
containing glass beads in a Waring blender.
Biliary excretion.
Two twelve week old male rats weighing 330-360 g were anaesthesised 
with urethane (1.75 g/kg as 25% solution in water) by subcutaneous administration 
Complete anaesthesia was achieved one hour after urethane administration. The 
ventral surfaces of the animals were shaved using clippers and the necessary 
area was bathed with Wescodyne iodophor (Bengne & Co., Wembley, Middlesex). A 
mid ventral line incision about two inches was made through skin and body wall 
with a scalpel. After locating the common bile duct and clearing off the 
connective tissues, the hepatic end of the common bile duct was ligated loosely 
anterior and posterior to the site of incision. A ’V ’ shaped notch was made 
with scissors on the bile duct between the two loose ligations and a 35 cm 
polythene cannula (i.d. 0.4 mm, o.d. 0.8 mm) was inserted into the incision and 
the anterior ligature tightened to hold the cannula firmly. Bile started
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flowing through the cannula immediately. The duodenal end of the common 
bile duct was then tied.off by tightening the posterior ligation. The 
cannula was passed successively through the abdominal wall and the skin by 
making two incisions with a hypodermic needle. To close the vertical midline 
incision the abdominal wall was stitched by suture thread and the skin closed 
with suture clips.
The bile was collected in preweighed tubes and when steady flow was 
attained (3040 mins) 1 ^ C-labelled linalool (1 yCi; 20 mg) was administered 
interperitoneally as a 101 solution in prolyiene glycol. Bile was collected 
at half hourly intervals over a period of 6 hours in preweighed 3 ml tubes.
The animals were covered with cotton wool and were kept warm by suitably 
located Anglepoi.se lamps fitted with 60 W tungstan-filament bulbs; Saline 0.9 
was administered interperitoneally at intervals to replace body fluid lost due 
to collection of bile. '
Enterohepatic circulation.
Biliary excretion of 14C .and delayed excretion of radioactivity in the 
faeces indicated the possibility of involvement of linalool in enterohepatic 
circulation. This possibility was more pronounced when the study of tissue 
distribution revealed that after the carcass the specific activity of 14C was
'V
mostly concentrated in the liver and in the gut indicating the possible 
existence of enterohepatic circulation of linalool.
To demonstrate the enterohepatic circulation two male rats of twelve 
weeks old (358 g and 364 g) were anaesthesized with urethane ' (1.75 g/kg body wt. 
as 251 solution in water) and their bile ducts cannulated as in Fig.l. The 
hepatic end of the common bile duct of the first animal was cannulated as 
described earlier. After passing the cannula through the two incisions 
through the abdominal wall and skin and stitching the ventral midline incision 
the cannula was introduced into the incision made in the duodenal end of the 
common bile duct of the second animal. The hepatic end of the common bile
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Fig. 4 .1  C ross Over Experiment to dem onstrate Enterohepatic 
Circulation.
Com m on b ile  duct
Cannula 2
Cannula 1
Duodenum
Two m ale rats w ere anaesthesised  and b ile  ducts w ere cannulated. 
A cannula from the bile duct of the first animal w as inserted  into 
the duodenal end of the b ile  duct of the second animal while another 
cannula was inserted into the hepatic end of the bile duct of the 
second animal, the bile duct being ligated between the cannulae. 
The presence of radioactivity in the bile of the second animal after
i .p . adm inistration of 14 C -lab e lled  linalool to the first anim al 
w as indicative of enterohepatic circulation.
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duct of the second animal was cannulated and cannula 2 was introduced. The 
bile duct was ligated at position (L), between two cannulae to ensure that 
there was no diffusion of radioactivity either way. After making necessary 
incision to pass the cannula through the abdominal wall and the skin the 
'ventral midline incision of the second animal was stitched and bile was 
collected in preweighed 3 ml tubes.
Determination of radioactivity.
The lhC content of the various samples was determined by the addition of 
15-20 ml of scintillator solution to 0.1-0.5 ml of material and counting in a 
Packard Tricarb Spectrometer Model 3320.
The following scintillators were used depending on the accommodative 
capacity of water in the samples.
(a) 30/70 scintillator - 300 ml of absolute alcohol, 700 ml of toluene 
(analar BDH), 0.1 g POPOP (1,4 bis-2 (4-methyl 5-phenyl oxazolyl-benzene) and 
3 g PPO (2,5 diphenyl oxazole). This scintillator could accommodate 0.7% - 
0.8% water. This scintillator was therefore used for counting radioactivity 
in urine (0.1 ml) and bile (0.05 ml or 50 yl). This scintillator was also 
used for determining the radioactivity in the 14C02 absorbed liquid that 
contained expired air.
(b) Gel scintillator - Naphthalene.(60 g), PPO (4 g), POPOP (0.2 g), 
1,2-ethanediol (20 ml) , methanol (100 ml) and 1,4 dioxane was added to make 
the volume to 1 litre. This scintillator has a capacity of accommodating 
water upto 10% and was used for counting samples of the tissue digests. 
Radioactivity in urine and expired air.
Urine and expired air (in the liquid absorber) were collected at intervals 
of 0-6, 6-12, 12-24, 24-36, 36-48 and 48-72 hours after intragastrie 
administration of 1 kC-linalool. Aliquots of 0.1 ml urine were counted in 15 ml 
of 30/70 scintillator while for expired air, 2 ml aliquots of the liquid 
absorber were counted in 15 ml of the same scintillator. All the samples were 
counted in duplicate ana corrected for counting efficiency by internal
standardization using luC-toluene (5 yl, 2381 dpm).
*
In order to confirm that the radioactivity in the expired air was 
principally as ltfC02 the following experiment was performed. Aliquots of 5 ml 
of the liquid absorber taken at the intervals 0-6 h, 6-12 h, 12-24 h, 24-36 h, 
36-48 h and 48-72 h were pooled together. An equal volume of 2 M barium 
chloride was added to precipitate ll*C02 as barium carbonate (Calvin, et al., 
1949), the mixture was then shaken for half an hour in a mechanical shaker and 
allowed to stand over night. Inactive barium carbonate (500 mg) was added as 
carrier, shaken for twenty minutes, allowed to stand for an hour and filtered 
through a Gooch crucible. An aliquot of 2 ml of the filtrate was counted 
for ndioactivity, if any, after precipitation of Balt+C03. The barium carbonate 
precipitate was washed, dried and counted for llfC in 20 ml gel scintillator.
The radioactivity present in the barium carbonate precipitate was compared with 
that of the known quantity of the pooled liquid absorber. This suggested that 
radioactivity present in the expired air was principally due to 14C02 and not 
■due to 14C labelled linalool or other volatile metabolites.
Radioactivity in tissues.
Tissue homogenates containing 100 mg of tissue were treated with 1 ml of
hyamine hydroxide 10 x 2, (BDH) and incubated at 37° for 12-16 hours in
' %
scintillation vials. The samples were prepared in duplicate. Gel scintillator 
(20 ml) was added to the vials and counted for 14C.
Faecal radioactivity.
The faeces were collected over five intervals 0-12, 12-24, 24-36, 36-48, 
48-72 hours instead of six intervals as the animals did not defaecate during 
0-6 hour period. Each faecal collection was treated in the cold with two 
volumes of absolute methanol and allowed to stand overnight. The methanol 
was decanted off and the faeces were homogenized in further methanol. After 
addition of one more volume of absolute methanol the homogenized mass was 
extracted thoroughly for one hour using a mechanical shaker. The methanol 
layer was decanted after centrifugation. Extraction with fresh absolute alcohol
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was repeated three times. The pooled methanol extract (0.5 ml) was then 
♦
counted for radioactivity in 15 ml of 30/70 scintillator. The remaining 
radioactivity in the extracted faecal residues was determined by digestion of 
10-15 mg portion overnight at 37°C with 1.5 ml of hyamine-10 X hydroxide and 
0.5 ml of water prior to the addition of gel scintillator (20 ml) (Crew, et al., 
1971). The counting efficiency was determined by using 1UC toluene as 
internal standard. All samples were counted in duplicate.
Biliary radioactivity.
Bile (50 yl) was assayed for ltfC in 15 ml 70/30 scintillator. The samples 
were counted in duplicate and corrected for counting efficiency as before. 
Analysis of blood.
Heparinized (0.1 ml) blood was digested at 37°C for 24 hours with 1 ml 
hyamine hydroxide in the scintillation vial. The digested blood was then 
counted for llfC in 20 ml gel scintillator. lhC toluene, as before, was used 
as the internal standard for the correction for counting efficiency.
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RESULTS
‘The appearance of radioactivity (% dose) in urine, faeces and expired air 
for the time intervals of 0-6 h, 6-12 h, 12-24 h, 24-36 h, 36-48 h and 
48-72 h after oral administration of 1,2 14C-labelled linalool to the male 
rats are presented graphically in figure 2. It was observed.that 57—58% of 
dose of radioactivity was excreted in the urine in 72 h and most of it 
(51-521) was excreted over the first 36 hours with no significant delay between 
dosing and appearance of activity in the urine. After a delay of several hours, 
substantial amounts of radioactivity (23% dose) appeared in the expired air.
In the experiment for the determination of extent of the radioactivity present 
as llfC02 in the expired air no appreciable amount of radioactivity above 
background count was detected in the filtrate after precipitation of lt*C0z> as 
BaltfC03. The counts (dpm) in the aliquots were also similar to that from 
BallfC03 obtained from a similar volume of the original absorbent solution. This 
therefore, indicated that the activity in the expired air was principally as 
1UC02 and not as 1^ C-labelled linalool or any other volatile metabolites. The 
excretion of radioactivity in the faeces was 14-15% of dose between 0-72 hours. 
The shape of the curve signifies delayed excretion occurring mainly (ca. 7% of 
dose) between 36-48 hour periods. The residual radioactivity in the tissues 
72 h after dosing is shown in Table 4.2 from which it can be seen that the
activity was located principally in the liver, gut, skin and skeletal muscle
with insignificant amounts in the other tissues. Radioactivity in the blood
at this stage corresponded to 0.003% of the dose/ml.
The comparative rates of excretion of radioactivity through urine, faeces 
and expired air after intragastric administration of 1 ,fC-linalool were also 
studied in a group of three female rats. The results have been tabulated in 
Table 4.1 from which it can be seen that there is no significant sex difference 
in the amount of the dose excreted by the three routes studied.
The results of experiments with cannulated bile ducts have been shown in 
figure 4.3. After intraperitoneal administration of 1^C-linalool, substantial
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Fig. 4. 2 Cumulative Excretion of Radioactivity ( % dose) in Rat 
Urine, Faeces and Expired Air after single Intragastric 
Administration of 14C Labelled Linalool (10 p.Ci).
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Linalool was administered intragastrically to 12 week old male 
wistar rats as a 25% solution in propylene glycol at a dose level 
of 500 mg/kg body weight.
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biliary excretion took place, more than 25% of the dose appearing in the bile 
-in 6 hours, mainly in first 4 hours. Hie radioactivity present in the bile 
was exclusively in the form of polar conjugates, no free linalool being 
detectable. Hie conjugates were hydrolysed to the extent of 68-691 by 
3-glucuronidase and almost complete hydrolysis was achieved by the mixture of 
3-glucuronidase and sulphatase with the formation of ether-extractable non­
polar substances. The characterization of the biliary metabolites is dealt 
with in Chapter 5.
In the crossover experiment (fig. 4.4), 2.5% of the radioactivity 
administered intraperitoneally to the first animal appeared in the bile of the 
second animal indicating that linalool enters into enterohepatic circulation. 
The peak of excretion occurred between 7 and 9 hours.
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TABLE 4.2 Distribution of residual radioactivity in tissues of male
and female rats 3 days after intragastric administration of 
1^ C-labelled linalool (10-5 yCi)
Radioactivity present* 72 hours after dosing
TISSUES MALE
% original 
dose
% residual 
activity
FEMUE
% original % residual 
dose activity
Brain 0.01 0.30 - -
Lung 0.01 0.30 - -
Liver 0.48 15.40 0.65 . 18.6
Heart 0.01 0.30 - -
Spleen 0.01 0.30 - -
Gut 0.55 . 17.70 0.6 17.2
Kidney 0.05 1.60 - -
Testes/Ovary 0.06 1.90 - -
Cornea + - -
Skin 0.80 25.50 - -
Skeletal muscle • 1.15 36.70 - -
Carcass less liver 
and gut
- - 2.25 64.2
Total (residual 
activity)
3.1 100.00 3.5 100.00
* Mean of two animals 
+ Denotes no significant radioactivity 
- Determinations were not made.
Linalool was administered intragastrically to 12 week old Wistar rats as a 
25% solution in propylene glycol at a dose level of 500 mg/kg body weight.
DISCUSSION
From fig. 4,2 it can be seen that linalool appears to be rapidly absorbed 
■from the gut as there was extensive and rapid urinary excretion of radioactivity 
(ca. 52% of dose) over the first 36 hours with no significant delay between 
dosing and appearance of radioactivity in the urine. Delayed appearance of 
radioactivity was observed in the expired air that contained substantial amounts 
of radioactivity (23% of dose) principally as 1UC02 and not as linalool or 
other volatile metabolites. The appearance of ll|C02 and the delay in its 
excretion suggests that linalool may be entering into pathways of intermediary 
metabolism. This is supported by the observation that a substantial amount 
of urinary radioactivity was present in the form of 14C-urea (see Chapter 5, 
page 122).
Faecal excretion of radioactivity was delayed and occurred mainly between 
• 36-48 h after dosing and ultimately 14-15% of the dose was excreted by this 
route. Hie delayed excretion of radioactivity in the faeces after 
.intragastric administration is not wholly explicable in terms of time for 
gastrointestinal transit and therefore, suggests the possibility of biliary 
excretion.
From figure 4.3 it can be seen that 25-26% of the dose of radioactivity
%
was excreted in bile, exclusively in the form of polar conjugates which, on 
hydrolysis with 3-glucuronidase and sulphatase liberated a substantial amount 
of non-polar ether-extractable radioactivity. Further evidence of hydrolysis 
of biliary conjugates in the gut is afforded by the presence of non-polar 
ether-extractable metabolites (about 5% of dose) in the faeces and these 
non-polar metabolites (see Chapter 5?page 123)were absent from bile. In view 
of the apparent rapid absorption of linalool from the gut,, it is probable that 
the faecal metabolites originate from hydrolysis of biliary conjugates in the 
lower colon. Hie nature of the faecal metabolites (Chapter 5) supports this 
view since little unchanged linalool was present. Hiis therefore, suggests 
that polar conjugates in the bile after entering the gut may be hydrolysed by
the 3"glucuronidase of the gastrointestinal tract or by the gut microflora 
and the liberated aglycone may be reabsorbed to establish enterohepatic 
circulation. Tissue distribution 72 h after dosing revealed that 16-18% of 
the residual radioactivity was located in the liver and 18-19% in the gut.
The persistence of radioactivity in the liver and the gut 72 hours after dosing 
along with the observation of delayed excretion of radioactivity in faeces also 
suggests the possibility that linalool enters enterohepatic circulation after 
oral administration.
In the crossover experiment 2.5% of the dose administered intraperitoneally 
to the first rat was excreted (Fig. 4.4) in the bile of the second animal and 
this therefore substantiates that linalool enters enterohepatic circulation, 
at least after intraperitoneal administration.
Hie observation that 2.5% of the dose was excreted in the bile of the 
second animal in the crossover experiment (Fig. 4.4) demonstrates the 
occurrence of extensive enterohepatic circulation. Assuming, as previously 
observed, that 25% of the original dose appeared in the bile of the first 
animal over the period studied and also that 25% of the conjugates which are 
hydrolysed and reabsorbed appeared in the bile of the second animal, it can be 
calculated that 40% of the biliary conjugates are hydrolysed and reabsorbed on 
the first pass. Thus extensive enterohepatic circulation is possible and may . 
account, in part, for the delayed faecal excretion. Hie results in Table 4.1 
reveal that there was no significant sex difference in the excretion of 
radioactivity after intragastric administration. In view of this and the 
insignificant amount of residual radioactivity present in the organs of the male 
rat, other than liver and gut, the tissue distribution in the female rat was 
carried out on the liver, gut and the carcass (less liver and gut). Hie total 
residual radioactivity and the radioactivity in liver and gut in the female rats 
72 hours after dosing were in all cases comparable to that in the male, Therefor.: 
it can be argued in view of the continued existence of radioactivity in botli the
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liver and the gut 72 hours after dosing that enterohepatic circulation is 
also likely in the female rat.
This study therefore, suggests that large doses of linalool may be 
metabolised in the'rat by conjugation and excretion in the urine, faeces and 
bile while substantial portion of the dose may enter pathways of intermediary 
metabolism. The rapid excretion of linalool and its metabolites suggests no 
long term hazard from tissue accumulation on chronic exposure to levels 
normally encountered in foods. However, at high dosage enterohepatic 
circulation might have the effect of prolonging the metabolic load on the 
liver over a relatively short period.
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CHAPTER 5
In vivo Metabolic End Products of Linalool: Identification
and Quantitative Determination
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INTRODUCTION
In the experiments described in Chapter 4 it was observed that most 
of the orally administered linalool was excreted in the bile, urine and 
faeces (28%, 59% and 60% respectively); only 20% was excreted in the 
expired air. It was also observed that expired air contained mostly CO2 and 
did not contain linalool or any of its volatile metabolites. It Is generally 
considered that most foreign compounds are primarily metabolized in the liver 
and the metabolizing enzymes can occur in the soluble, mitochondrial and 
microsomal fractions principally the latter. However, before a food 
additive or orally administered drug enters the portal circulation it is 
exposed to the-metabolic activity of the gut microflora (see chapter l)and in 
the complete study of the metabolism of foreign compounds it is essential 
to study the contribution made from this source. In the liver the most 
common route of metabolism of foreign compounds involve oxidations, reductions 
and hydrolysis (phase I reactions) and conjugation (phase II reactions, 
see chapter 1) to render the ingested substance more polar and water soluble 
for elimination through bile, urine and faeces. In the previous chapter 
it was noted that the biliary metabolites were exclusively in the form of 
highly pol'ar compounds and in the urine only a . relatively small proportion 
of the metabolites were ether extractable. In the faeces, significant amounts 
of the excreted radioactivity was in the form of non-polar metabolites.
This suggests that the conjugation was occurring prior to excretion in the 
urine and bile but that some hydrolysis of conjugates might have occurred 
in the gut.
In this chapter the nature of the metabolites described in chapter 4 was 
examined in detail to determine this qualitative and quantitative composition 
and to elucidate the roles of mammalian and intestinal metabolism.
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MATERIALS
3-Glucuronidase and 3-glucuronidase' sulphatase mixture (Sigma Chemicals); 
urea, hydrochloric acid,analar (BDH); linalool and tetrahydrolinalool 
(Koch-Light Ltd.); were purchased and purified. Dihydrolinalool was 
synthesised as described in chapter 3.
EXPERIMENTAL
Thin-layer chromatography:examination for glucuronides
Bile, urine and faeces were examined by t.l.c. for glucuronide conjugates
/
using silicagel G thin-layer plates and acetic acid butan-l-ol/ 1,2-dichloroethane 
water (4:14:4:1 v/v) (Iveson, et al., 1971).. The glucuronides were detected 
as blue spots by spraying with naphthoresorscinolreagent (0.2% w/v 
naphthoresorscinolin acetone mixed with 9% H3P0if in water v/v in the proportion 
of 5:1) and heating the plates for 10 minutes at 120°.
Hydrolysis of polar conjugates in urine, faeces and bile 
Enzyme Hydrolysis
Samples of bile (3 ml), urine (10 ml) and aqueous faecal extract (5 ml) 
were adjusted to pH 5 with 1 M MCI.
The enzymes 3~glucuronidase, or a mixture of 3-glucuron.idase and 
sulphatase were added (1000 U/ml) separately in separate tubes (in duplicate). 
Equal volume of 0.1 M acetate buffer, pH 5.0 was added and incubated for 
16 hours at 37°C. The incubation was repeated for another 10 hours with fresh 
enzymes before the termination of the experiment.
Controls of bile, urine and faeces were taken through the same procedure.
The enzymic hydrolysates were adjusted to pH 7 with 1 M NaOH and then 
extracted four times with equal volumes of ether.
Acid Hydrolysis
The aqueous layers from the enzymic hydrolysates were further hydrolysed 
with acid for conjugates which were unaffected by enzyme hydrolysis. The 
acid hydrolysis was carried out by making the aqueous layer 6 M with respect 
to HC1 by addition of conc. HC1. The hydrolysis was carried out in a boiling
water bath for 4 hours (Simmons, et al, 1973).
Determination of Urea
Urea forms crystalline compounds with certain acids and most important
of these are urea nitrate C0 (NH2)HN03 and urea oxalate (C0(NH2) ) H2C20u.
2 2 2
Urea (3 g) was dissolved in 15 ml of urine. Concentrated nitric acid (10 ml) 
was added to precipitate urea as urea nitrate and filtered off. Hie urea 
nitrate was dissolved in 20 ml of water and treated with 2 g of activated 
charcoal in a boiling water bath for 2 minutes. After filtration ’the 
filtrate was treated with conc. HN03 to reprecipitate urea nitrate. The 
precipitate after filtering was dried and powdered. The powdered urea was 
then counted for its lltC content in gel scintillator (as in Chapter 4)'.
Thin-layer chromatography of the hydrolysates
Silver nitrate impregnated silicagel G and methylene chloride:chloroform: 
n-propanol:ethyl acetate = 10:10:1:1 system was used as in Chapter 3. After 
double development the separated substances were located by spraying with 
phosphomolybdic acid reagent (7.51 in 95% alcohol).
Combined Gas chromatography-mas spectrometry (GC/MS)
The same combined GC/MS system of LKB, under similar conditions as 
described in Chapter 3, was used.
Quantitative evaluation of the metabolites
The quantitative estimations of metabolites were carried out by measuring 
the peak areas of GC/MS total ion current trace and also by thin-layer and 
scintillation spectrometry, as described in Chapter 3 (pages 61 and 63).
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RESULTS
Ether extractable radioactivity in urine and faeces
Thin-layer chromatography of the ether extract of urine and bile showed 
the presence of three major substances having values 0.38, 0.54, 0.71 
corresponding to linalool, dihydrolinalool and tetrahydrolinalool respectively. 
GC/MS examination confirmed the presence of these three terpenoids.
Hie ratio of linalool, dihydrolinalool and tetrahydrolinalool in the urine 
extract was 1.0:1.2:1.9 and in the faecal extract was 1.0:1.0:1.6 as estimated 
from the peak areas of gas chromatograms. Quantitative determination of the 
radioactivity present in each of the component by using -thin-layer 
chromatography and scintillation spectrometric technique revealed that linalool, 
dihydrolinalool and tetrahydrolinalool were present as 1.2%, 1.11 and 2.2% of 
the dose in the urine extract and 1.2%, 1.7% and 2.7% of the dose in the faecal 
ether extract (see figures 5.1 and 5.3).
Polar substances in bile 
Enzyme hydrolysates
Thin-layer chromatography for glucuroni.de conjugates indicated the 
presence of glucuronides of R£ values 0.42, 0.53, 0.57, 0.64, 0.71. Out of 
these the substances of R^ values 0.53 (A), 0.57 (B) and 0.64 (C) were 
radioactive; A being the major and B and C were very minor metabolites.
Thin-layer chromatography of the ether extract of B-glucuronidase hydrolysate 
of bile containing 17% of the dose of radioactivity separated three 
radioactive components having R£ values 0.38, 0.49 and 0.68 corresponding to 
linalool, dihydrolinalool and tetrahydrolinalool and the confirmatory evidence 
of the presence of these was obtained by combined GC/MS. The quantitative 
determination of the radioactivity (% dose) present in each of linalool (15.4%) 
dihydrolinalool (0.6%) and tetrahydrolinalool (0.8%) was carried out by 
thin-layer chromatography and scintillation spectrometry. Linalool was present 
in large amounts compared with the small amounts of the other half saturated
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and fully saturated derivatives.
Hie hydrolysis with 3-glucuronidase/sulphatase mixture increased the 
radioactivity of the ether extractable materials by ca 1% of the dose thus 
indicating the extent of sulphate conjugates (ca 7%) excreted in bile.
Hi in-layer, GC/MS confirmed the presence of linalool to a very large extent 
compared to dihydro and tetrahydrolinalool, the ratio of which was 
22:0.7:0.9 respectively as determined by peak areas. Quantitative determination 
of the radioactivity present (% dose) in linalool (22.1%), dihydrolinalool (0.9%) 
and tetrahydrolinalool (1.0%) was carried out by thin-layer and scintillation 
spectrometry. The aqueous layer contained about 2.0% of the dose of 
radioactivity.
Acid hydrolysate of bile
Hie ether extract of the acid hydrolysate of bile contained almost all 
the radioactivity leaving little in the aqueous layer. Combined GC/MS 
examination suggested the presence of linalool, dihydrolinalool, tetrahydro­
linalool in the proportion of 1.1:0.12:0.14 along wTith some (0.7%) unidentified 
substances possibly as artifacts that might have arisen from acid catalysed 
isomerisation of the terpene alcohols. Thin-layer chromatography indicated 
the presence of a substance having value 0.55 which corresponded to 
authentic geraniol, an isomer of linalool^' r. . . which is.known to
be produced by an acid catalysed allylic rearrangement.
Polar materials in urine
Hiin-layer chromatography showed the presence of a number of glucuronides 
of R£ values 0.47, 0.52, 0.58, 0.63, 0.70, 0.76 of which three R^ values 
0.52 (A), 0.58 (B) and 0.65 (C) were radioactive.
Enzyme hydrolysates
3-Glucuronidase hydrolysis showed that 31% of dose was excreted in the 
urine as glucuronide. The combined GC/MS examination of the 3-glucuronidase 
hydrolysis confirmed the presence of linalool,dihydrolinalool and
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tetrahydrolinalool in the proportion of 3.1:1:1.5 estimated from the area 
under .their respective peaks. The quantitative determination of the 
radioactivity present in linalool (18% dose), dihydrolinalool (5%) and 
tetrallydrolinalool (8%) was carried out by thin-layer chromatography and 
scintillation spectrometry. These proportions agreedwell with those obtained 
by GC/MS. The glucuronidase-sulphatase hydrolysed urine sample showed an 
increase of the radioactivity of 6% over glucuronidase hydrolysis alone 
indicating the presence of sulphate conjugates of the metabolites. Thin-layer 
GC/MS and thin-layer scintillation spectrometry examination revealed that 
linalool, dihydrolinalool and tetrahydrolinalool were present to the extents 
of 19.7%, 7.4% and 10.5% of dose.
Acid hydrolysates
The radioactivity in the aqueous layer not removed by ether extraction 
after 3-glucuronidase-sulphatase hydrolysis was further recovered to the 
extent of 4.0% of the dose of radioactivity by ether extraction after acid 
•hydrolysis. Tnin-layer chromatography - GC/MS confirmed the presence of 
linalool, dihydrolinalool and tetrahydrolinalool along with some small peaks 
of unidentified minor components probably artifacts derived from the isomerisatioi 
of the terpenealcohols produced by the action of aci d. Trie amount of
'v
radioactivity associated with linaloof, dihydrolinalool and tetrahydrolinalool was
1.0%, 0.9% and 1.2% respectively (see figure
Polar materials not hydrolysable with enzymes and acid
. In the experiment for the determination of urea in the urine the 
precipitated urea nitrate was found to contain 10.5% of dose radioactivity.
The filtrate after filtering urea nitrate contained 3.2% of radioactivity 
(% dose). This fraction was not further investigated in view of the insufficient 
material present.
Polar substances in faeces
'Thin-layer chromatography, GC/MS and thin-layer chromatography- 
scintillation spectrometry examinations showed that the ether extract of the
3-glucuronidase hydrolysate contained linalool, dihydrolinalool and 
tetrahydrolinalool respectively which, contained 1.1%, 1.7% and 2.3% of the 
dose of radioactivity. The mixture of glucuronidase-sulphatase hydrolysis 
produced linalool, dihydrolinalool and tetrahydrolinalool containing 1.3%.,
1.8% and 3.9% of the dose of radioactivity respectively. The sulphate 
conjugate, therefore, contains 1.9% of the dose of radioactivity. The aqueous 
layer after ether extraction contained about 2.3% of the dose of radioactivity. 
Hydrolysis with acid and subsequent extraction with ether indicated little 
residual activity in the aqueous layer thus pointing to the likelihood of 
the presence in the faeces of acid hydrolysable conjugates other than 
glucuronides and sulphates. The peak areas of the GC/MS total ionisation 
current traces indicated the presence of linalool, dihydrolinalool and 
tetrahydrolinalool in the proportion of 1:0.8:1. The percentage composition of 
linalool (0.8%), dihydrolinalool (0.7%) and tetrahydrolinalool (1.2%), was 
determined by thin-layer and scintillation spectrometric analysis (see 
figure 5.3).
Bile from enterohepatic circulation ; 'Enzyme hydrolysate
The ether extract of 8-glucuronidase-sulphatase hydrolysate of bile from 
the enterohepatic circulation experiment on examination by t.I.e.-GC/MS and 
t.I.e.-scintillation spectrometric analysis showed that linalool, dihydrolinalool 
and tetrahydrolinalool were present to the extents of 0.8%, 0.7% and 1.1% of 
dose respectively.
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DISCUSSION
From the results above it was observed that after oral administration, 
linalool is metabolized primarily to dihydro and tetrahydrolinalool and 
excreted mainly as conjugates in urine and faeces and the excretion in the 
bile was effected exclusively as conjugates. The bile from the enterohepatic 
circulation (and urine from animals dosed intragastrically with linalool) 
contained conjugates of dihydro and tetrahydrolinalool as major metabolites 
whereas these reduction products of linalool were present in insignificant 
quantities in the 'first pass' bile of animals which had been dosed 
parenterally. It may therefore be suggested that the reduction products 
originated in the gut. . In the in vitro metabolism of linalool by the gut 
microflora of rat (Chapter 3) it was observed that rat gut microflora 
reduced linalool to dihydro- and tetrahydrolinalool. This observation, 
therefore, further substantiates the assumption that gut was the origin 
of the production of dihydro- and tetrahydrolinalool formed by the gut 
microflora from linalool.
It was also observed that linalool and its metabolites were excreted 
in the bile exclusively in the foim of polar conjugates whereas faeces 
contained free linalool, dihydro and tetrahydrolinalool (4-51 of dose)^  
and it is possible that the polar conjugates of linalool were hydrolysed 
and reduced in the gut. After being liberated from conjugation linalool, 
dihydrolinalool and tetrahydrolinalool were reabsorbed and this was the 
mechanism by which enterohepatic circulation was established as demonstrated 
in Fig. 4.1 (see Chapter 4).
The appearance of conjugates of dihydrolinalool and tetrahydrolinalool 
in urine suggests that substantial reduction in the gut occurred before 
absorption of linalool or reabsorption of linalool released from biliary 
conjugates.
In addition to the presence of conjugates of linalool, dihydrolinalool 
and tetrahydrolinalool in the urine, 10-111 of radioactivity was present in
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the urine as urea indicating the involvement of linalool in intermediary 
metabolism. Radioactivity (20-231) was excreted in the expired air as llfC02 (see 
Chapter. 4) suggesting the possibility that linalool was entering the pathways 
of intermediary-metabolism and this assumption could therefore be 
substantiated by the availability of radioactivity in the urea. On the 
basis of the present findings the possible in vivo metabolic transformations 
of linalool has been proposed in figure 5.4.
The percent dose excreted as metabolites through the three major routes 
of excretion, viz. expired air, urine and faeces is shown as a balance sheet 
in table 5.5.
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Chapter 6
Effect of Linalool on some Drug Metabolising Enzymes
\
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Introduction
The potential toxicity of food additives is not an isolated problem 
but must be considered in context with the exposure of man and animals to 
other foreign compounds (Gillette and Brodie, 1970).
A substance may be harmless when administered alone but may be toxic 
when taken with other substances. For example,if persons being treated with 
tranylcypromine or trifluoperazine, the monoamine oxidase inhibitors, eat 
cheese, they may suffer hypertensive attack due to build up of unmetabolized 
amines, (Asatoor, et al, 1963). Benkos, et al.(1961) studied the effects of 
essential oils on atherosclerosis of cholesterol-fed rabbits. They suggested 
that the formation of a the ros cl eros is plaques was prevented by treatment 
with terpenes, notwithstanding a high level of serum cholesterol. They 
visualized that this effect of terpenes partly resulted from competitive 
inhibition or perhaps they acted by blocking mediatory factors promoting the 
penetration of lipids into the arterial wall. Keto and Gozsy (1958) found that 
linalyl acetate, citronellal, bomeolacetate and 104 other volatile oils and 
■ their chemical derivatives enhanced the therapeutic efficacy of small doses of 
dihydrostreptomycin in the treatment of experimental tuberculosis of the 
guineapig. Salaman (1961) reported that repeated application of oil of 
orange, lemon, grapefruit, lime and bergamot to skin of mice produced and 
maintained epidermal hyperplasia and this was regarded by Salaman as evidence 
of tumour promoting action. Roe and Field (1965) demonstrated that rats 
pretreated with subcarcinogenic doses of benzpyrene or urethane developed skin 
tumours if treated subsequently with citrus oil.
Some foreign compounds are bio transformed by enzymes of intermediary
metabolism because of the resemblance of these chemicals to normal endogenous
\
substrates but most foreign compounds, since they have no endogenous 
counterpart, are metabolized by the drug metabolizing enzymes of the endoplasmic 
reticulum. The liver is the main site for metabolism of foreign compounds; 
other tissues including gut also participate in varying degrees. The enzymes
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o£ the endoplasmic reticulum carry out the oxidative reactions and 
conjugations such as glucuronide formation. The enzymes of the mitochondria 
also catalyse some bio transformations. In view of the autooxidation of many 
intermediary metabolites the conversion of azo and nitro compounds to amines 
is of minor importance in well oxygenated tissues. The anaerobic conditions 
in the gut is therefore important in the reduction of azo and nitrocompounds 
by the enzymes of the gut and particularly by the gut microflora.
Jori, et al. (1969) studied the effect of menthol, a-pinene and eucalyptol 
on the metabolism of other drugs in rat. Subcutaneous administration or aerosol 
spray of eucalyptol was found to increase hepatic metabolism of aminopyrine, 
p-nitroanisoles, aniline and pentobarbital in vitro. These workers, therefore, 
suggested that' eucalyptol induces the microsomal enzymes and enhances the 
metabolism of foreign compounds to protect against their toxic effects.
In this context Parke and Rahman (1969) studied the short term (after 3 days 
repeated administration, 150 mg/kg body weight) effect of some terpenes.
They found that linalool, nerolidol and squalene had no effect on biphenyl 
4-hydroxylase, glucuronyl transferase and cytochrome P-450 but 4-nitrobenzoate 
reductase was increased by 25-50%. In view of the present widespread use of 
linalool in natural (citrus fruits, spices and herbs) and synthetic food 
additives (in soft drinks) the long term effects of linalool on the drug 
metabolizing enzymes after repeated doses have been studied.
\
136
MATERIALS AND METHODS *
Materials
Buffers
Tris (2-amino-2-hydroxymethyl propane-1,3 diol) was obtained from 
Sigma Chemical Co. After preparing solutions of requisite ionic strengths, 
dilute hydrochloric acid was added to adjust to the required pH. Phosphate 
buffers were prepared from Analar grade (BDH), potassium dihydrogen phosphate 
and dipotassium hydrogen phosphate of the required ionic strength, and pH 
as described by Dawson, et al.(1959).
. Acetate buffer (0.2 M, pH 4.6) was prepared by addition of 510 ml of 0.2 M 
acetic acid (BDH) to 490 ml of 0.2 M sodium acetate (BDH).
Glycine buffer (0.5 M, pH 10.4) was prepared by dissolving 18.76 g of 
glycine (BDH, Analar grade) in 450 ml of water and the pH 10.4 was adjusted 
with dilute NaOH solution. The total volume was finally made upto 500 ml with 
water. Glycine buffer (0.1 M, pH 9.6) was prepared similarly by dissolving 
37 g of glycine, adjusting the pH to 9.6 with dilute NaOH solution and making 
the volume to one litre.
Substrates
Biphenyl, m.p. 70°C (British Drug Houses, England) purified as described 
by Bridges, et al (1965); 185 mg in Tween 80 (2.0 g) was diluted to 1Q0 ml
with hot 1.151 KC1 solution. Any crystals of biphenyl which precipitated 
were redissolved by warming before use (Creaven, et al, 1965).
4-Methylumbelliferone, m.p. 182-184° (Koch-Light Ltd.), 32 mg recryst. 
4-methvlumbelliferone fMead, et al, 1955) was dissolved in 100 ml hot 1.151 
KC1, and aliquots of 0.3 ml (0.6 ymol) were used in 1 ml incubation mixture. 
Coenzymes
Nicotinamide adenine dinucleotide phosphate monosodium salt was dissolved 
in 1.15% KC1 (5.04 mg/ml). An aliquot of 0.25 ml contained 1.5 ymol per 
incubation.
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Uridine-5'-diphosphoglucuronic acid ammonium salt, (Sigma Chemicals Co.
Ltd.) was dissolved in 0.1M Tris buffer, pH 7.6 (5.8 mg/ml).
Nicotinamide adenine dinucleotide (Sigma Chemicals Co. Ltd.), 10 mg was 
dissolved in 1 ml of 0.1 M glycine buffer (pH 7.6). An aliquot of 0.2 ml was 
used in 2.4 ml incubation mixture for the determination of alcohol 
dehydrogenase activity.
Standards
Protein standard was prepared by dissolving crystalline bovine serum albumin 
(Koch-Light Ltd.) in water (20 mg/ml).
DNA standard (stock solution) was prepared by dissolving DNA (Sigma 
Chemicals Co. Ltd.) in 5 mM sodium hydroxide solution (40 mg/100 ml). The 
working standard (200 yg/ml) was prepared by mixing stock DNA solution with 
10% perchloric acid solution (1 volume/1 volume).
4-Hydroxy biphenyl, m.p. 162° (British Drug HousesVas purified as described 
by Bridges, et al (1965). The solution was made up as described by Creaven, 
et al.(1965).
4-Methylumbelliferone stock solution (0.1 ymol/ml) was prepared by 
dissolving recrystallized 4-methylumbellifercne in 1.15% KC1 solution 
(17.6 mg/litre). The working standard 0.01 ymol/ml was prepared by diluting 
10 ml of stock solution to 100 ml with 1.15% KC1 solution as required. . ;.
4-Methylumbelliferone in 1 litre 1.15% KC1 solution. The working 
standard 0.01 ymol/ml was prepared by diluting 10 ml of stock solution to 
100 ml with 1.15% KC1 solution as required.
Enzymes .
3-Glucuronidase (E.C. 3.2.1.3.1) (Sigma Chemical Co. Ltd.) was dissolved 
in 0.2 M acetate buffer pH 4.6 to give an activity of 500 units/0.5 ml.
Other materials •
Tween 80 (polyoxyethylene Sorbitan monooleate) was obtained from Koch-Light. 
Folin and CiocalteuTs reagent from BDH was used as supplied. Diphenyl amine
reagent was obtained from BDH. Sodium dithionite, copper sulphate, sodium 
•carbonate, sodium-potassium tartarate, magnesium chloride and other chemicals 
were obtained from British Drug House and other usual sources.
Experimental
Animals and linalool administration
Four week old 48 male Wistar albino rats were divided into 12 groups 
each consisting of four animals, six groups for controls and six groups for 
linalool fed. Each group of the animals was caged in polypropylene cages 
(26” x 15gn x 8M) and were kept on laboratory pellet diet (Spillers Ltd.) 
and'water ad-libitum. Linalool was administered to the rats by daily 
intragastrie intubation at a dose level of 500 mg/kg/d as a 25% solution in ' 
propylene glycol used as vehicle. The controls were given a similar volume 
of propylene glycol. The animals were accommodated under the controlled 
conditions of relative humidity (50%), temperature (20-22°C) and lighting 
(12 h light and 12 h dark).
Preparation of liver fractions
At intervals of 0, 3, 7, 14, 30 and 64 days from the commencement of 
dosing, animals were weighed and killed by cervical dislocation in the morning 
between 9 a.m. to 10 a.m. to minimise diurnal variation (Ractzialowski and 
Bousquet, 1968). Immediately after killing the livers were rapidly excised, 
freed from connective tissues, blotted with filter paper (Whatman No.l) to 
remove excess blood and weighed in a beaker containing 1.15% KC1 which helped 
in keeping the temperature, down and washing off the blood which may interfere 
in the determination of cytochrome P-450. Liver homogenate was prepared and 
fractionated according to the method of Basu, et al.(1971). into the following 
fractions (a) 10,000 g supernatant (microsomal fraction); (b) 105,000 g 
supernatant (soluble fraction); (c) 105,000 g pellet, washed and resuspended 
in the original volume of 1.15% KC1 (microsomal suspension).
Preparation of intestinal mucosal fraction
From duodenum (inclusive) a 30 cm section of the small intestine was 
excised and immersed in ice cold 1.151 KC1 (4°C). The gut section was washed 
free of chyme with ice cold 1.15% KC1 using a needleless syringe inserted into 
the gut. section. The gut was then opened by a longitudinal incision. The 
mucosa was removed by gently scraping the inner gut wall with a microscope 
slide, using the blunt edge, and placed in a preweighed ice-cold beaker.
The undiluted mucosa was homogenized for one minute by repeated up and 
down strokes in the .Potter Elvehjem homogenizer driven by a Black & Decker 
electric drill at a speed 2950 r.p.m. The partially homogenized material was 
diluted with three volumes of ice-cold 1.15% KC1 (W/v) and further homogenized 
for one minute. The mucosal suspension (1 in 4) was diluted five fold with 
ice-cold 1.15% KC1 to make a 5% (W/v) mucosal homogenate. The homogenate was 
centrifuged at 0-4°C at 10,000 g in M.S.E. High Speed centrifuge in 50 ml 
.stoppered polypropylene centrifuge tube in 80 x 50 ml angle head rotor. 
Determination of biphenyl 4-hydroxylase (E.C. No.1.99.1.1) activity
Biphenyl 4-hydroxylase activity was determined fluorimetrically in the
10,000 g supernatant by the method of Creaven, et al. (1965) as modified by
' N • '
Neale (1971). All the samples were run in duplicate. Standards of 
4-hydroxy biphenyl were prepared by the same procedure (30 yg/ml). The activity 
of the enzyme was expressed as ymoles of product formed per gram liver per 
hour. .
Determination of 4-rnethylumbelliferone glucuronyl transferase (E.C. No.2.4.1.17) 
activity (a) in the liver and (b) in the intestinal mucosa
(a) Hepatic 4-methylumbelliferone glucuronyl transferase 
The activity of 4-methylumbelliferone glucuronyl transferase was determined 
in the 10,000 g supernatant previously diluted twenty fold with 1.15% KC1.
The assay was carried out fluorimetrically according to Bollet, et al. (1959) .
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All the samples were run in duplicate. A standard curve of 4-methylumbelliferone 
was prepared by measuring the fluorescence of varying amount (0.001 - 0.01 ymol) 
of 4-methylumbelliferone in acetate buffer (0.1 M) pH 4.6. After measuring the 
fluorescence in the samples of liver preparations the concentration of
4-methylumbelliferone was calculated from the standard curve. The enzyme 
activity was expressed as pinole of product formed per gram liver per hour.
(b) 4-Methylumbelliferone glucuronyl transferase (E.C. No. 1.99.1.1) in 
the intestinal mucosa.
The activity of the enzyme (pmole/g liv./hr) in 10,000 g mucosal fraction 
(5%, 1 in 20) was determined fluorimetrically following the same procedure as 
in the liver fraction (Bollet, et al., 1959).
Determination of alcohol dehydrogenase activity (E.C. No. 1.1.1.1)♦
Hepatic alcohol dehydrogenase is remarkably unspecific and catalyses 
reversibly the interconversion of broad groups of alcohols and their 
respective aldhydes or ketones (Theorell, 1965).
CH3CH20H + NAD+ * CH3CHO + NADH+ + H*'
The assay of liver alcohol dehydrogenase activity (ymol/100 mg/protein/hr)
was based on spectrophotometric measurements of the reduction of NAD+ to 
+ +NADH + H by excess ethanol as substrate at alkaline pH (9.6) as developed 
by Theorell and Bunnichsen (1955) and subsequently modified by Dalziel (1957).
The change in absorption at 340 nm due to formation of NADH + H* per minute 
was the measure of enzyme activity and was expressed as ymol/1,000 mg protein 
(soluble fraction) /hr as calculated using the coefficient of NADH + H+ at 
340 nm (£340 = 6.22 x 106 cm2/mole).
Determination of cytochrome P-450
Cytochrome P-450 was determined in the microsomal suspension. The 
microsomal suspension was diluted three fold with 0.2 M potassium phosphate 
buffer, pH 7.4. The cytochrome P-450 in the hepatic microsomal suspension was 
determined according to Sladek and Mannering (1966). Hie difference in
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absorption between the reduced and CO-complex of the reduced haemoprotein 
within the range 450 nm to 490 nm was the measure of cytochrome P-450 
concentration (nmole/g liver) calculated according to Omura and Sato (1964) 
using a molar extinction coefficient of AE450-490 = 91 cm 1 mM 1.
Determination of cytochrome b5
Hie concentration of cytochrome b5 was determined in the diluted 
microsomal suspension, prepared as for the determination of cytochrome P-450, 
by the method of Schehkman, et al. (1965). Hie difference in absorption between 
the reduced and oxidized microsomal suspension within the range 410 nm to 
424 nm was the measure of cytochrome b5 concentration (nmol/g liver) and was 
calculated using the molar extinction coefficient AE424— 410 = 185 mM 1 cm 1. 
Determination of Protein Content
The concentration (mg/g liver) of protein in the microsomal suspension 
and -in-the soluble fraction was determined according to Lowry, et al.(1951).
The microsomal suspension was diluted to 1 in 200 with 1.151 KC1 and the 
soluble fraction was diluted to 1 in 400 and protein determinations carried 
out in 1 ml of the diluted suspensions. A standard curve was prepared by 
plotting the optical density against the corresponding concentrations of 
bovine serum albumin (20 yg - 200 yg). The concentrations of protein content 
in the samples were calculated by plotting the optical densities onto the ' • 
standard curve.
Determination of DMA
DMA from the liver homogenate was extracted according to the method of 
Schreider (1945) as modified by Burton (1955). The determination of DNA 
content based on the colour reaction with diphenylamine reagent was described 
by Dische (1930) and partly modified by Burton (1955). All the samples were 
run in triplicate. Standard curves were prepared with known amounts of DNA 
(20 yg - 200 yg) by running through the same procedure for colour development 
with diphenylamine reagent. Hie DNA content (mg/g liver) in the liver
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homogenate was calculated from the standard curve by plotting the measured 
optical densities at 600 nm.
Results
The results of 0-64 days pretreatment with linalool are shown in 
figures 6-1 to 6-10. Tabulated results are shown in the Appendix, tables 
6-i to^ xi.e - 
Body weight
From Figure 6-1 it can be seen that there was a slight but statistically 
not significant decrease in body weight gain in animals treated with linalool 
relative to their controls.
Liver weight and relative liver weight
Figures 6.2 and 6.3 show the effect of linalool on pretreated rats 
compared to controls with respect to liver weight and relative liver weight.
It was observed that there was no significant difference between the tests and 
controls in these two parameters upto the 30th day of exposure. After 
continued exposure for 64 days, significant, although slight, increases were 
observed (p < 0.05) in both these parameters.
Biphenyl 4-hydroxylase
Figure 6-4 compares the activity of biphenyl 4-hydroxylase in the controls 
and linalool treated rats. There was no significant change in the activity of, 
the enzyme in linalool treated rats compared to untreated animals. However, 
one noticeable observation was that the level of this enzyme was gradually 
dropping in developing rats compared to 28 days old animals. To begin with 
28 day animals the enzyme level was 4.7 ymol/g liver/h and after 64 days at 
the age of 13 weeks the level had dropped to 3.5 ymol/g liver/h amounting to 
a 26% decrease.
4-Methylumbelliferone glucuronyltransferase
Figure 6.5 shows the 4-methylumbelliferone glucuronyltransf erase activity 
in the liver of controls and linalool treated animals. It was observed that
the activity of this enzyme was dramatically increased by chronic exposure 
to linalool. Hie activity increased steadily by 17% (p < 0.02); 29% (p < 0.01); 
81% (p < 0.001); 98% (p < 0.001) and 150% (p «  0.001) after exposure to 
linalool for 3, 7, 14, 30 and 64 days respectively.
The intestinal 4-methylumbelliferone glucuronyltransferase, unlike liver, 
showed a biphasic response to linalool (Fig. 6.6). After an initial depression 
of 33% in the activity there was steady increase reaching the control value 
on 14th day. By the 30th day the activity was increased by 45% (p < 0.01) 
relative to controls and by the 64th day the increase in activity was 8.3%
(p ■< 0.001).
Alcohol dehydrogenase .
Alcohol dehydrogenase in the soluble fraction (105,000 g supernatant) of 
the linalool treated rats showed a biphasic response (Figure 6.7). It was 
initially depressed by 33% (p < 0.02) on the three days pretreatment followed 
by sharp dramatic increase of 36% (p < 0.001) on the 7th day. After 14 days 
exposure in the treated rats the enzyme activity was 11% higher (p < 0.05) 
than the control, thereafter, no significant change was observed between the
test and the controls of 30 days and 64 days.
105,000 g Supernatant (soluble fraction) protein concentration
Figure 6.8 shows the protein content (mg/g liver) in the soluble fraction, 
of untreated and linalool treated rats. The protein concentration in the 
soluble fraction remained unchanged for the entire period of 0-64 days 
treatment. The significant change in alcohol dehydrogenase in the treated 
animals has therefore shown no noticeable effect on the protein concentration 
of the soluble fraction. ~ .
Cytochrome P-450 concentration
The progressive change in the concentration of cytochrome P-450
(n mol/g liver) in the linalool treated rats has been shown in Fig. 6.9;
a biphasic response was observed. The enzyme was inhibited to the extent of
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20% (p < 0.02) in the test animals after 7 days pretreatment compared to 
controls. It regained control value on 14th day with a sharp increase 
(50%, p < 0.01) on the 30th day. The concentration of this cytochrome 
continued to remain at this elevated level after 64 days exposure to linalool. 
Cytochrome b5 concentration
The concentrations of hepatic cytochrome b5 (n mol/g liv.) at the 
different stage of treatment in the linalool treated rats compared to controls 
have been shown in Figure 6.10. It resembles cytochrome P-450 in showing a 
biphasic response with 29% inhibition after seven days exposure with 
non-significant change on three days pre treatment. The level of cytochrome 
b5 reached the level of the control value on the 14th day with a sharp increase 
(50%, p < 0.01) after 30 days pretreatment. The 64 day exposure led to a 75% 
increase in the test compared to the control.
Microsomal protein concentration
The change in microsomal protein concentration (mg/g liver) is shorn in 
Figure 6.11. Hie microsomal protein concentration was unchanged in the test 
animal compared to controls up to the 14th day of exposure. However, after 
continued exposure for 30 days a significant increase (20%, p < 0.02) was 
observed in the pretreated rats and the microsomal protein concentration 
remained at this elevated level after 64 days pretreatment. ' • ■
DMA Concentration
The change in DNA concentration (mg/g liver) is shown in Figure 6.12.
The DNA concentration in the tests was unchanged, compared to controls after 
3 days pre treatment. Seven days pre treatment caused a sharp increase of 32% 
in DNA concentration but further exposure for 14 to 64 days did not cause a 
significant difference in DNA concentration between tests and controls.
Discussion
In an earlier study involving a number of terpenoids, Parke and Rahman . 
(1969) administered linalool intraperitoneally to rats at a dose level of 
150 mg/kg for three days and found no significant effect on liver weight, 
cytochrome P-450 concentration, biphenyl-4-hydroxylase and glucuronyl 
transferase activities. The current study using high dose levels by the 
oral route shows that, with most of the parameters studied, prolonged 
administration was necessary for significant effects to be observed.
The liver weight and relative liver weight increased over control values 
slowly but consistently after exposure to linalool for 14 days but the 
differences only became statistically significant after 64 days. This increase 
in liver weight was preceeded by a peak in the DNA concentration at 7 days 
(p < 0.001) which subsequently returned to control levels. This suggests 
increased mitotic activity at this stage indicating that the increased 
liver weight involved some hyperplasia in addition to cell hypertrophy. 
Microsomal (but not soluble) protein concentration also increased in the 
later stages of the study, being significantly higher than control values 
after 30 and 64 days of dosing and it appears that the earlier hyperplasia 
was followed by a proliferation of endoplasmic reticulum with associated cell 
hypertrophy. .The latter effect appears to be the major contributor to the 
observed hepatomegaly. The time course of the changes in the parameters 
studied is of particular interest (see Fig. 6.13).
The earliest observable effects of administration of linalool were in the 
activity of 4rmethylumbelliferone glucuronyl transferase and alcohol 
dehydrogenase. The activity of the former enzyme was significantly increased 
after only 3 days which, together with the observations (Chapter 4) that 
linalool and its metabolites are largely excreted in urine and bile as 
conjugates with glucuronic acid, suggests an adaptive response to the increased 
metabolic demand. The up-surge in glucuronyl transferase activity between
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7th and 14th day may result from gradual tissue accumulation since it was 
'observed (Chapter 4) that linalool may enter into enterohepatic circulation, 
delaying complete excretion. Subsequently the higher level of glucuronyl 
transferase activity was maintained and it is to be expected that in the 
later stages of the experiment it was sufficient to maintain acceptable tissue 
levelsof linalool despite the repeated dosing.
The up-surge in glucuronyl transferase activity between the 7th and 14th 
day coincided with anobservable increase in microsomal protein concentration 
which had appeared normal up to that point. This suggests that the initial 
increase in glucuronyl-transferase activity resulted from activation of the 
enzyme already present in the endoplasmic reticulum while the second up-surge 
in activity resulted from proliferation of the endoplasmic reticulum. This 
agrees with the observations of cytochrome P-450 and b5 concentrations where 
some inhibition is evident after seven.days but subsequently, as microsomal 
protein concentration increased, so did the concentration of the cytochromes. 
Since linalool is already oxygenated and readily conjugated via the OH group, 
it would not be expected to act as a substrate for cytochrome P-450 and hence 
the increase in concentration of this cytochrome might reflect a non-specific 
proliferation of endoplasmic reticulum associated with the increased synthesis 
of glucuronyl-transferase. However, it has been shown (Chapter 7) that 
linalool binds to cytochrome P-450 to produce a reverse type I binding spectrum 
and is a mild inhibitor of its monooxygenase function. Thus the increase in 
cytochrome P-450 concentration might,, at least in part, reflect adaptation to 
this inhibition.
The early biphasic effect on alcohol dehydrogenase activity may also 
relate to initial tissue accumulation of linalool which is observable first 
as an inhibition of alcohol dehydrogenase activity after three days. The 
subsequent increase in activity after seven days then probably results from
160
the combined effect of an adaptive induction of alcohol dehydrogenase together 
with an increased capacity for glucuronidation (vide Supra) which would lower 
the inhibitory effect. Subsequently, when the increased activity of 
glucuronyl-transferase was fully able to cope with the increased metabolic 
demand, alcohol dehydrogenase levels returned to, and remained, normal.
It is interesting to note that, despite the biphasic fluctuation in the 
cytochrome concentrations, the activity of biphenyl 4-hydroxylase was 
unaffected throughout the course of the study. This might seem surprising 
at first sight, but other workers (Rahim, Parke and Walker, 1974) have 
reported selective induction of biphenyl 4-hydroxylase or ethylmorphine-N- 
demethylase with antioxidants in which there was no correlation between the 
function of the enzyme and cytochrome P-450 levels with one or other substrate.
Hie increase of cytochrome P-450 and bs which are at the terminal end of 
the microsomal electron transport system may be involved in the oxidation of 
NAIH2 to keep up the level of oxidized NAD+ for the synthesis of UDPGA for 
continued conjugation to dispose off the load of linalool,
UDPG + 2NAD ^ UDPGA + 2NADH2. . -  — . . -> *-
UDPG dehydrogenase
UDPGA' + ROH R0C6H906 + UDP
. . — .1 ■ ,1,1 ».|„|| ■ .« — , - Ml.
UDP transglucuronylase 
+
In mobilizing'the reserve of NAD the cytochrome P-450 and b5 may therefore 
enhance the metabolism of other exogenous and endogenous compounds including 
cholesterol (steroid) metabolism as was observed earlier by Benkos, et al. 
(1961) who suggested that formation of atherosclerosis plaques was prevented . 
by terpene treatment.
The intestinal 4-methylumbelliferone glucuronyl-transferase, unlike the 
liver enzyme showed a biphasic response. The initial inhibition at 3 days 
indicates that the intestinal 4-methylumbelliferone glucuronyltransferase is 
first inhibited and then more rapidly synthesized to give the adaptive
161
response to the increasing load of linalool. In this regard the steady 
increase of liver 4-methylumbelliferone glucuronyltransf erase may be 
indicative of a more efficient adaptability of the liver enzyme than the 
intestinal one.
The results of the present investigation therefore show that with the
exception of alcohol dehydrogenase and glucuronyltransferase prolonged
exposure to linalool is necessary before highly significant effects are
observed on the other drug metabolizing enzymes. • It appears that the
observed effects represent a physiological adaptation to the continued
exposure of linalool and not a pathological condition. However, the increase
in DNA concentration after the 7 day period, indicative of increased mitosis,
suggests that an increased vulnerability to carcinogens might occur at this 
(c.f. Peraino et al.,1971) 
stagq^* Experiments to investigate this possibility and to study the possible
synergistic effect of linalool on chemical carcinogenesis seem warranted.
This is particularly important since a number of essential oils have been
reported to possess carcinogenic and co-carcinogenic activity (Roe and Field,
1965).
Chapter 7
Studies of the Effects of Linalool on some 
. Microsomal Enzymes
INTRODUCTION
In Chapter 6 the increase in 4-methyl umbelliferone glucuronyltransferase 
activity was described and was considered to be an adaptive response of 
this enzyme to the requirement for glucuronidation of linalool. It was 
therefore decided to investigate the ability of microsomal glucuronyltransferase 
to conjugate linalool directly both in normal rats and rats which have been 
exposed to linalool. It was further suggested that delayed induction of 
cytochrome P-450 may have been due to linalool acting as an inhibitor of 
this enzyme. It seems unlikely that the already oxygenated linalool would 
be a substrate for cytochrome P-450 in vivo but experiments to investigate 
whether linalool might bind to cytochrome P-450 and act as an inhibitor of 
cytochrome P-450 were indicated.
164
MATERIALS AND METHODS 
Chemicals
Linalool, 99% was obtained from Ralph N. Emanuel Ltd., ltfC linalool 
was synthesised in our laboratory (see Chapter 2) and Uridine 5' -diphospho- 
glucuronic acid (UDPGA) ammonium salt was procured from Sigma, London.
The other' chemicals have been mentioned elsewhere in the text.
Animals
Male Wistar rats were used and accommodated under controlled conditions 
of temperature (20°-22°C), relative humidity 52% and lighting (12 h light,
12 h dark).
In vitro inhibition studies
Four 28 day old normal rats (untreated) were killed by cervical 
dislocation, their livers pooled and a double washed microsomal suspension 
prepared according to the method of Basu, et al. (1971). The biphenyl 4- 
hydroxylase activity of this microsomal preparation was measured over a range 
of substrate concentrations and in the absence or presence of various 
concentrations of linalool.
Linalool was added as a 250 mM solution in 95% aqueous ethanol at a 
maximum volume of 6 yl per incubation mixture and a similar volume of 95% 
ethanol was added to controls without linalool.
Biphenyl activity was assayed by the method of Creaven, et al. (1965) 
as modified by Neale and Parke (1970), except that the substrate concentration 
was varied between 0.6 - 3.0 pM and linalool was added at a concentration of 
0 - 6.25 mM.
Spectral dissociation constant (Ks) of linalool
A double-washed hepatic microsomal suspension (2 mg protein per ml in 
0.1 M phosphate buffer pH 7.6) was prepared according to the method of 
Schenkman, et al. (1967) from the liver of 28 days old rats. The Ks was 
determined according to the method of Schenkman, et al.modified as follows:
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Microsomal suspension (2.5 ml) containing 2 mg of protein per ml was 
pipetted into both of the two glass cuvettes. These were sealed with 
.subaseal .stoppers (Gallenkamp Ltd.', London) and placed in the reference and 
sample beams of the SP 1800 spectrophotometer. Serial additions of microlitre 
quantities of linalool- in'alcohol (0.1 to 0.6 mM) were made to 2.5 ml 
microsomal suspension in the. sample cuvette and equal quantities of alcohol 
(95%) in the reference cuvette. The difference spectrum at 380 nm to 425 ran 
was measured.
In vitro conjugation study . . .
Linalool was administered intragastrically (500 mg/kg in 25% propylene 
glycol) to 28 day old rats, for four weeks. Three paired fed controls 
received the same quantity of propylene glycol and three controls had access 
to food and water ad' libitum. The rats were killed on the 29th day. Double 
washed microsomes were prepared from the liver and intestinal mucosa of 
these three groups of animals each separately.
The glucuronide formation in the microsomal suspension was determined
according to Axelrod and Inscoe (1960) as modified by Yeh and Mitchell (1972)
except that lkC labelled linalool (6.0 pinole containing 111,500 dpm) was used
as substrate and microsomal suspension of 12.5% from liver microsomes and
' >
25% from the intestinal mucosal microsomes were used as enzyme sources.
Hie incubation mixture contained O'. 2 ml of double-washed microsomes (liver 
or intestinal mucosa), 6.7 ymoles of UDPGA (0.3 ml), 42.5 yl of 1 ^ C-linalool 
solution in alcohol (1.4 x 10 1 M 1 ^ C-linalool in alcohol) that contained 
6 ymole 1 ^ C-linalool (lli,000 dpm), 0.3 ml Tris buffer (0.05 M Tris buffer, 
pH 8.0), 0.2 ml MgCl2 (1 mmole) solution in 1.15% ICC1 and the final volume 
of the mixture was 1.0 ml. Incubations were carried out in duplicate in a 
shaking water bath at 37°C for 30 minutes under atmospheric air. The reaction 
was terminated by placing the tubes in ice cold water and the excess 
unconjugated 1IfC linalool was extracted three times with ether. The water
layer after being freed of residual ether by a slow stream of nitrogen at
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room temperature, was hydrolysed with 500 units of 3-glucuronidase in 
acetate buffer (0.1 M) of pH 4.6 according to Arias (1962). After hydrolysis 
the liberated llfC-linalool was extracted with ether. The amount of linalool 
in the ether extract was determined by counting for 1 in 30/70 scintillator 
in a Packard Tricarb Spectrometer model 3320.
The enzyme activity was expressed as ymole of linalool conjugated per 
gram liver per hour.
RESULTS
Inhibition Studies
The inhibiting"effects of varying concentration of linalool on biphenyl 
hydroxylase activity is shown as Dixon plots' in figure 7.1. The straight 
line curves intersect one another on a point on the base line where Vv= 0
t
and linalool concentration is 1.9 x 10 3 M. This, therefore, characterises 
linalool as a non-competitive inhibitor with a Ki of 1.9 x 10 3 M.
Figure 7.2 is the Lineweaver-Burk plot of velocity over a range of 
substrate concentration and extrapolation of the plot to ^ /v= 0 cuts the absciss
at -(Vs) - - "2TTT x 10 3 M which is equivalent to - hence the value of
—  1 ^Km = 3.45 x 10 k M. The intercept at the y-axis ( /v) correlates with the
theoretical value of (1 + ^ -) x ^  thus showing a characteristic of non­
competitive inhibition.
Spectral dissociation constant (Kg)
The spectral interaction of linalool with microsomal suspension exhibited 
a difference spectrum with trough at-390 nm and peak at 420 nm. This spectral 
change is associated with the reverse type I compounds (Orrenius, 1970; 
Schenkman, 1972) and thereby, linalool is characterised as reverse type I 
compound. The extent of the binding of linalool with cytochrome P-450 was 
represented by the magnitude of the difference (AE) between absorbance at 
420 nm and 390 nm at various linalool concentration. The double reciprocal 
plot of AE against linalool concentrations is shown in Fig. 7.3. The plot
was extrapolated to AE = 0, where it cut the abscissa- at a substrate 
concentration -1.9 x 10 4 M ( " ^  = “5.3 x 10 3 M) which by definition is 
- the negative equivalent of the substrate concentrates at half maximal 
spectral change. The value of Kg = 1.9 x 10 * M indicates considerable affinity 
of linalool for cytochrome P-450.
Conjugation study
The results have been tabulated in table 7.1. No appreciable variation 
was observed between‘the activity in the control and the pair-fed animals 
whether in'the liver or gut mucosa. However the liver microsomes from 
linalool-treated animals showed a 711 increased rate of conjugation whereas 
with the intestinal mucosal microsomes the rate of conjugation was increased 
by 33% compared with their respective control values.
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DISCUSSION
The in vitro studies indicate that linalool binds to cytochrome P-450, 
‘exhibiting a reverse type I type of reaction difference spectrum and is a 
non-competitive inhibitor of the hepatic microsomal drug metabolizing enzymes. 
Biphenyl is a substrate of cytochrome P-450; hence during the process of 
biotransformation linalool and biphenyl may inhibit each other competitively 
if they bind on the same site of the cytochrome P-450. Our present study 
revealed that linalool binds to the reverse type I "site" of the cytochrome 
P-450 and that linalool inhibits biphenyl 4-hydroxylase non-competitively. 
Biphenyl is a type I compound (Tredger ,19 74) . Inhibition of biphenyl 4-hydroxylase 
by linalool is, therefore, non-competitive because of interaction of biphenyl 
and linalool at different site of cytochrome P-450. The apparent interaction 
of linalool at the reverse type I "site" may be due to a conformational change 
of the cytochrome. It is therefore unlikely that linalool. is a substrate for 
cytochrome P-450, which could be anticipated as linalool is an oxygenated 
compound with a potential hydroxyl group for ready elimination from the 
body as polar conjugates.
Despite the fact that linalool was found to be an inhibtor of biphenyl 
4-hydroxylase in this study, it is not clear why it was without effect on
/ N
biphenyl 4-hydroxylase activity after administration in vivo.
The initial inhibition of cytochrome P-450 and subsequent sharp 
induction (see Chapter 6) are likely to be caused by tissue build up of 
linalool due to repeated doses and enterohepatic circulation which inhibit 
the mixed function oxidases at early stages (7 days pretreatment) and then 
rapid synthesis of these enzymes is triggered off amounting to sharp induction 
to meet the requirement for normal metabolism of endogenous and exogenous 
substances. .
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Table 7.2 Comparison of spectral dissociation constants (K ). and
dissociation constants (X) of enzyme-inhibitor complex.
Compound Type of 
Binding
Species K.l Reference
Linalool RI R 1.9x10"3M 1. 9x10"*1
Dexamethasone RI R 1.21x10"1
I H 0.9xl0_1 ) '
CorticosteronLe I R 2.Ixl0~1
I H 0.7X10"1 )
Prednisolone II ? R 0.7x10"1 )Tredger (1974)
I H 0.7x10"1 )
Betamethazone II? R 0.7X10"1
I H 0.3X10"1
J
Cortisol RI R -
)
)
I H 1.2x10"1
Phenobarbita] 2.4x10"1 Kutt,et al. (1971)
Ethoxyquin I R 4.3x10~6M 1.1x10"2 Parke,et al.(1974)
SKF 525 A I R 6.0x10"eM 0.7x10"2 )Manneririg (1969)
) and
SKF 8742 A I . R 3.6xl0~6M - )Anders (1971)
Aniline II R — 12.5x10“1 Sweat,et al.(1970)
RI = Reverse type I ? The type of binding of prednisolone and betamethasone
R = rat could not be categorised. Prednisolone gave max at
H = hamster 425 nm min 380 nm and betamethasone max at 415 nm
and min 375 nm.
F ig . 7 .1  Dixon plot showing non-com petitive inhibition of biphenyl 
4 -hydroxylase activity by linalool.
1 .4 -1
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-2 -1 1 2 3 4 5 6 7 8 9
Concentration of linalool x 10"3 M
Biphenyl 4-hydroxylase activity (ju m o le /g  liv er /h ) was determ ined by 
the method of Creaven et a l (1965) a s m odified by Neale (1970), at 
substrate concentrations of 0 .6  mM, 1, 8 mM, 3 .0  mM and linalool 
concentrations 1 .2 5  mM to 7. 5 mM.
Fig. 7.2 Lineweaver - Burk reciprocal plot for the determination of the
apparent Michaelis constant ( Km ) of biphenyl 4 -hydroxylase.
Km =  3.4-5 x 10 M
1.2“
1.0H
r—I
o S §.g 0.6"si ft a —i
•8* 123 “
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Ph ^  rH /
75 61 3 42124 3
 1________
Biphenyl x  10 3 M
Biphenyl 4-hydroxylase activity (jumole/g liv er /h ) w as determ ined by 
the method of Creaven et al.(1965) as modified by Neale (1970) at 
substrate concentrations of 0 .1 5  mM to 1. 5 mM.
Fig. 7. 3 Lineweaver - Burk reciprocal plot for the determination
of the Spectral dissociation constant (Ks) of linalool.
o<M
o
10-4
5 -4  -3 -2 -1 1 2 3 4 5 6 7 8 9 10 11 12
r ;  - .---------- — r:—  (M) x 10Linalool concentration
Spectral d issociation  (Ks) of linalool w as determ ined by the 
method of Schenkman et al.(1967). Increasing concentrations 
of linalool (0.1 mM - 0 .6  mM) w ere added to 2. 5 ml of double 
washed m icrosom al suspension (2 mg protein /m l) made from  
rat liver  m icrosom e preparation in 0 .1  M phosphate buffer,. 
P H -  7. 6. Maximum volum e of 10 p i of ethanolic solution of 
linalool (250 mM) w as added to the 2. 5 ml of the above m icro ­
som al preparation in cuvettes of 1 cm pathlength.
The K and of linalool have been compared in table 7.1 with those
of some known inducers and inhibitors of drug metabolizing enzymes. Tredger
(1974) studied the binding characteristics of some of the glucocorticoids.
Cortisol and dexamethasone were reported to bind to the reverse type I
"site" of the rat liver microsomal P-450 but exhibited characteristics of a
type I substrate with hamster liver cytochrome P-450. These steroids and
others such as corticosterone, prednisolone, betamethazone were shown to
possess Kg values of similar order to that of linalool. Since cortisol and
dexamethasone have similar ’'reverse type I” binding characteristics to linalool
they may compete with one another for metabolism or may be synergistic. In
this regard the work of Benkos, et al. (1961) may be worth mentioning. He
reported that the formation of atherosclerosis plaques was prevented by terpene
treatment, nowithstanding a-high level of serum cholesterol in the cholesterol
fed rabbit. The K value of linalool was also comnared to other inducers ands
inhibitors. Phenobarbital, an inducer of drug metabolism has Kg 2.44 x 10 1 mM 
of similar order to linalool 1.9 x 10 1 mM. In comparing the JL of linalool 
(1.9 x 10 3 M) with other potent inhibitors like SKF 525 A (6.0 x 10 6 M),
SKF 8742 A (3.6 x 10 6 M) and ethoxyquin (4.3 x 10 G M) it is plausible that 
linalool is a mild inhibitor.
However, the ability of a compound to form a binding spectra with 
cytochrome P-450 does not guarantee its metabolism. Imai and Sato (1967) have 
pointed that barbital and benzene are hydroxylated by microsomes although they 
do not produce binding spectra. Conversely, many alkylamines combine avidly 
with cytochrome P-450 to produce type II binding spectra but are not metabolized 
(Jefcoate, et al, 1969). Linalool having a potential -OH group could undergo 
phase II reaction to be eliminated from the system and phase I oxidations 
would appear to be unnecessary for detoxication.
In the light of the earlier metabolic studies (see Chapter 6) increased 
activity of the glucuronyltransferase in the hepatic and intestinal mucosal 
microsomes may also be considered as an adaptive response to the increasing
load of linalool so that the latter could be eliminated from the body after 
.conjugation with endogenous substances.
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General Discussion
As the experimental results have been discussed in the individual 
chapters, this general discussion will be confined to broader implications.
The in vitro studies on the metabolism of linalool by caecal 
microflora indicated the potential of these organisms to effect reduction 
to dihydrolinalool and tetrahydrolinalool, and these metabolites were 
also identified , both free and conjugated with glucuronic acid or 
sulphate, after in vivo metabolism. The fact that, after intraperitoneal 
administration, very small amounts of these reduction products appeared 
in bile after the first pass (linaloolidihydrolinalool + tetrahydrolinalool, 
9:1) whereas after the second pass the reduction products predominated 
(linalool:dihydrolinalool + tetrahydrolinalool, 1:3) confirms that the 
major site of reduction of linalool is in the intestine. The in vitro 
studies are therefore a fair indication of intestinal microbial metabolism 
in vivo.
Reduction of - C O  double bonds by intestinal micro-organisms has 
been reported previously for dietary unsaturated fatty acids (Polan et- al. 
1964, Watson, 1965; Wilde & Dawson, 1966) and for a number of xenobiotics 
including coumarin, cinnamic acid and its derivatives (Hansen &
Crawford, 1968; Scheline, 1968; Peppercorn & Goldman,. 1972, Booth &
Williams, 1963). This, therefore, appears to be a common route of 
microbial metabolism of unsaturated compounds and may result from 
specific reduction mechanisms or merely as a result of the low redox 
potential generated in the gut by the microbial population.
Further, since linalool was excreted in bile as conjugates on the 
first pass and appeared as conjugates of the reduction products on the 
second pass, it seems likely that hydrolysis of the glucuronides 
occurred in the gut'with subsequent reduction of the aglycone prior to
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reabsorption. There are two important consequences of this. First,
linalool or its reduction products, enter into enterohepatic
circulation which delays their excretion so that any biological effects
are more prolonged and second, whether the compound is'administered
orally or parenterally, similar metabolites may ultimately.be produced
in the gut. These consequences are not confined to linalool since it
is well known that drugs such as stilboestrol enter into enterohepatic
circulation which delays excretion and Tyrolones pharmacological activity
parenterally administered ;
(Clark et al., 1969) while conjugates of]\chloramphenicol may be
hydrolysed in the gut and further, metabolised to toxic compounds which
{£arke,1968) j
are reabsorbed causing blood dyscrasias^. It would appear, then, that 
in conventional animals, biliary excretion is a less effective and less 
reliable detoxication mechanism than is urinary excretion, though this 
may not be the case in axenic (germ-free) animals.
The extent to which a compound is excreted in bile is dependent 
inter alia on a number of molecular parameters, principally polarity 
and molecular weight (Williams et aL, 1965). There appears to be a 
species-dependent threshold molecular weight above which compounds 
may be excreted in bile and hence there will be species differences 
in the extent to which parentally administered compounds reach the 
gut for metabolism by gut microflora. There may thus be consequent 
species differences in pharmacological activity or toxicity.
The wide species differences observed in the metabolism by the 
gut microflora (Chapter 3) raise questions of species selection in 
toxicity testing. In many cases, the intestinal microflora are 
responsible for the production of toxic metabolites (Scheline, 1973, 
Section VII) and species differences in toxic response to a test 
compound may sometimes arise from differences in intestinal metabolism.
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Thus Walker et al. (1970) demonstrated that the species differences 
between rat and mouse in the toxicity of orally adminstered Brown FK 
resulted from differences in the extent of intestinal reduction to myotoxic 
amines.
A number, but not all, of the species examined produced a-terpineol 
and y-terpinolene by a cyclisation process not previously reported to 
occur with intestinal micro-organisms. These cyclic compounds may then 
undergo aromatization, as occurs with quinic acid (Scheline, 1968) and 
some steroids (Goddard & Hill, 1973), although aromatized metabolites 
were not detected in the current study. Little is known about the 
toxicity of a-terpineol and y-terpinolene but the presence of the latter 
compound is of concern because of the tumour promoting effects of a 
number of essential oils appears to reside in the hydrocarbon fraction 
(see Chapter 1).
It seems prudent to consider the consequences of intestinal 
metabolism in the selection of species for toxicity testing and 
extrapolation of the results obtained to man. However, a further 
difficulty arises in this area since there is obviously no archetypal 
man in respect of intestinal metabolism. In the current study, the 
faecal microflora of a habitual spice-user metabolised linalool in a 
substantially different way from the flora of a subject who regularly 
ate a bland diet and similar differences have been observed in the 
metabolism of cyclamate by Japanese and Europeans. (Kojima &
Ichibagase, 1966; Hill et al, 1971). In the latter case, the difference 
was explained by large qualitative and quantitative differences in 
intestinal microbial populations which were believed to arise from dietary 
differences. It has been reported that individuals on a high cereal 
diet consistently harbour more yeasts in the intestine than normal 
( Schelinq 1968) while considerable changes in the intestinal microflora
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accompany weaning (Lee & Gemmell, 1972) with a reduction in the 
number of aerobes and the establishment of dominant population of 
strict anaerobes. It seems likely, therefore, that the inter- 
individual differences observed in the current study arose from the 
differences in diet. The microflora of the spice-user would have been 
repeatedly exposed to essential oils containing terpenoid compounds 
and may consequently have adapted by selection of organisms which 
were capable of metabolising these compounds and/or which were 
relatively resistant to their bactericidal effects (Lee & Gemmell, 1972). 
In this context,coriander is regularly used in oriental cuisine and is 
particularly rich in linalool. Adaptation on chronic exposure with 
subsequent enhanced ability to metabolise cyclamate to cyclohexylamine 
has been reported (Kojima and Ichibagase, 1966) and the interindividual 
differences in linalool metabolism may be a manifestation of a 
similar phenomenon.
It is noteworthy that, while rat caecal microflora and the 
faecal microflora of the human non-user of spices produced mainly 
reduction products with tetrahydrolinalool predominating, mouse and 
sheep only effected reduction as far as dihydrolinalool while the cow 
and the spice-user produced no detectable reduction products. Mice 
have previously been reported to be less effective than rats in reducing 
azo compounds (Walker et al., 1970) and it was thought that this may 
result from differences in the redox potential generated by the gut 
flora. From the current study, ruminants,mouse and the spice-user 
were only poorly able to reduce linalool and this probably reflects 
differences in gut populations. It was noted above that weaning 
caused a change from essentially aerobic or facultative populations to 
anaerobic populations in which Bacteroides, Bifidibacteria and 
Fusobacteria predominate and it is possible that the ingestion of
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essential oils by the spice-user was having a selective bactericidal 
effect on these fastidious anaerobes. As a consequence, the symbiotic 
equilibrium would be shifted towards the facultative and aerobic 
organisms with a raising of the redox potential in the lumen. In this 
context it is noteworthy that only in those species in which reduction 
products of linalool were not detected did the unidentified carboxylic 
acid (metabolite J),produced by an oxidative route, appear. Further 
studies on the effects of essential oils on intestinal microflora 
and vice versa, are obviously indicated.
The fact that radioactivity from llfC-linalool was excreted to the 
extent of about 97% in 72h, mainly in the first 48h, suggests that there 
is unlikely to be a problem of tissue accummulation at the normal levels 
ingested in foods. Since linalool was observed to enter pathways of 
intermediary-metabolism with the formation of 14C02 and ll|C-urea, the 
residual activity in the tissues at the end of 72h may well be present 
as normal tissue components. However, when one considers the weight 
of individual organs and tissues, the residual activity was concentrated 
to some extent in the gut, liver and kidney and this may arise from the 
observed enterohepatic circulation of linalool, and its metabolites, 
delaying excretion with some activity entering the urine on each turn 
of the enterohepatic cycle.
The dose levels used in the in vivo studies (500 mg/kg) were very 
much higher than are likely to be ingested in foods and consequently 
the demands on the detoxicating pathways vis a vis pathways of 
intermediary metabolism may have been increased. At lower dose levels 
comparable to those ingested in foods, intermediary metabolism may 
predominate and it would be of interest to study the effects of dose 
level on the relative proportions of the metabolites produced.
Since most of the urinary and biliary metabolites of linalool 
were.conjugated with glucuronic acid, the importance of this Phase II 
detoxication mechanism is emphasized. It was perhaps not surprising, 
therefore, to find that repeated dosing with linalool had a more 
rapid and marked effect in increasing the activity of glucuronyl 
transferase than on the other enzymes studied. This increase in 
hepatic glucuronyl transferase activity with, later, an increase also 
in intestinal mucosal glucuronyl transferase activity, might therefore 
be considered as an adaptive response. In the normal individual receiving 
linalool in the diet at customary levels, this detoxication mechanism 
is. probably quite adequate but it is well known that in neonatal 
animals and in certain strains and species (e.g.Gunn rat; cat) 
glucuronyl transferase activity is depressed (Parke, 1968). In these 
cases, toxic effects might occur with linalool due to competition 
with endogenous substrates like bilirubin resulting in hyperbilirubinaemia 
and icterus. Similar considerations apply to individuals with impaired 
liver function due to disease, alcoholism etc., and further work on the 
potential of linalool to cause injury in these cases would be justified. 
The Gunn rat might be a useful experimental model in this sort of work.
The relative activities of hepatic and intestinal glucuronyl transferase 
suggest that conjugation in the intestine is unlikely to be adequate 
fo.r the complete detoxication of linalool when hepatic activity is 
depressed.
While the involvement of glucuronyl transferase in conjugating 
linalool and an adaptive increase in this enzyme was not unexpected, 
it was perhaps more surprising to find that linalool also had an effect 
on the Phase 1 microsomal mixed function oxidase system. As linalool 
is already oxygenated it would not be expected that further oxidative 
detoxication mechanisms need operate. This apparent anomaly was
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explained by the observation that linalool interacts with cytochrome 
P450 to produce a reverse Type 1 binding spectrum and is a mild 
inhibitor of the activity of this enzyme with respect-to hydroxylation 
of biphenyl. A number of compounds displaying this type of spectral inter­
action are not substrates for cytochrome P450 (Schenkman et al., 1972)9 
but apparently cause conformational changes and non-competitive inhibition. 
Linalool has been shown to be a non-competitive inhibitor of biphenyl 4-hydroxy­
lase in the current study.
The biphasic response of cytochrome P450 and cytochrome b5 to 
repeated dosing with linalool was explained (Chapter 6) as initial 
inhibition with a somewhat delayed adaptive response. 'While the increase 
in these cytochromes may have little toxicological significance per se, 
a number of other considerations arise.
During the inhibitory phase when cytochrome P450 was depressed 
(days 3-7) the detoxicating activity with respect to other xenobiotics 
would be likely to be impaired, modifying their pharmacological and 
toxic effects. Thus Parke, et al. (1974) observed that single doses 
of ethoxyquin had an inhibitory effect on hexobarbital metabolism in 
rats with a dramatic increase in the sleeping time from 15 min to over 
8 h. whereas repeated dosing caused induction of hepatic enzymes and a 
slight reduction in sleeping time. Prior to the adaptation, then, 
the pharmacological activity of hexobarbital was enhanced and similar 
considerations apply to the inhibitory phase of the linalool induced 
changes. This raises questions concerning the not uncommon practice 
of using essential oils as pharmaceutical adjuvants where initially 
they may increase the pharmacological activity and toxicity of a drug 
and subsequently, in the adaptive phase, render it less effective.
Furthermore, some enzyme inducers like phenobarbital are claimed
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to potentiate the carcinogenicity of other compounds.such as 
N-fluorenylacetamide (Peranio et aL, 1971). This may result from 
an increased sensitivity to the carcinogenic effects when the liver is 
enlarging as a consequence of exposure to the enzyme inducer. In this 
context, prolonged exposure to linalool caused hepatomegaly with 
a transient increase in DNA on day 7. Hepatomegaly therefore appeared 
to result both from hyperplasia and cell hypertrophy and during the 
stage of increased mitotic activity, sensitivity to carcinogens may be 
enhanced. One cannot, therefore, merely discuss the observed changes 
as an adaptive response with no toxicological significance; consideration 
needs to be given to these other possible consequences. A study of the 
effects of co-administration of linalool and drugs or carcinogens might 
well be justified to determine the validity of these speculations.
One final point to emerge from this study is the possible effects 
of linalool in neonatal animals and man. It has already been mentioned 
that, due to the lower activity of the detoxicating enzymes in neonates, 
the toxicity of environmental chemicals may be increased. Conversely, 
the increase in the activity of the drug metabolising enzymes which 
accompanies weaning (Parke & Rahman, 1969) may result from exposure to 
dietary anutrients including essential oils. Weaning is also accompanied ' 
by dramatic changes in intestinal microflora so that at this stage of 
development considerable changes in patterns of metabolism both by 
mammalian and microbial mechanisms is to be expected. While changes in 
the former would usually result in improved detoxicating capacity, changes 
in the latter might lead to the production of different, more toxic, 
metabolites. In addition, the complication of enterohepatic circulation 
is likely to increase when conjugating activity in the liver and 
hydrolytic activity in the gut are increasing simultaneously.
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As far' as the toxicity studies of essential oils are concerned 
only the acute toxicity lias so far been reported in most cases. .The 
toxicologiccil implications including the biochemical and biological 
effects of the essential oils and their synthetic constituents in the 
GRAS list need to be investigated in view of thei? continued use in 
every day life, particularly in food.
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APPENDIX
Table 6-i Effect of chronic administration of Linalool on the
body weight of developing rats.
Days Body Weight (g) in Rats ’p' values
Controls Pretreated
0 78 + 1 75 + 2 ns
3 96 + i 88 + 2 ns
7 124 + 2 . 113+6 ns
14 190 + 4 187 + 1 ns
30 266 + 10 * 250 + 10 ns
64 324 + 10 369 jh 12 ns
Linalool was administered intragastrically to 28 days old. Wistar male rats 
as a 25% (^ /v) solution in propane 1,2-diol at a dose level of 500 mg/kg 
body weight. Controls and pretreated each consisted of four animals. Values 
given are the means _+ SEM.
"’ns1denotes 'p1 values are statistically non-significant.
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Table 6-ii Effect of chronic administration of Linalool of the
liver weight of developing rats.
Days Liver weight 
Controls
(g) in rats
Pretreated
*p’ values
0 2.9 +0.4 2.9 +0.4 ns
3 4.2 +0.4 3.7 +0.2 ns
7 5.2 + 0.7 5.0 +0.4 ns
. 14 8.1 + 0.4 9.0 + 0.3 ns
30 11.0+0.5 11.7 +0.8 ns
64 12.8 + 0.5 15.5 + 0.7 0.05
Linalool was administered intragastrically to 28 days .old Wistar male rats 
as a 251 (W/v) solution in propane 1,2-diol at a dose level of 500 mg/kg 
body weight. Controls and pretreated each consisted of four animals. Values 
given are the means _+ SEM.
n^s'1 denotes ’p’ values are statistically non-significant.
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Table 6-iii Effect of chronic administration of Linalool on the
relative liver weight of developing rats.
Days
.
Relative Liver weight (g) in rat
T p 1 values
Controls Preteated
0 4.11+0.7 4.11+0.7 ns
3 4.4 +0.3 4.22+0.3 ns
7 4.2 +0.4 4.4 +0.3 ns
14 4.3 +0.1 4.7 +0.2 ns
30 4.22+0.1 4.7 +0.0 ns
64 3.2 +0.2 4.1 + 0.0 0.05
Linalool was administered, intragastrically to 28 days old Wistar male rats 
as a 25% (w/v) solution in propane- l,2,*-diol at a dose level of 500 mg/kg 
body weight.
Controls and pretreated animals consisted for four animals.^
Values given are the means _+ SEM.
’ns’denotes 'p1 values are statistically non-significant.
Table 6-iv. Effects of chronic administration of Linalool on the
Biphenyl 4-hydroxylase activity of the developing
rats
Days
Biphenyl 4-hydroxylase activity 
(ymol/g liver/h) in rats ’p 1 values
Controls Pretreated
0 4.9+0/3 4.9 + 0.3 ns
3 4.5 +0.3 3.9 + 0.3 ns
7 3.6 + 0.1 4.0 +0.1 ns
14 3.9 +0.2 4.1 + 0.2 ns
30 3.5 + 0.0 3.7 + 0.1 ns
64 3.5 + 0.3 3.4 + 0.2 ns
•
Linalool was administered intragastrically to 28 days old Wistar male rats 
as a 25% (W/v) solution in propane. 1,2-diol at a dose level of 500 mg/kg 
body weight.
Controls and pretreated animals consisted of four animals.
Values given are the means _+ SEM.
f '’’ns'denotes fp* values are statistically non-significant.
Table 6-v Effect of chronic administration of Linalool on hepatic
'4-methylumbelliferone glucuronyltransferase activity
of developing rat
Days
4-Methylumbel1iferone glucuronyltransferase 
(pmol/g liv./hr) fp* values
Controls Preteated
0 34.7 + 3.2 34.2 + 3.1 ns
3 37 + 2 44 + 1.0 <0.02
7 35 + 2  • 45 + 2 < 0.01
14 35 + 2 64 + 3 < 0.001
30 37 +1 73 +1 . < 0.001
64 33 + 3 83 + 1 < 0.001
Linalool was administered intragastrically to 28 days old Wistar male rats 
as a 25% solution (w/v) in propane 1,2-diol at a dose level of 500 mg/kg 
body weight.
Controls and pretreated animals (tests) each- consisted of four animals. 
Values given are the means _+ SEM.
’ns’denotes the fp1 values are statistically non-significant.
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Table 6-vi Effect of chronic administration of Linalool on
4-methylumbellifcrone glucuronyl transferase activity 
(ymol/g liver/li) in the intestinal mucosa of developing
rats.
Days
.
4-Methylumbelliferone glucuronyltransferase 
(ymole/g liver/h)
*pf values
Controls Pretreated
0 4.6 + 0.3 4.6 +0.3 ns
. 3 4.3 +0.4 2.9 + 0.3 < 0.02
7 3.9 + 0.6 3.7 +0.5 ns
14 4.0 + 0.2 5.9 + 0.2 < 0.01
30 3.5 + 0.3 6.2 +0.4 < 0.001
Linalool was administered intragastrically to 2.8 days old Wistar male rats 
as a 25% solution (W/v) in propane 1,2-diol at a dose level of 500 mg/kg 
body weight.
Controls and pretreated animals (tests) each consisted of four animals. 
Values given are the means _+ SEM.
»ns»denotes the !p* values are statistically non-significant.
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Table. 6-vii Effect of chronic administration of Linalool on
alcohol dehydrogenase (ymol/100 mg protein/hr) 
of developing rats
■
Days
;
Alcohol dehydrogenase 
(ymol/100 mg protein) fp 1 values
Controls Pretreated
0 33.1 + 2.2 33.8 + 2.2 ns
3 34 . + 1 20 + 2 < 0.002
7 35 +1 45 + 1 < 0.001
14 38 + 6 42 +2 ns
30 35 + 1 37 + 1 ns
64 22 +1 21 +1 ns
Linalool was administered intragastrically to 28 days old Wistar male rats 
as a 25% solution (W/v) of propane 1,2-diol at a dose level of 500 mg/kg 
body weight. .
Controls and tests each consisted of four animals.
Values given are the means _+ SEM.
’ns’denotes the ’p* values are statistically non-significant.
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Table 6-viii Effect of chronic administration of Linalool on
105 jOQQ g Supernatant (soluble fraction) protein 
content of developing rats
'
Days
105,000 g Supernatant Protein, 
(mg/'g liver) ‘pf values
Controls Pretreated
0 68 + 4 68 + 4 ns
3 70 + 1 73 + 2 ns
7 69 + 1 73 + 1 ns
14 70 + 2 71 1 1 ns
30 79 + 4 75 + 2 ns
64 74 + 3 73 + 4 ns
Linalool was administered intragastrically to 28 days old Wistar male rats 
as a 25% solution (w/v) of propane 1,2-diol at a dose level of 500 mg/kg 
body weight.
Controls and tests each consisted of four animals.
Values given are the means +_ SEM.
’ns’denotes the Tp * values are statistically non-significant.
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Table 6-ix Effect of chronic administration of.Linalool on hepatic
cytochrome P-450 concentration of developing rats.
Cytochrome P-450 (nmole/g/liv.) in rats
Days Controls Pretreated ’p’ values
0 17.7+0.7 17.7 + 0.7 ns
3 20.8 + 0.9 25.6 + 1.4 ns
7 19.4 + 1.0 15.5 + 0.8 0.02
14 16.8+1.0 20.0+1.3 ns
30 22.2 + 2.1 34.0+1.5 0.01
64 19,8 + 1.1 29.5+1.0 0.01
Linalool was administered intragastrically to 28 days old Wistar male rats 
as a 25% solution (W/v) of propane 1,2-dioi at a dose level of 500 mg/kg 
body weight.
Controls and tests each consisted of four animals.
Values given are the means _+ SEM.
'ns’denotes the *p' values are statistically non-significant.
Table 6-x Effect of chronic administration of Linalool on
cytochrome bs content of developing rats.
Cytochrome b 5 (nmole/g liver) in rats
Days Control Pretreated 1p1 values
0 9.2 + 1.2 9.3 +1.0 ns
3 11.3+0.4 12.6 +0.1 ns
7 11.8 + 0.2 8.6 + 0.2 0.02 '
14 8.6 + 0.3 10.6 + 0.9 ns
30 11.2+1.2 16.5 + 0.3 0.01
64 9.44+ 0.6 16.1+0.8 0.002
Linalool was administered intragastrically to 28 days old Wistar male rats 
as a 25% solution (w/v) of propane 1,2-diol at a dose level of 500 mg/kg 
body weight.
Controls and tests each consisted of four animals.
Values given are the means +_ SEM.
ns’denotes the fpf values are statistically non-significant.
Table 6-xi Effect of chronic administration of Linalool on the
liver microsomal protein content of. developing rats.
Microsomal protein (mg/g liver) in rats.
Days Controls Pretreated
Tp 1 values
0 22.2+1.3 22.2+1.3 ns
3 24.5+1.5 26.5 + 0.3 ns
7 23.2+1.5 21.4 + 0.5 ns
14 19.8 + 0.3 20.8 + 2.3 ns
30 27.6 + 2.3 32.8 + 1.1 < 0.02
64
.
26.9 + 0.6 32.1 + 0.6 < 0.02
Linalool was administered intragastrically to 28 days old Wistar male rats 
as a 25% solution (w/v) of propane 1,2-diol at a dose level of 500 mg/kg 
body weight.
Controls and tests each consisted of four animals.
Values given are the means _+ SEM.
’ns’denotes the ’p’ values are statistically non-significant.
